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Abstract
Under optimum conditions, alumina ceramic-on-ceramic and cobalt chromium (CoCr)
metal-on-metal prostheses have low wear rates with the generation of predominately
nanoscale wear particles. Delayed type IV hypersensitivity reactions and
pseudotumours have been reported in patients with metal-on-metal prostheses. In vitro
studies have revealed that CoCr, and to a lesser extent, alumina wear particles induce
cytotoxic, genotoxic, and pro-inflammatory responses. Little is known about the
mechanism of how the wear particles induce toxic effects, in particular how particles
interact with the cell membrane. The aim of this study was to determine if CoCr and
alumina particles were able to damage the cell membrane with toxic consequences or
whether they passed through the membrane and exerted toxic effects intracellularly.
Cobalt chromium (mode size 40 – 49 nm) nanoscale particles were generated using a
pin-on-plate tribometer and compared against commercially available micron sized
CoCr (mode size 2 – 3 μm) particles. Micron sized alumina (mode size 400 – 450 nm)
particles were isolated via filtration methods and nanoscale alumina (mode size 30 –
39 nm) particles were obtained from a commercially available source. All particle
stocks were characterised using TEM, EDX, and compared against the published
literature. The effect of the particles on the integrity of a model membrane was
assessed using vesicle leakage assays. None of the particle types tested induced
extensive vesicle leakage, even in the presence of 10% (v/v) serum, or with isolated
membrane proteins incorporated into the lipid vesicles. Particle binding to a solid
supported bilayer lipid membrane (sBLM) was assessed using quartz crystal
microbalance with dissipation (QCM-D) methods. Weak interactions with the
membrane were observed by an increase in the dissipation measurements. In the
presence of serum and with isolated primary fibroblast membrane proteins within the
sBLM, nanoscale and micron sized alumina particles bound to the membrane at
particle concentrations of 10 and 100 μg.ml-1. However, this did not occur for the
nanoscale and micron sized CoCr particles. These results demonstrated that the
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formation of a protein corona and the presence of membrane proteins are critical for
alumina particle binding to a model membrane system. However, membrane binding
does not necessarily correlate to particle toxicity. Further experiments, such as
investigating if the particles are actively taken up by the cells, is required to understand
the interaction of nanoscale a micron sized CoCr particles with the cell membrane.
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Chapter 1
Introduction
1.1 Introduction
Total hip replacements (THRs) have been used reliably since the 1960s to reduce pain
and improve mobility in patients with diseased joints, such as rheumatoid arthritis and
osteoarthritis (Charnley and Cupic 1973; Caton and Prudhon 2011). Hip prostheses
consist of a head and stem component, which replaces the natural femoral head and
the acetabular cup of the pelvis (Figure 1.1) (Charnley and Cupic 1973). The continued
success of THRs led to over 83,000 primary hip prostheses being implanted in England
and Wales in 2014 (NJR 2015). Materials commonly used as bearing surfaces include
ultra-high molecular weight polyethylene (UHMWPE), cobalt-chromium (CoCr), and
alumina (Al2O3) -based ceramics. The cobalt chromium alloy consists of predominately
cobalt with chromium and molybdenum. Alumina matrix composites (AMCs) have also
been developed and include alumina toughened zirconia (ATZ) and zirconia toughened
alumina (ZTA) (Isaac et al. 2006).
The majority of THRs are based upon the design of Sir John Charnley and consist of a
low friction UHMWPE acetabular cup articulating against a metal or ceramic femoral
head. The survivorship of the Charnley prosthesis has been excellent, with a 92%
survival rate after 9 – 10 years, with some implants surviving up to 25 years (Charnley
and Cupic 1973; Caton and Prudhon 2011). However, the performance in younger,
more active patients has been reported to be less successful, with a reduction in the
survival rate to 65% after 13.8 years in patients younger than 21 years (Bessette et al.
2003).
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Figure 1.1 – Diagram of the main components of a total hip replacement
The early failure of THRs was partly attributed to UHMWPE wear particles generated
and the subsequent biological reaction to them. UHMWPE wear particles have been
associated with osteolysis, leading to aseptic loosening (Ingham and Fisher 2000).
Osteolysis is proposed to be caused by the engulfment of the UHMWPE wear particles
by surrounding macrophages, leading to frustrated phagocytosis and the release of
inflammatory mediators. These signals can impact on the remodelling of the
surrounding bone and can promote bone resorption (Ingham and Fisher 2000; Ingham
and Fisher 2005). Once aseptic loosening is extensive enough to cause significant pain
to the patient, then revision surgery is required (Holding et al. 2006). The high
incidence of osteolysis of 24% for conventional UHMWPE-on-metal THR in patients
less than 55 years old, five years after implantation, led to the development of
alternative bearing surfaces in order to minimise wear (Mall et al. 2011).  An increase in
the popularity of hard-on-hard bearings occurred during the 1990s, such as the second
generation metal-on-metal cobalt-chromium (Co-Cr) and alumina or zirconia (ZrO2)
based ceramic-on-ceramic THRs and hip resurfacing implants (Figure 1.2A&B) (Rieker
et al. 1998; D'Antonio et al. 2012).
Large diameter metal-on-metal THRs and hip resurfacing bearings were introduced
more recently to theoretically promote lubrication and hence reduce wear (McMinn
2012). Metal-on-metal hip resurfacing implants have large diameter femoral
components (>36 mm) with a redesigned, shortened, femoral stem, thus preserving
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patient bone stock (McMinn 2012). Moreover, it was thought that these types of
bearings would improve joint mobility, such as range of motion and the reduce risk of
dislocation, and therefore were marketed as an attractive alternative for younger
patients (McMinn 2012).
Figure 1.2 – Hard-on-hard total hip replacement bearings – (A) Ceramic-on-ceramic
(zirconia toughened alumina (ZTA) composite) implant. (B) Metal-on-metal hip resurfacing
implant.
Recent reports have shown that large diameter CoCr bearings, particularly hip
resurfacing implants, are susceptible to accelerated wear (Langton et al. 2011). It is
thought that the suboptimal surgical implantation causes edge loading and disruption of
the lubrication regime (Fisher 2011). Biological consequences, such as
pseudotumours, hypersensitivity reactions, and necrosis have been reported in patients
with metal-on-metal bearings and have been associated with the CoCr wear particles
and ions generated (Willert et al. 2005; Pandit et al. 2008; Natu et al. 2012). This most
notably led to the voluntary removal of the hip resurfacing implant, Acetabular Surface
Replacement (ASR) by the manufacturer DePuy Synthes due to high early failure rates
of 12% at 5 years (Langton et al. 2011; NJR 2011). The Medical and Healthcare
Products Regulatory Agency (MHRA) have released a number of alerts on the use of
large diameter metal-on-metal bearings. In particular, the MHRA released an alert in
2010 stating that all patients with metal-on-metal implants should be monitored closely
5 years post-operatively (MHRA 2010). However, this has been superseded by the
MHRA alerts issued in 2012 and 2015 recommending that all patients with metal-on-
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metal bearings should be monitored annually for the lifetime of the bearing and the use
of metal-on-metal prostheses should be severely limited (MHRA 2012; MHRA 2015).
Following the concerns surrounding metal-on-metal THRs, the number of ceramic-on-
ceramic bearings has risen, from 21% of all uncemented THRs in 2003 to 45% in 2011
in England and Wales (NJR 2015). This is due to metal-on-metal THRs often being
replaced with ceramic bearings alongside UHWMPE-on-metal or UHWMPE–on-
ceramic THRs in England and Wales (NJR 2015). However, ceramic-on-ceramic THRs
are less popular in the USA, particularly following the poor longevity of the Mittelmeier
prosthesis (Smith & Nephew) (Berry & Lieberman 2012). Historically ceramic-on-
ceramic bearings have also been linked with incidences of squeaking or catastrophic
failure of the implant (Jarrett et al. 2009; D'Antonio et al. 2012). Nevertheless, modern
ceramic-on-ceramic THRs are rarely associated with osteolysis or other notable
adverse tissue reactions (Niche et al. 2006; Amanatullah et al. 2011).
In vitro cellular studies have demonstrated that CoCr wear particles and ions can
induce cytotoxic, genotoxic and inflammatory effects (Germain et al. 2003; Brown et al.
2006). However, these studies have provided limited information on the precise
mechanism of how CoCr wear particles can cause larger scale problems in patients. In
particular, little is known about how the particles interact with the cell membrane and
subsequent internalisation of the particles. This is especially important as particle entry
mechanisms can dictate the subsequent biological consequences of the particles
(Canton and Battaglia 2012). Whilst alumina- based ceramic THRs are relatively inert,
there are very limited studies on the internalisation and subsequent effects of alumina
wear particles (Hashimoto and Imazato 2015). Therefore more research is required to
gain a deeper understanding of how wear particles interact with the cell plasma
membrane and how this can effect particle toxicity mechanisms.
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1.2 Wear
Excessive wear can lead to failure of the total joint replacement (TJR) and adverse
biological reactions to the generated wear particles (Fisher 1994; Stewart 2010). Five
modes of wear can occur within THRs, which are abrasive, adhesive, fatigue, erosive,
and corrosive (Affatato et al. 2008). During articulation of the THR bearing surfaces,
more than one mode of wear can occur at one time. For UHMWPE components, it is
proposed that fatigue and adhesion processes produce most of the wear debris (Fisher
et al. 1991). Accelerated wear has been reported for polyethylene-on-metal THRs
caused by third body wear. The third body wear debris, such as bone cement, can be
embedded in the UHMWPE cup and causes roughening of the metal femoral head and
subsequently increases asperity contact. Third body wear has also been reported for
highly cross-linked UHMWPE prostheses (Kubo et al. 2009). Corrosive wear is limited
to metallic materials, such as CoCr bearing surfaces, or metallic femoral stems and
taper junctions and is described in more detail in Section 1.2.2.1.
Investigating the wear mechanisms of different bearing couples is important in reducing
volumetric wear rates and hence survivability of the implant. In addition, the wear
mechanisms can influence particle morphology and size. Three modes of lubrication
theoretically exist within the THR environment and include boundary, mixed, and fluid-
film lubrication. Boundary lubrication occurs when there is asperity contact between the
two surfaces, whereas fluid lubrication is when the surfaces are separated by lubricant,
causing minimal or no asperity contact. As the name suggests, mixed lubrication is a
mixture of boundary and fluid lubrication (Jin et al. 2006). Prostheses comprised of
UHMWPE-on-metal operate towards a boundary lubrication regime whereas metal-on-
metal THRs have been reported to operate in the mixed lubrication regime, with the
potential to operate towards the fluid-film lubrication regime. Jin et al. (1997) proposed
the adapted lubrication theory, which stated that a reduction in wear would be observed
with larger diameter heads, with a small radial clearance and low surface roughness. In
hard-on-hard bearings, larger diameter heads cause an increase in the sliding distance
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and hence increase the sliding speeds, which promote lubrication. Ceramic-on-ceramic
THRs have been reported to operate under a mixed lubrication regime. However, due
to the hardness of ceramic-on-ceramic THRs, the bearing surfaces are very smooth
and therefore have minimal asperity contact and hence generate minimal wear under
optimal conditions (Vassiliou et al. 2007).
1.2.1.1 Malpositioning of total hip replacements and accelerated wear
Malpositioning occurs when the femoral head component is not centric to the
acetabular cup, causing head-to-cup edge contact. Rotational malpositioning of THRs
is associated with steep inclination angles, whilst translational malpositioning is caused
by the superior translation of the acetabular cup (Nevelos et al. 2000; Fisher 2011).
Head to acetabular cup contact has been of particular interest for ceramic-on-ceramic
and metal-on-metal implants as edge wear patterns have been observed on retrievals
(Nevelos et al. 2000; Langton et al. 2010).
1.2.2 Wear of metal-on-metal total hip replacements
Optimal implantation of metal-on-metal THRs was associated with lower wear rates in
comparison to UHMWPE-on-metal THRs. McKellop et al. (1996) reported average
wear rates from retrieved McKee Farrar, Ring and Müller metal-on-metal THRs of 1.2,
2.3 and 3 mm3 per year, respectively. Sieber et al. (1999) analysed the wear of 118
retreived metal-on-metal Metasul THRs and reported penetration rates of 5 µm3 per
year. Morlock et al. (2008) also revealed that retrieved metal-on-metal hip resurfacing
implants had a wear rate of less than 1 mm3 per year when no evidence edge loading
was detected. Simulator studies of metal-on-metal THRs, using two directions of
motion, that were out of phase, reproduced the wear scars and wear volumes of 1.23
mm3/ 106 cycles, which was comparable to retrieval studies (Firkins et al. 2001a; Tipper
et al. 2001).
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The wear of metal-on-metal THRs is characterised by two distinct phases, known as
the “running-in” phase, followed by the “steady-state” phase (Isaac et al. 2006). The
running in phase typically occurs during the first million cycles, with a wear rate of 2 – 3
mm3/ 106 cycles. Once the transition point of 0.5 million cycles is reached, the wear rate
is reduced and eventually falls to a steady state of less than 0.1 mm3/ 106 cycles
(Dowson et al. 2004).
More recently wear rates for metal-on-metal hip resurfacing implants and THRs with
large femoral head diameters (i.e. a diameter greater than 36 mm) have been reported
to be higher due to edge loading. This has been characterised by high ion levels in the
serum of patients with poorly functioning implants (Sampson and Hart 2012). Wear
rates of 11.02 mm3 per year have been reported for poorly functioning ASR™ implants,
which is significantly higher than well-functioning implants (Lord et al. 2011). A major
concern with the high wear rates is the dissemination of nanoscale wear particles from
their site of release to other parts of the body. Indeed CoCr wear particles have been
observed in the kidney, spleen, and distant lymph nodes (Case et al. 1994; Urban et al.
2004). Therefore there are concerns about the systemic effects of long-term exposure
to CoCr wear particles and released ions.
The high failure rate of large diameter metal-on-metal implants is thought to be due to a
number of factors, however rotational and translational malpositioning have been
implicated (Fisher 2011). In particular, the ASR™ implant was reported to have cup
coverage of only 160 degrees (Underwood et al. 2011). Truncated cup coverage
reduces the tolerance to rotational and translational malpositioning and edge contact,
and therefore there is an increase in contact stress and a disruption of the lubrication
(Fisher 2011). These factors are thought to be the main contributors to the high wear
rates observed for large diameter metallic bearings (Sariali et al. 2008; Sariali et al.
2009).
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Variable wear rates associated with failed metal-on-metal implants are thought to be
caused by factors other than acetabular cup angle alone (De Haan et al. 2008).
Translational malpositioning has also been implicated for metal-on-metal bearings,
which would elevate wear rates. Williams et al. (2013) revealed that the introduction of
translational malpositioning elevated the wear rates of 36 mm large head diameter
metal-on-metal THRs from 0.6 ± 0.18 mm3/106 cycles under standard simulator
conditions to 1.32 ± 0.91 mm3/106 cycles under adverse simulator conditions.
Furthermore Leslie et al. (2009) demonstrated a 17 fold increase in wear for metal-on-
metal hip resurfacing implants at a high acetabular cup angle of 55° when tested under
translational malpositioning conditions. Interestingly, these authors observed a greater
variation in the wear of the implants when positioned at higher cup angles in
comparison to standard conditions. In addition, Al-Hajjar et al. (2013b) also reported an
increase in wear of 28 mm and 36 mm diameter metal-on-metal THRs when
translational malpositioning was introduced alongside acetabular cup angles of 45° and
65°. In addition, the generation of a stripe wear corresponding to edge contact was
observed in these implants. However, whilst the introduction of translational
malpositioning increased the wear rates for the large head diameters of 36 mm, no
significant difference in wear was observed between the two inclination angles.
1.2.2.1 Corrosion and ion release
The long-term survivability of hip implants containing metal components is also
dependent on the resistance to corrosion (Yan et al. 2006). Metal corrosion can occur
at the bearing surface of metallic components, at the stem: cement interface and any
modular junctions of the stem component (Goldberg and Gilbert 2003). Most THRs
contain metallic components such as a femoral stem and taper. Therefore corrosive
wear can occur in all types of THRs, regardless of the composition of the THR bearing
surfaces. Alongside this, wear at the taper junction, which predominately produces
CoCr wear particles and ions, can occur. Retrieval studies have reported extensive
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taper fretting and corrosion both at the head-neck and cone-taper interface, which is
currently an increasing area of research within the field of THR wear (Langton et al.
2011; Cooper et al. 2012; Meyer et al. 2012; Rehmer et al. 2012; Baxmann et al.
2013). Furthermore, the metal wear particles generated can subsequently corrode,
releasing metal ions (Billi and Campbell 2010).
Corrosion occurs during the simultaneous action of mechanical wear and corrosion on
the metal surface (Virtanen et al. 2008). In hip implants, CoCr bearing surfaces are
protected from corrosion by the formation of a chromium oxide (CrO3) rich passive film.
This passive film makes the CoCr alloy highly resistant to corrosion (Yan et al. 2006).
During tribocorrosion of metal-on-metal implants, the mechanical action of the bearings
articulating against one another can cause a localised breakdown of the passive film.
This causes the surface to be exposed to the corrosive biological fluids and a shift from
a passive to an active regime occurs (Yan et al. 2006). However, re-passivation can
occur, which restores the passive film. Nevertheless, the constant breakdown and re-
passivation of the film can lead to accelerated corrosion (Metikos-Hukovic and Babic
2007). Whilst the presence of proteins has been reported to promote lubrication and
wear in metal-on-metal bearings, proteins can increase corrosion by the dissolution of
the Cr ions causing the ions to form complexes with the proteins (Yan et al. 2006).
1.2.2.1.1 Chromium ion release from bearing surfaces
Chromium ions can exist as Cr(VI) and Cr (III),whereby Cr(VI) can undergo two
mechanisms of reduction to Cr(III) as shown in Figure 1.3 (O'Brien 2003). The
reduction process also causes the formation of radicals and as such Cr(VI) is classed
as a group one human carcinogen by the International Agency for Research on Cancer
(IARC) (O'Brien 2003).
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Figure 1.3 – Intracellular reduction of chromium ions. (O'Brien 2003)
Merritt and Brown (1995) reported high levels of chromium ions in red blood cells
(RBCs) in comparison to serum samples from patients with metal-on-metal THRs or
CoCr alloy containing knee prostheses. The authors hypothesised that Cr(VI) was the
most likely ion to be released from the bearing surfaces of metal-on-metal THRs in
comparison to Cr(III). However, Walter et al. (2008) compared the chromium ion levels
of whole blood, serum, plasma and RBCs from patients with well-functioning
Birmingham hip resurfacing implants. Higher concentrations of chromium ions were
measured in the serum and plasma fractions in comparison to the RBC fraction and the
authors proposed that Cr(III) rather than Cr(VI) was released from the bearing surface.
In vitro spiking of blood with Cr(VI) and Cr (III) ions revealed that Cr(III) accumulated in
the serum fraction whereas Cr(VI) was detected in RBCs (Sidaginamale et al. 2013).
Hart et al. (2010) reported the presence of Cr(III) in periprosthetic tissues of patients
who had received metal-on-metal prostheses using synchroton x-ray analysis.
Chromium (VI) was not detected in any of the samples. Interestingly, no difference in
chromium ion species was detected across the four different types of metal-on-metal
implants used in this study.
1.2.3 Wear of ceramic-on-ceramic total hip replacements
High survivorship rates of 97% are reported or ceramic-on-ceramic THRs at 10 years
after implantation (D'Antonio et al. 2012). This is attributed to the low wear of the
bearing surfaces, with retrievals of alumina ceramic THRs typically generating
volumetric wear rates of less than 1 – 5 mm3 per year (Nevelos et al. 1999).
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Historically, ceramic-on-ceramic THRs have been associated with fractures, causing
catastrophic failure of the implant. A number of ceramic bearing materials have been
introduced to reduce the risk of fracture and this has included increasing the toughness
through the inclusion of zirconia within the ceramic composite. This has led to the
development of alumina toughened zirconia (ATZ) and zirconia toughened alumina
(ZTA) composites. In addition, the use of hot isostatic pressing (HIPed) of alumina
methods has been introduced to reduce the grain size and hence improve the
toughness of the material (Stewart et al. 2003; Stewart 2010). However, Tipper et al.
(2002) reported no significant difference in wear between 28 mm diameter non-HIPed
and HIPed ceramic-on-ceramic THRs. In contrast, alumina matrix composites (AMC)
THRs significantly improved the wear rates in comparison to HIPed alumina, following
the bedding in wear period (Stewart et al. 2003). Furthermore, ATZ have been reported
to produce 12 fold less wear (0.06 ± 0.004 mm3/106 cycles) than alumina-on-alumina
THRs (0.74 ± 1.73 mm3/106 cycles. The same study also revealed ZTA THRs
generated fivefold less wear (0.14 ± 0.1 mm3/106 cycles) in comparison to alumina-on-
alumina THRs (Al-Hajjar et al. 2013c).
Retrieval studies of ceramic-on-ceramic THRs revealed an elliptical stripe on the
femoral head and on the rim of the acetabular cup (Nevelos et al. 1999; Esposito et al.
2012). Fluoroscopy studies of patients with THRs revealed that during heel strike, the
femoral head translated superiorly, with the head coming into contact with the edge of
the cup, which occurred in 50% of patients tested (Lombardi et al. 2000). Nevelos et al.
(2000) reproduced the wear stripe observed in the retrieval studies via the introduction
of translational malpositioning conditions into hip simulator testing.
Simulator studies have demonstrated that translational malpositioning can significantly
increase ceramic-on-ceramic wear rates (Stewart et al. 2003; Williams et al. 2007; Al-
Hajjar et al. 2010; Al-Hajjar et al. 2013a). Al-Hajjar et al. (2010) reported an increase in
wear for AMC ceramic-on-ceramic prostheses, under translational malpositioning
conditions in comparison to standard gait conditions. However, increases in the cup
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inclination angle from 55º to 65º did not significantly affect the wear with measured
wear rates of 1.13 mm3/ 106 cycles and 1.1 mm3/ 106 cycles reported, respectively.
1.3 Wear Particle Characterisation
Particle characterisation in vivo and in vitro can be used to determine and predict the
biological responses to the wear debris in vivo. This is especially important as the
biological response to wear particles is largely dependent on particle size and volume
(Green et al. 1998).
1.3.1 Characterisation of cobalt-chromium wear particles
Wear particles from metal-on-metal THRs have been reported to be nanoscale in size
from both retrieval and simulator studies (Doorn et al. 1998; Firkins et al. 2001b; Brown
et al. 2007). Doorn et al. (1998) isolated CoCr wear particles from the periprosthetic
tissues of 13 patients undergoing revision THR surgery. The medians of the particle
sizes of the different samples ranged from 51 to 116 nm, with an average of 81 nm.
The particles were also observed to be round in morphology, with some shard-like
particles. Simulator studies have reported CoCr wear particles to be slightly smaller,
with a mean size of less than 40 nm, with no shard-like particles detected (Firkins et al.
2001b; Brown et al. 2007).
The discrepancies in particle size and morphology between studies are often caused
by the isolation method. Isolating CoCr wear particles from serum is particularly
challenging due to their small size and low wear volumes. Metallic particles have a
tendency to aggregate and also corrode, particularly at high temperatures and
aggressive pH levels (Catelas et al. 2001a). Moreover, alkaline and acidic digestion
protocols commonly employed in particle isolation have been reported to alter the
morphology, shape, and composition of CoCr wear particles (Catelas et al. 2001b).
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Particle preparation for TEM analysis has been shown to cause aggregation, thus
causing particle size inaccuracies (Firkins et al. 2001b). A number of isolation methods
have been developed, including Brown et al. (2007), which involved a multiple step
enzymatic digestion protocol. However, enzymatic digestion has been reported to
affect particle size and induce aggregation (Catelas et al. 2001a; Lu et al. 2012). Lu et
al. (2012) developed a freeze dry method, which removed most of the water from the
serum, followed by enzyme digestion. However, the method also involved repeated
centrifugation steps, which may lead to a particle loss. In addition, Billi et al. (2012)
optimised an isolation method involving an ultracentrifugation process, which deposits
the particles onto a silicon wafer. However, retrieval of the particles from the wafer is
not possible for further particle experiments.
Characterisation of CoCr wear particles generated under adverse conditions has
received increased attention due to the high early failure rates of metal-on-metal
bearings. Leslie et al. (2009) reported an increase in particle size under translational
malpositioning conditions. Under standard conditions, the mode particle size was 20 –
29 nm, but increased to 30 – 39 nm under translational malpositioning. However the
particle morphology was reported to be the same under both conditions. Xia et al.
(2011) reported larger (20 – 500 nm), needle shaped particles from periprosthetic
tissues from patients suffering from pseudotumours (section 1.5.1.2). In addition,
Goode et al. (2012) revealed a wide CoCr wear particle size distribution of a few
nanometres to 5 µm in length from periprosthetic tissues of a patient with a failed ASR
implant.
1.3.2 Characterisation of alumina ceramic wear particles
A limited number of studies have been published on the particle characterisation of
alumina ceramic wear particles from THRs. The low wear rates of ceramic-on-ceramic
wear particles means it is technically very difficult to isolate particles under normal wear
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conditions. Alumina ceramic wear particles from periprosthetic tissues were reported to
have a wide size range of 5 – 90 nm when visualised using TEM and 0.05 – 3.2 µm
size distribution when analysed using SEM (Hatton et al. 2002). It is thought that the
large size distribution was caused by the introduction of translational malpositioning.
Tipper et al. (2002) observed alumina wear particles generated from wear simulators,
under standard gait conditions, to be 2 – 27.5 nm in diameter when visualised by TEM.
However, when translational malpositioning conditions were introduced, the particle
diameters increased to 0.02 – 1 µm. These authors proposed that during standard gait
conditions, alumina wear particles were generated by relief wear, thus producing
smaller particles. When translational malpositioning occurred, the head component
came into contact with the rim of the cup and generated larger, irregular sized alumina
particles by grain fracture. This was further confirmed by Affatato et al. (2012), who
analysed the wear surface of 6 retrieved alumina ceramic-on-ceramic THRs by SEM,
13 years after implantation. The areas of high wear on the femoral head and acetabular
cup were characterised by large granular, pitted surfaces. However, in unworn areas,
the surface appears to be smooth, with minimal defects.
1.4 Biocompatibility of total hip replacements
Numerous studies have evaluated the biocompatibility of alumina and CoCr wear
particles including adverse reactions reported in patients with THRs and in vitro cell
studies on the toxic potential of the particles. Alumina and CoCr wear particles were
hypothesised to induce fewer incidences of osteolysis than conventional UHMWPE due
to the low wear rates and the wear particles produced being predominantly nanoscale
in size. The implication was that the particles were outside the “critical size range” of
0.3 to 10 µm, and therefore would not promote osteolysis (Green et al. 1998).
Osteolysis is largely associated with the engulfment of UHMWPE wear particles by
macrophages, causing frustrated phagocytosis and the release of pro-inflammatory
mediators, such as tumour necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), IL-6,
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IL-8, monocyte chemo-attractant protein (MCP)-1, prostaglandin E-2 (PGE2), and
macrophage inflammatory protein (MIP)-1 (Green et al. 1998; Ingham and Fisher 2000;
Ingham and Fisher 2005; Liu et al. 2015; Singh et al. 2015). The secreted pro-
inflammatory mediators are able to influence osteoclast differentiation and promote
bone-resorbing activity and osteolysis (Fuller et al. 2002; Peng et al. 2015).
Nevertheless, alumina, and in particular CoCr, wear particles have been associated
with alternative biological reactions which are discussed in the following sections.
1.4.1 Patient reported effects of ceramic-on-ceramic bearings
In comparison to UHWMPE-on-metal and metal-on-metal THRs, ceramic-on-ceramic
prostheses have not been as strongly associated with adverse effects in patients.
Incidences of aseptic loosening with ceramic-on-ceramic were coupled with high wear
rates caused by severe malpositioning of the implant (D’Antonio et al. 2014). In
particular the Mittelmeier THR was associated with loosening of the implant and an
absence of osteointegration, leading to poor survivorship (Garcia-Cimbrelo et al. 1996).
Ceramic-on-ceramic THRs have also been associated with catastrophic failure of the
implant due to the brittle nature of the material. However, improvements of the purity,
density, reduction in porosity and grain size of the ceramic components have improved
the incidence of fracture (Hannouche et al. 2003). Another complication has been the
detection of an audible squeak in less than 1 – 4.2% of patients with a ceramic-on-
ceramic THR. The possible causes of this phenomenon as not clear, but THR design,
malpositioning and altered lubrication have been proposed (D’Antonio et al. 2014;
Owen et al. 2014).
Chapter 1
16
1.4.2 Patient reported effects of CoCr alloy metal-on-metal bearings
Patient complications associated with metal-on-metal and ceramic-on-ceramic bearings
have been reported. Of particular concern have been the reported complications
associated with large diameter metal-on-metal bearings. These include
pseudotumours, delayed type IV hypersensitivity type reactions, and necrosis of the
periprosthetic tissues (Pandit et al. 2008; Hart et al. 2009; Natu et al. 2012). However,
the nomenclature of these tissue responses varies between studies and may also be
referred as metallois, adverse local tissue reaction (ALTR), adverse reaction to metal
debris (ARMD) and acute lymphocytic vasculitis and associated lesions (ALVAL),
making direct comparisons between studies difficult (Gill et al. 2012). For clarification
the terms pseudotumour, delayed type IV hypersensitivity reactions and ALVAL are
only used to describe adverse reactions to metal-on-metal implants.
1.4.2.1 Cobalt and chromium ion levels in patients with metal-on-metal
prostheses
The presence of elevated levels of Co and Cr ions in the blood, urine, and organs of
patients with metal-on-metal THRs have been reported (Sargeant and Goswami 2007;
Walter et al. 2008). Elevated Co and Cr ion levels have been reported in the joint fluid
of patients with metal-on-metal implants (De Smet et al. 2008; Langton et al. 2010).
Langton et al. (2010) reported a large range of elevated Cr (~1000 µg/L to 46,000 µg/L)
and Co (~1000 µg/L to 10,000 µg/L) levels in patients. However, De Smet et al. (2008)
demonstrated a correlation between blood serum Co and Cr ion concentrations and hip
joint fluid ion concentrations. In addition, serum levels have been shown to increase as
the inclination angle of metal resurfacing implants increases (De Haan et al. 2008).
Sidaginamale et al. (2013) reported that Co ion concentrations equal or greater than
5.04 μg/L from whole blood samples demonstrated 93% sensitivity and 96% specificity
from abnormal wear (greater than 3mm3 per year).These results suggested that serum
Co and Cr ion concentrations are an indicator of implant wear. Consequently this led to
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the MHRA guidelines stating 7 µg/L as the threshold level for acceptable Co and Cr
blood ion levels. However, large variations in whole blood and serum ion
concentrations have been reported (Davda et al. 2011; Renner et al. 2016). This is
further compounded by the contamination of samples such as collecting the blood
sample in the incorrect blood sample tube (Moyer & Sierra 2011). Ion concentrations
lower than the threshold set by the MHRA have been associated with delayed type IV
hypersensitivity reactions and pseudotumours (Hallab et al. 2010; Sampson and Hart
2012). Ion concentrations of either Cr or Co at 4 µg/L have been reported to have 90%
specificity for detecting adverse reactions to metal-on-metal prostheses (Haddad et al.
2011). This indicates that patient-specific responses to the Co and Cr ions may occur,
which vary across individuals, rather than a biological effect occurring when a threshold
level of metal ions has been achieved.
1.4.2.2 Pseudotumours
Pseudotumours are described as a mass or a fluid-filled cyst around the hip prosthesis
(Engh et al. 2006; Engh Jr et al. 2010). This phenomenon is a major concern with large
diameter metal-on-metal bearings. Pandit et al. (2008) were the first to use the term
pseudotumour associated with metal-on-metal replacements after observing soft tissue
masses, which were extensively necrotic and infiltrated with lymphocytes in 17 female
patients. Furthermore, large volumes of metal wear debris were observed in the
necrotic tissue, thus suggesting an association with metal wear particles. Clinical
presentation of pseudotumours is varied and pain around the hip can range from slight
discomfort to functional impairment. The board spectrum of pseudotumour
characteristics has led to the development of a classification system using MRI, as
explained in Table 1.1 (Hauptfleisch et al. 2012). The highly invasive nature of
pseudotumours has potential catastrophic consequences with nerve damage,
dislocation, and extensive soft tissue damage being reported (Grammatopoulos et al.
2009; van der Veen et al. 2015).
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Table 1.1 – Classification system for pseudotumours. Magnetic resonance  imaging is used
to classify pseudotumours, ranging from thin walled cysts (type 1) to predominantly solid
masses which have minimal cyst lesions (type 3) (Hauptfleisch et al. 2012).
Classification Description
1 Thin-walled cystic mass (cyst wall <3 mm)
2 Thick-walled cystic mass (cyst wall >3mm)
3 Mostly consists of a solid mass
Histological analysis of pseudotumours demonstrated an association with metal wear
particles (Pandit et al. 2008). Indeed a correlation between high wear levels, elevated
blood Co and Cr levels and pseudotumour prevalence has been reported (Hart et al.
2009; Langton et al. 2010; Davda et al. 2011). In contrast, pseudotumours have also
been reported in patients with low wear. Matties et al. (2012) found that 40% of patients
with a pseudotumour had wear rates less than 5 µm per year in a cohort of 103
patients with metal-on-metal hips. In addition, 40% of patients with pseudotumours had
Co and Cr blood levels less than the threshold limit of 7 µg/L. Interestingly the authors
reported no association between adverse cup positioning and pseudotumour
prevalence. In addition to this, asymptomatic patients with pseudotumours have been
observed (Kwon et al. 2011; Hart et al. 2012).
1.4.2.3 Hypersensitivity reaction and aseptic lymphocytic vasculitis-associated
lesions
Incidences of patients suffering from a painful hip, shortly after implantation of a metal-
on-metal bearing have been reported in the absence of infection (Blumenfeld et al.
2010). Extensive surface ulceration and the presence of wear debris within the
periprosthetic tissue have been observed (Davies et al. 2005; Blumenfeld et al. 2010).
This suggests that an immunological response, more specifically a delayed type IV
hypersensitivity reaction may be associated with early implant failure. Type IV
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hypersensitivity is characterised by a delayed reaction (1 – 3 days) including T
lymphocytes which are activated by antigen presenting cells (Janeway et al. 2005).
Hypersensitivity reactions are thought to be due to the wear particles or the released
ions forming immunocomplexes with native proteins, which subsequently initiate an
immune response. The most common reported metal sensitisation is to nickel. The
next most potent allergens are cobalt and chromium, whereby chromium is found to
show cross reactivity with cobalt and nickel (Hallab et al. 2010). The frequency of
hypersensitivity reactions in failed metal-on-metal implants is low and ranges from 0.3
– 1.0% (Engh Jr et al. 2010).
1.4.2.3.1 Histological evidence for hypersensitivity reactions
Willert et al. (2005) observed lymphocyte infiltration, occasionally with plasma cells, in
the periprosthetic tissues of 19 patients with suspected hypersensitivity reactions. The
lymphocyte infiltration was found to be distinctly different between the different layers of
the tissue, whereby in the inner layer of the neocapsule, the lymphocyte infiltration was
diffusely distributed. In contrast, in the deeper intermediate vascular layers, the
lymphocytes surrounded post-capillary venules walls. High endothelial venules (a
capillary venous swelling to enable lymphocytes in the blood to enter the lymph nodes)
were also detected. The differences in lymphocyte infiltration in the deeper tissue
layers was also observed by Natu et al. (2012) and Davies et al. (2005). However,
these studies also observed the presence of plasma cells, B cells, and fibrin exudation,
which are not characteristic of a type IV hypersensitivity reaction. Nevertheless, Willert
et al. (2005) hypothesised that a form of hypersensitivity reaction was likely to be
occurring, as patients who received another metal implant following early failure of the
primary implant did not report any alleviation of symptoms. In contrast, the patients who
received a polyethylene-on-metal or polyethylene-on-ceramic implant reported
symptoms had been relieved. The term aseptic lymphocytic vasculitis-associated
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lesions (ALVAL) is also used extensively to described this form of immunological
reaction.
1.4.2.3.2 Potential mechanisms of delayed type IV hypersensitivity reactions
and pseudotumours
The pathogenesis of delayed type IV hypersensitivity reactions and pseudotumours
has been of much debate. In vitro experiments have demonstrated CoCr wear particles
and associated ions can promote cytokine release, which includes interleukin-6 (IL-6),
IL-8, and tumour necrosis factor-α (TNF-α) as shown in Table 1.2 (Granchi et al. 1999;
Trindade et al. 2001; Masui et al. 2005; Papageorgiou et al. 2007; Kaufman et al. 2008;
Dalal et al. 2012; Rose et al. 2012; Posada et al. 2014; Pearson et al. 2015; Posada et
al. 2015b). However, there is no clear consensus on the cytokines CoCr wear particles
can induce in cells, in particular TNF-α, which have been associated with inducing
inflammatory reactions. CoCr particles have been reported to induce TNF-α release in
osteoblasts, human macrophages, U937 histiocytes and peripheral blood mononuclear
cell (PBMNCs) (Granchi et al. 1999; Kaufman et al. 2008; Dalal et al. 2012; Rose et al.
2012; Posada et al. 2015a).
The conflicting outcomes of the studies may be caused by a number of factors,
including cell specificity. Dalal et al. (2012) demonstrated that osteoblast cells were
more sensitive to CoCr particles in comparison to macrophages and fibroblasts.
Furthermore the inconsistencies can be caused by use of large particle sizes, thus
particles are not clinically relevant and therefore the in vivo biological effects may be
underestimated (Trindade et al. 2001). Particle retrieval studies from failed prostheses
have revealed CoCr wear particles to be nanoscale in size (Doorn et al. 1998).
Nevertheless, some studies have used micron sized particles, as shown in Table 1.2 ,
which have been demonstrated to be less cytotoxic and induce a different
immunological response (Brown et al. 2013).
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It is hypothesised that these adverse reactions are linked with osteolysis and aseptic
loosening of metal THRs. Korovessis et al. (2006) hypothesised that CoCr wear debris
activates lymphocytes, which then release IL-2, IFN-γ, and RANKL, which can promote
osteoclast activity and inhibit osteoblasts. However, osteolysis is predominately a
macrophage response to wear particles, whereas histological analysis of ALVAL has
revealed a large lymphocyte response (Natu et al. 2012). Further, osteolysis is
associated with long-term failures of THRs, whereas delayed type IV hypersensitivity
reactions occur shortly after implantation. Therefore, the link between the
predominately adaptive immune response of hypersensitivity reactions with the
inflammatory response of osteolysis is unlikely.
Pseudotumour formation has also been linked with hypersensitivity reactions.
Mahendra et al. (2009) analysed tissue samples of pseudotumours and detected
plasma cells and perivascular lymphoid aggregates, which was similar to the
characteristic histology of hypersensitivity reactions. Campbell et al. (2010) analysed
periprosthetic tissue, collected during revision surgery of failed metal-on-metal bearings
and reported samples with high wear rates had a low ALVAL score. However, tissue
samples with low volumes of wear debris had a high ALVAL score and demonstrated
reactions similar to hypersensitivity reactions. These authors suggested that during
high wear scenarios, there is an increased risk of pseudotumours, whilst
hypersensitivity will predominate during low wear. However as previously described,
pseudotumours have been reported in patients where low wear rates have occurred.
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Table 1.2 – Summary of cytokine release studies after exposure to cobalt chromium wear
particles
Study Cell type
Cytokine
Expression
Particle
size
Particle/Ion
concentration
Assay
Granchi et
al.(1999)
Mononuclear
cells from
patients of
failed metal
THRs
↑ TNF-α, but
no increase in
IL-6 or GM-
CSF.
- Cr ions = 5.5
ng/ml
Co ions = 1 μg/ml
ELISA
Trindade
et
al.(2001)
Macrophages
and
lymphocytes
↑ IL-6 and
TNF-α
1 – 5 μm. Insufficient details
given of particle
concentration
ELISA
Masui et
al.(2005)
Murine
trabecular
bone model
No effect on
TNF-α
No effect on
RANKL/OPG
ratio.
1.8 ± 0.7
μm
Approximately 1 x
108 particles per
25.5 gram mouse
ELISA
Papageor
giou et
al.(2007)
Fibroblasts
No increase in
TNF-α, IL-6,
IL-10, TGF-β
29.5 ± 6.3
nm and
2.904 ±
0.064 μm
0.0005 – 5000
μm3/cell
ELISA
Kaufman
et
al.(2008)
Human
macrophages
↑ TNF-α, IL-6,
IL-1β, IL-8.
0.48 μm 853 particles per
macrophage
Protein
chip
analysis
Dalal et
al.(2012)
Macrophages
Fibroblasts
Osteoblasts
↑ IL-6, TNF-α,
IL-8, IL-1β.
1.1 μm 1:5 – 1:100
particles per cell
ELISA
Rose et
al.(2012)
Macrophages ↑ TNF-α
0.147 ±
0.37 μm
0.001 – 1 mg/100
μl
ELISA
Posada et
al. (2015a)
U937
histiocytes
↑ TNF-α, IL-6,
IFN-γ
150 nm –
6.5 μm
156.25 μg/cm2 ELISA
A proposal by Brown et al. (2013) suggested that ALVAL and pseudotumour reactions
are dependent upon on CoCr particle size. Micron sized (2.9 µm ± 1.06 µm) and
nanometre sized (32 nm ± 21 nm) CoCr particles were injected peri-articularly into the
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right knee of 6-8 week old mice. After 40 weeks, the knee tissues from the mice
exposed to the nanometre particles retained Cr but lost Co, suggesting that Co is lost
through corrosion. However, the ratio of Co:Cr for the micron sized particles remained
similar to the bulk metal material and loss of Co and Cr was thought to be caused by
the physical removal of the particles. Mononuclear cells isolated from the treated mice
also demonstrated significantly elevated expression of IL-2 and IFN-γ, but not IL-4 and
IL-10 when challenged with Co and Cr ions, at four weeks. These authors proposed
that the micron sized particles are physically removed, possibly by macrophages,
which caused the activation of lymphocytes. It is thought that a Th1 lymphocyte
response predominates as indicated by the cytokine expression profile, which was
indicative of a type IV hypersensitivity reaction. This work is particularly interesting as it
suggests that particle size, rather than wear volumes has a greater effect on the
immune response.
1.4.3 Adverse effects of ceramic-on-ceramic bearings in vivo
The biocompatibility of alumina or zirconia wear particles is relatively good due to the
low wear rates and inert nature of ceramics. Isolated incidences of osteolysis have
been reported for ceramic-on-ceramic THRs, however this was associated with severe
malpositioning, leading to high wear (D'Antonio et al. 2012). Nich et al. (2006)
observed no osteolysis in 41 patients who had received ceramic-on-ceramic implants,
after a 16 year follow-up study. Historically, failure of ceramic-on-ceramic THRs was
often associated with catastrophic fracture of the implant. Whilst, the hardness of
ceramics leads to minimal wear, their brittle nature means they are susceptible to
fracture. Modern cup designs have been designed to reduce the risk of fracture, for
example the use of metallic acetabular cup liners. Nevertheless, Amanatullah et al.
(2011) reported a fracture rate of 2.6% in 125 patients, 5 years after implantation of
ceramic-on-ceramic THRs. Furthermore, ceramic-on-ceramic THRs have been
associated with squeaking when the patient uses the affected hip joint, although the
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incidence of this is currently low with estimation ranging from 0.2 – 4.2% of ceramic-on-
ceramic THRs (Jarrett et al. 2009; Amanatullah et al. 2011; Owen et al. 2014).
Histological analysis of the periprosthetic tissues from patients with ceramic-on-ceramic
THRs revealed the presence of wear debris within the tissues (Hatton et al. 2002;
Shishido et al. 2006; Esposito et al. 2013). However, the characteristic adverse
responses of a high ALVAL score and necrosis observed in tissues surrounding metal-
on-metal THRs were not apparent. Although a low level macrophage and lymphocyte
infiltrate were observed in the periprosthetic tissues (Esposito et al. 2013). Similarly
Hatton et al. (2002) reported the presence of necrotic tissues as well as macrophages,
neutrophils and lymphocytes in periprosthetic tissues of patients who had received a
Mittelmeier ceramic-on-ceramic THR. Interestingly, in comparison to periprosthetic
tissue from patients undergoing revision surgery for Charnley prosthesis, significantly
more neutrophils were observed. However, as previously described, ceramic-on-
ceramic THRs are not as strongly associated with osteolysis as UHMWPE-on-metal
THRs (D’Antonio et al. 2014).
1.4.3.1 Immunological responses to alumina wear particles
The effect of alumina and zirconia wear particles on cells of the immune system in vitro
has also been investigated. Similar to the effect of CoCr wear particles, the expression
of cytokines after exposure to alumina or zirconia particles varies between studies as
described in Table 1.3. Indeed TNF-α expression in macrophages, osteoblasts and
fibroblasts was reported to increase in the presence of alumina wear particles (Dalal et
al. 2012). However, Granchi et al. (1999) reported no increase in TNF-α release in
osteoblasts challenged with 1 µm sized alumina wear particles at particles doses of
0.001 to 1 mg.ml-1. Interestingly Catelas et al. (1999) observed no difference in
cytokine production in osteoblasts cells challenged with 4.5 µm sized alumina particles
and 0.6 µm sized zirconia particles. The discrepancies between the results may be
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partially explained by the use of particles and particle doses which are not clinically
relevant. For instance, a number of studies have used large micron sized particles,
however ceramic simulator and ex vivo studies have demonstrated a bimodal
distribution of both nanoscale and micron sized particles (Hatton et al. 2002; Tipper et
al. 2002). In addition to this, the particle volume of 500 µm3 per cell required to induce
cytokine release from macrophages is relatively high and the wear rates of ceramic-on-
ceramic THRs are low, indicating that these volumes of particles are unlikely to occur in
vivo (Hatton et al. 2003).
Table 1.3 – Summary of cytokine release studies after exposure to alumina or zirconia
wear particles.
Study Cell type Particle
size
Particle
dose
Cytokine
Expression
Assay
Catelas et
al. (1999)
Macrophages Alumina
(up to 4.5
µm)
Zirconia
(up to 0.6
µm)
5 – 2500
particles per
macrophage
↑ TNF-α
No effect on IL-
1α and IL-1β
ELISA
Hatton et
al. (2003)
Human
peripheral
blood
mononuclear
phagocytes
Bimodal
alumina
particles (5
– 20 nm
and 0.2 –
10 µm)
Particle
volume of 1 –
500 µm3 per
cell
↑ TNF-α at high
concentrations
ELISA
Granchi et
al. (2004)
Osteoblast
and osteoclast
Alumina
(1.0 µm)
1, 0.1, 0.01,
and 0.001
mg/ml
No effect on
TNF-α, GM-
CSF. ↑ IL-6
ELISA
Kaufman et
al. (2008)
Human
macrophages
Alumina
0.23µm
Average
number of
particles per
cell: 3732
↑ TNF-α, IL-6,
IL-1β, IL-8.
Protein
chip
analysis
Dalal et al.
(2012)
Macrophages
Fibroblasts
Osteoblasts
0.5 – 0.9
µm
5:1 – 100:1
particle: cell
ratio
↑ IL-6, TNF-α,
IL-8, IL-1β.
ELISA
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1.4.4 The effect of alumina and cobalt chromium wear particles on
cell viability
In vitro studies have investigated the effect of alumina and CoCr wear particles on the
cell viability of various cell types which are detailed in this section.
1.4.4.1 The effect of alumina wear particles on cell viability
A number of studies have observed limited or no reduction in cell viability upon
exposure to alumina or zirconia wear particles (Catelas et al. 1999; Hatton et al. 2002;
Germain et al. 2003; Granchi et al. 2004; Gutwein and Webster 2004; Dalal et al. 2012;
Rose et al. 2012). Interestingly, no difference in the cytotoxic effects of alumina and
zirconia particles has been reported (Catelas et al. 1999). However, many of these
studies did not use clinically relevant particle sizes (Yoshida et al. 2003; Granchi et al.
2004; Gutwein and Webster 2004; Yamamoto et al. 2004). Germain et al. (2003)
demonstrated cell specific reactions to clinically relevant ceramic wear particles,
whereby no cell death was observed for a fibroblast cell line. However, in contrast, at
the highest particle volume of 50 µm3 per cell, a significant reduction in cell viability was
reported for a histiocyte cell line.
Particle size has been reported to affect the cytotoxic effects of alumina wear particles.
Germain et al. (2003) reported that clinically relevant wear particles, isolated from hip
simulators, induced more cell death in comparison to micron sized particles. However,
other studies reported that a reduction in particle size also led to a decrease in cell
death (Gutwein and Webster 2004; Dalal et al. 2012; Rose et al. 2012). Gutwein &
Webster (2004) hypothesised that the large particles used in these studies were more
likely to be phagocytosed, leading to macrophage activation and subsequent cell
death. As described in section 1.3.2, a bimodal particle distribution of nanoscale and
micron sized alumina particles have been retrieved from microseparation hip simulator
studies. Therefore the mechanism of particle uptake, which is partly dependent on
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particle size, may have an effect on cell viability. However, the conclusions from these
studies are limited as it is not known if interference of the particles with the assay
results was taken into consideration. Particles have been previously reported to have a
direct impact on biochemical assays, either by reducing or increasing assay output
readings, which may have caused the differences between the studies (Monteiro-
Riviere et al. 2009).
1.4.4.2 The effect of cobalt chromium wear particles on cell viability
Extensive necrosis in periprosthetic tissues has been reported in patients with metal-
on-metal implants. Numerous in vitro studies have demonstrated a reduction in cell
viability following exposure to CoCr wear particles as well as Co and Cr ions. Many
reports demonstrated that Co and Cr ions induced cytotoxic effects in a time and dose
dependent manner (Catelas et al. 2001c; Germain et al. 2003; Fleury et al. 2006;
Papageorgiou et al. 2007; Andrews et al. 2011; Posada et al. 2014; Posada et al.
2015b). However, direct comparisons between studies is complex, particularly if
different particle sizes, particle concentrations, assay choice and cell types are used.
This is further compounded if details of particle sizes or the exact concentration of
particles used in the published literature is unclear.
From the published literature particle size has been reported to affect CoCr wear
particle cytotoxicity, with micron particles predominantly inducing a lower reduction in
cell viability than nanoscale particles (Germain et al. 2003; Brown et al. 2006; Bhabra
et al. 2009; Brown et al. 2013). For example, Papageorgiou et al. (2007) reported that
nanoscale CoCr wear particles at a particle volume of 50 μm3 per cell or greater
significantly reduced cell viability after 24 hours, whilst micron sized CoCr particles only
induced a significant reduction after 4 days at the particle volume of 500 μm3per cell.
Another important parameter is the concentration of particles added to the cells in the
various in vitro studies. The range of particle concentrations varies greatly between
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studies. For instance, Yoshia et al. (2003) studied the effect of micron sized CoCr
particles on the viability of macrophages, however it was estimated from the method
details given that an approximate particle volume per cell was over a hundred times
greater than the highest particle volumes used by Germain et al. (2003), Brown et al.
(2006), and Papageorgiou et al. (2007). Considering the annual volumetric wear of a
well-positioned metal-on-metal THR is approximately 1 – 3 mm3, the particle doses
used in this study were not deemed clinically relevant.
Whilst cytotoxic effects of CoCr wear particles have been studied, limited studies have
investigated if CoCr wear particles Co and Cr ions can promote cell necrosis or
apoptosis (Granchi et al. 1998; Catelas et al. 2001c; Posada et al. 2014). Catelas et al.
(2001c) demonstrated that Co(II) and Cr(III) ions at a concentration of 10 and 500 ppm,
respectively induced apoptosis in J774 murine macrophages after 24 hours.
Interestingly Posada et al. (2014) demonstrated that nanoscale CoCr wear particles
cultured with Co ions caused a significant reduction in cell viability of U937 histiocytes
in comparison to Co ions alone. The authors hypothesised that in an acidic
environment, such as at the site of inflammation, ion dissolution is greater and cell
death could be intensified by the presence of both ions and particles.
1.4.5 Wear particles, oxidative stress and genotoxic effects
Alongside cell viability studies, the effect of alumina and CoCr wear particles on
oxidative stress and genotoxicity have been reported.
1.4.5.1 Alumina wear particles, oxidative stress and genotoxic effects
Alumina particles have been reported to induce genotoxic effects in vitro, however to a
lesser extent than CoCr particles (Parry et al. 2010; Tsaousi et al. 2010). Currently no
patient studies have reported any adverse effects from the genotoxic effects of alumina
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particles. Tsaousi et al. (2010) investigated the effects of alumina particles of different
size (0.2 – 2 µm) and alumina fibres (0.9 µm by 12 µm) on primary human fibroblasts
(HFBs). After 24 hours, alumina particles were reported to induce the increase of
micronucleated cells, with alumina fibres having the greatest effect. No double
stranded DNA breaks were detected. However, the authors used very large alumina
fibres, which have not been detected in alumina wear particle retrieval studies (Hatton
et al. 2002). Therefore the clinical relevance of these results is limited. Parry et al.
(2010) also reported single stranded breaks in the DNA of primary HFBs cultured with
alumina model particles across a placenta-like BeWo cell barrier. Furthermore, Petit et
al. (2005) reported no protein oxidation or nitration, which is an indicator of oxidative
stress of U937 histiocytes, of U937 histiocytes cultured with alumina model particles
using Western blot techniques.
1.4.5.2 Cobalt chromium wear particles, oxidative stress and genotoxic effects
Epidemiology studies on the carcinogenic effect of exposure to CoCr wear particles
and associated ions have been inconsistent. Gillespie et al. (1988) observed an
elevated incidence of haemopoietic and lymphatic cancers in patients 10 years post
implantation of a UHMWPE-on-metal implant. Furthermore, metal-on-metal THR
patient studies have reported an increase in lethal and non-lethal aneuploidy and
chromosomal translocations (Dunstan et al. 2008). In contrast, Visuri et al. (2010)
reported no increase in the risk of cancer in patients with THRs, including metal-on-
metal prostheses, compared to the general population 13 years using the Finnish
Arthroplasty Register and Finnish Cancer Registry. Similarly Lalmohamed et al. (2013)
studied the increased risk of cancer after implantation of a THR, including metal-on-
metal THRs and hip resurfacing implants in 11,450 patients in England. Using data
from the Clinical Practice Research Datalink, National Joint Registry and Hospital
Episode Statistics databases, between 2003 and 2010, no association between metal-
on-metal prostheses and an increased risk of cancer was reported.
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Cobalt chromium wear particles have been reported to induce DNA damage, whereby
nanoscale particles (30 nm) induced more DNA damage than micron sized particles
(2.9 μm) in fibroblast cells (Papageorgiou et al. 2007). Furthermore, Parry et al. (2010)
and Bhabra et al. (2009) reported nanoscale CoCr wear particles (30nm) could cause
indirect DNA damage of fibroblast cells across a cellular barrier of human trophoblast
choriocarcinoma cells (BeWo cells). The DNA damage consisted of DNA double
stranded breaks and chromosomal aberrations. It was proposed that the CoCr particles
induced damage to the BeWo cells either via mitochondrial damage, or hypoxia-like
induced conditions. Parry et al. (2010) reported that the threshold of 0.00036 mg/cm2 of
CoCr nanoscale wear particles were required to caused DNA damage across a
trophoblast cell barrier. The authors hypothesised that this particle dose was greater
than the wear volumes generated by well-functioning THRs,  but could be achieved in
malpositioned, high wearing THRs and as such, DNA damage could occur upon
exposure to CoCr nanoscale wear particle in vivo. However, the timescale used in this
study in comparison to the survivorship of metal-on-metal THRs make direct
comparisons complex.
In peripheral blood taken from patients with well-functioning metal-on-metal THRs, 1 –
4 ppb of Co and Cr ions have been measured. Interestingly, Parry et al. (2010)
reported that relatively low Cr (III) and Co(II) ions of 2 and 1.3 ppm, respectively could
cause single stranded, double stranded and alkaline labile sites across a trophoblast
cell barrier. In addition, studies have shown that Co ions can induce chromosomal
aberrations, causing single stranded breaks and crosslinking of DNA strands (Lloyd et
al. 1998; Baldwin et al. 2004; Witkiewicz-Kucharczyk and Bal 2006; Figgitt et al. 2010).
In addition to this, when Cr(VI) is reduced, Cr(III) is capable of binding to proteins,
amino acids, RNA and DNA (O'Brien 2003; Tkaczyk et al. 2009).
A number of studies have reported an association between oxidative stress and CoCr
wear particles and ions (Bagchi et al. 2002; Petit et al. 2005; Fleury et al. 2006; Petit et
al. 2006; Papageorgiou et al. 2007). Nanoscale and micron sized CoCr wear particles
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and Cr(VI) ions have been reported to induce radicals in cells, such as superoxide
anion radicals and hydroxyl radicals (Bagchi et al. 2002; Papageorgiou et al. 2007).
Papageorgiou et al. (2007) reported that micron sized CoCr particles (2.9 μm) induced
more oxidative stress than the nanoscale CoCr particles (30 nm) at a particle dose of
500 μm3 per cell after 24 hours. This suggests that CoCr particles of different sizes
potentially induce different mechanisms of DNA damage. In addition to generating
ROS, CoCr particles and ions can potentially cause oxidative stress by altering
antioxidant enzyme activity (Fleury et al. 2006; Tkaczyk et al. 2010). Furthermore,
Co(II) and Cr(III) ions can induce protein oxidation and nitration, which can cause a
reduction in protein function (Petit et al. 2005; Fleury et al. 2006; Petit et al. 2006). For
instance, Fleury et al. (2006) measured protein oxidation in a osteoblast cell line
cultured in the presence of 2.5 ppm of Co(II) ions and 25 ppm of Cr(III) ions after 72
hours, suggesting that Co ions are able to induce protein oxidation at low ion
concentrations.
1.5 The effect of wear particles from total hip replacements on
the cell plasma membrane
As previously described a wide range of the patient reported responses and cell
studies have demonstrated adverse effects to THR wear particles. However, the
interactions of wear particles with cells, and the factors influencing these, are not fully
understood (Gill et al. 2012). In particular interactions of wear particles with the plasma
membrane and possible toxic effects on the membrane are not known. A number of
reviews have called for studies into this area, as when the wear particles are released,
the first barrier the particle will encounter is the plasma cell membrane (Billi and
Campbell 2010; Simonsen et al. 2011; Gill et al. 2012).
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1.5.1 Internalisation of cobalt chromium and alumina wear particles
into cells
CoCr wear particles have been reported to be internalised within cells, including
macrophages in periprosthetic tissues from patients with metal-on-metal THRs and
therefore the particles must pass the plasma membrane (Willert et al. 1996; Davies et
al. 2005; Willert et al. 2005; Langton et al. 2010; Underwood et al. 2011; Goode et al.
2012; Matthies et al. 2012) A limited number of in vitro studies have also reported
internalisation of CoCr wear particles into fibroblasts and macrophages (Lewis et al.
2007; Papageorgiou et al. 2007; Behl et al. 2013). Papageorgiou et al. (2007)
demonstrated that both nanoscale and micron sized CoCr wear particles could be
internalised into primary HFBs. The nanoscale wear particles were observed within
vacuoles and dispersed randomly within the cytoplasm. In contrast, the micron sized
particles were located in the cytoplasm, surrounding the nucleus. Interestingly, the
micron-sized particles remained within the cells 5 days after exposure, whilst the CoCr
nanoparticles appeared to have been dissolved or corroded with large electron dense
deposits in the cell. The loss of cobalt was also reported for mice exposed to CoCr
nanoscale within the joint space after 40 weeks (Brown et al. 2013). Colognato et al.
(2008) also demonstrated the uptake of nanoscale Co particles and Co(II) ions in
human peripheral leukocytes. Whilst the Co nanoparticles were internalised, the
authors observed no change in Co2+ ion uptake over the baseline levels after 24 hours.
This is in contrast to reports, which suggest that Co2+ is more cytotoxic as it is able to
pass the cell membrane (Catelas et al. 1999; Andrews et al. 2011). At present there
are no reports on the internalisation of alumina wear particles from THRs into cells.
Hashimoto and Imazato (2015) observed model alumina particles within macrophages
using TEM techniques. However the authors failed to confirm the presence of the
particles using EDX analysis and therefore it is possible that the particles were actually
artefacts from the staining process used in sample preparation.
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1.5.1.1 Wear particle uptake and effects on cell viability
Currently there are few reports that investigate the interaction of CoCr and alumina
particles with the cell plasma membrane and the subsequent biocompatibility of the
wear particles. More specifically it is not known how particles bind to and are taken up
through the cell plasma membrane and how this consequently affects cell viability.
Lewis et al. (2007) reported micron sized CoCr model particles were internalised via
phagocytosis in fibroblast cells. However, fibroblasts are not professional phagocytes
and therefore it is not clear how relevant these findings were. Furthermore, Alexander
and Aaseth (1995) reported the internalisation of chromate into red blood cells and liver
cells via anionic-exchange carriers. The authors used an irreversible anion exchange
inhibitor, 4, 4’-diisothiocyanatostilbene-2, 2’-disulfonic acid to determine the uptake
mechanism. Nevertheless, the use of inhibitors is not always accurate as the inhibitors
can be cytotoxic and lack specificity (Soenen et al. 2011). Potnis et al. (2013) reported
the internalisation of CoCr particles into macrophages via the TLR-4 receptor using
more specific antibody inhibition and gene silencing techniques. Nonetheless the
authors used model particles, with an average size of 800 nm, which is much larger
than the wear particles characterised from THRs. Therefore, the effect of CoCr and
alumina wear particles on the cell membrane remains an area worthy of investigation.
1.5.2 Structure of the cell plasma membrane
The lipid bilayer of the plasma membrane is comprised of phospholipids and
cholesterol interspersed with membrane proteins (Voet et al. 2013). The lipid bilayer is
primarily formed from glycerophospholipids, also referred to as phosphoglycerides,
whereby the hydrophobic tails associate with each other and the polar, hydrophilic
head groups are exposed to the aqueous solvent (Voet et al. 2013). A second major
component of the plasma membrane is cholesterol, which has a fused ring structure
that provides rigidity and a polar hydroxyl group to give cholesterol its amphiphilic
properties. Cholesterol is a major component of the cell plasma membrane and the
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structure of the plasma membrane allows it to act as a selectively permeable barrier,
thus providing homeostasis within the cell. The main modes of entry of nanoparticles
into the cell, across the membrane barrier, are described in Table 1.4 (Canton and
Battaglia 2012).
Table 1.4 – Common modes of nanoparticle entry across the cell plasma membrane.
(Canton and Battaglia 2012)
Mode of entry Description
Phagocytosis Receptor mediated by the use of opsinins
Macropinocytotosis Non-specific engulfment of the extracellular
fluid by wave-like sheets of the plasma
membrane
Clathrin- mediated endocytosis Pits within membrane are coated with clathrin
to form clathrin coated vesicles
Caveolae- mediated endocytosis Membrane pits are coated with caveolae
Diffusion Passive process and cargo is not internalised
by vacuoles
1.5.3 The effect of particles on the cell plasma membrane within the
field of nanotoxicology
Whilst there are limited reports on the effect of wear particles from THRs on the plasma
membrane, there are a number of studies using manufactured nanoparticles such as
gold, silica and titanium dioxide. Therefore, studies on these can be used to help
predict the interactions of THR wear particles with the plasma membrane. The area of
nanotechnology is continually expanding, with applications in medicine, cosmetics, and
engineering. There has been significant interest in how nanoparticles bind and pass the
cell membrane, in particular within the area of drug delivery.
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1.5.3.1 Factors affecting particle and membrane interactions, uptake and cell
viability
Studies on manufactured nanoparticles, such as gold nanoparticles, have revealed a
number of particle characteristics which can influence their effect on the cell plasma
membrane (Krpetic et al. 2010). These factors are also likely to play a role in the effect
on THR wear particle interactions with the cell plasma membrane and subsequent
effects on cell viability. Whilst a number of nanotoxicology studies have investigated
specific factors effecting particle: membrane interactions, most notably particle size,
precise mechanisms are difficult to determine. This is due to the inconsistencies
between different studies, such as cell type, cell viability assays used and particle
concentration. A number of reviews on nanotoxicology have highlighted the need for
the standardisation of techniques, but thus far there is still wide variation between
research groups (Oberdorster et al. 2007; Kroll et al. 2009; Krug and Wick 2011).
Therefore the factors outlined below give a general overview of potential factors
impacting particle: membrane interactions and subsequent effects on the cell viability.
Furthermore, it is likely that the particle characteristics, such as surface chemistry and
particle size all contribute to particle: membrane interactions.
1.5.3.1.1 Particle size and composition
In general the particle entry pathway across the membrane is determined by the cargo
size (Krug and Wick 2011). For instance, Rejman et al. (2004) demonstrated that latex
particles, less than 200 nm in diameter, were able to enter murine melanoma cells via
clathrin mediated endocytosis, whereas 500 nm sized particles were internalised by
caveolae mediated endocytosis. In addition, phagocytosis was associated with
particles greater than 1 µm. However this study failed to investigate the possible effects
of the different internalisation mechanisms on cell viability. Furthermore, there is
conflicting evidence on whether nanoparticles can pass the cell membrane via non-
endocytic pathways or through diffusion and appears to be highly dependent on other
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factors such as particle composition. For example Mu et al. (2012) observed the
passive uptake of 14 nm silica particles into A549 lung epithelial cells, which induced a
reduction in cell viability at particle concentrations of 1 µg.ml-1 or higher.
1.5.3.1.2 Particle Morphology
Particle morphology is another parameter which can impact particle uptake and cell
viability. Champion et al. (2007) demonstrated that polystyrene particles of different
shapes, including needle-like and spherical particles, were internalised into
macrophages at varying rates. The spherical particles were more likely to be
internalised more than the needle-like particles. Furthermore, these authors stated that
when the surface area was too large, the macrophages spread around the particles,
rather than internalising them. This is similar to histological analysis of periprosthetic
tissue from UHMWPE implants, which reported the presence of giant cells around
needle shaped particles (Schmalzried and Callaghan 1999). Moreover, the particle
aspect ratio is also a key factor in particle uptake. The rate of uptake has been reported
to be reduced as the particle aspect ratio is increased (Canton and Battaglia 2012).
1.5.3.1.3 Particle Surface Chemistry
Research into the role of nanoparticle surface chemistry has reported a general trend
that anionic or neutral nanoparticles are internalised less readily than cationic particles
(Canton and Battaglia 2012). This is due to the cationic particles being able to bind to
the negatively charged proteoglycans expressed on the cell surface (Mislick and
Baldeschwieler 1996). However, this trend may be an oversimplification, as surface
chemistry also determines the colloidal stability of the nanoparticles in solution and
their ability to remain dispersed. This is particularly important for prevention of
aggregation of particles as this is likely to change the internalisation mechanisms of
particles into cells (Krug and Wick 2011).
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Another consideration is the release of ions from the particle surfaces. Mu et al. (2014)
studied the Zn(II) ion release of uncoated zinc oxide nanoparticles and aliphatic
polyether-coated zinc oxide nanoparticles in vitro. Uncoated zinc oxide nanoparticles
were reported to release more ions from the particle surface. However the coated
nanoparticles were observed to interact with the cell membrane and were internalised
into A549 lung epithelial cells at a faster rate. Furthermore, the coated particles were
demonstrated to reduce the cell viability to a greater extent than the uncoated
nanoparticles. The authors hypothesised that once internalised, the coated zinc oxide
nanoparticles were able to release more Zn(II) ions within the cell, which in turn had a
detrimental effect on the cell viability.
1.5.4 The effect of protein coronae on particle interactions with the
cell plasma membrane
When particles are released into biological fluid, such as the synovial fluid in vivo and
foetal bovine serum (FBS) in vitro, the surface of the particles is immediately covered
by proteins from the surrounding biological medium (Mahmoudi et al. 2011). The
variety proteins bound to the particle surface is dependent upon on where the particles
are released within the body and what supplemented medium is used for in vitro
experiments (Ma et al. 2015). The formation of a protein corona on the surface of the
particles can lead to the exposure of new epitopes and altered properties of the
particles. This can alter the particle: cell interactions and subsequent biocompatibility
(Rauch et al. 2013). It is hypothesised that cellular responses, including cell viability
and inflammation, reported in the literature are predominately caused by protein
coronae on particles rather than the bare particle surface (Rauch et al. 2013).
The formation of a protein corona is a dynamic process and evolves over time. The
high surface reactivity of nanoscale particles due to the large surface area: volume
ratio allows the rapid binding of proteins. Over time, there is an exchange of low-
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affinity, high abundant proteins with higher affinity, less abundant proteins. Eventually a
protein corona consisting of a hard and soft corona is formed. The hard corona is the
inner layer where a slow exchange with the proteins within the environment occurs. For
the outer layer, the soft corona, there is a faster exchange of free proteins in the
surrounding medium (Ma et al. 2015). It is thought that the hard corona determines the
biological fate of nanoscale particles and the interaction with the cell membrane (Nel et
al. 2009).
The formation of a protein corona on the particle surface is determined by a number of
factors. These include the characteristics of the particles such as size, charge, shape
and the biological medium that the particles are exposed to (Nel et al. 2009; Fleischer
and Payne 2014b; Mirshafiee et al. 2015; Pozzi et al. 2015; Shang and Nienhaus
2015). Upon the formation of a protein corona, the proteins bound to the surface can
denature, causing the unfolding of the structure and exposure of new epitopes, leading
to new biological interactions (Yan et al. 2013; Ma et al. 2015).
1.5.4.1 The effect of protein coronae on particle biocompatibility
The protein coronae is largely responsible for cellular uptake mechanisms and
subsequent cellular responses, such as cell viability (Horie et al. 2009; Mu et al. 2012;
Mbeh et al. 2014; Cheng et al. 2015; Duan et al. 2015; Franchi et al. 2015; Landgraf et
al. 2015). For example Duan et al. (2015) revealed reduced uptake of BSA coated
graphene oxide nanoparticles, which had a limited effect on the viability of A549 lung
epithelial cells in comparison to uncoated particles.
Within the area of THR wear particle toxicity, the phenomenon of protein coronae has
not been adequately investigated and there are a relatively small number of reports. It
is thought that the pathogenesis of delayed hypersensitivity reactions is caused by
cobalt and chromium ions binding to proteins and generating metal-ion modified
peptides, which can induce an immune response (Hallab et al. 2000; Hallab et al. 2004;
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Davies et al. 2005; Willert et al. 2005). However, the protein corona was not
characterised, and the mechanism of interaction with the membrane and how this may
influence the biological fate of the wear particles is unknown. Lewis et al. (2007)
reported micron sized CoCr particles incubated in minimum essential medium (MEM)
prior to exposure to fibroblasts were less likely to be internalised than particles which
had not been incubated in medium. However, the particles used were much larger than
those characterised from periprosthetic tissue and therefore this study is not clinically-
relevant.
The direct effect of protein coronae on nanoparticle interactions with the cell membrane
has also been investigated. Churchman et al. (2013) reported that zinc oxide (ZnO)
nanoparticles incubated with bovine serum albumin (BSA) induced more membrane
activity, such as an increase in ordering of the lipid bilayer. In addition to this, Lesniak
et al. (2012) reported that in the presence serum, silica particles bound to a model 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membrane to a lesser extent
than particles in the absence of serum. These authors hypothesised that the serum
bound to the membrane and subsequently reduced the number of available binding
sites on the membrane surface for the particles to come into contact with. Furthermore,
in the presence of serum, specific receptor binding to the cell plasma membrane has
also been reported to be effected. Denatured fibrinogen coated gold nanoparticles
were revealed to bind to the integrin receptor Mac-1 on macrophage cell plasma
membranes, which induced the release of inflammatory mediators, including TNF-α
(Deng et al. 2011).
Fleisher and Payne (2014a) demonstrated that particle composition can play a key role
in particle interactions with the cell plasma membrane. In the presence of MEM,
supplemented with 10% (v/v) FBS, uptake of cationic polystyrene nanoparticles was
increased in comparison to particles incubated in the absence of serum in kidney
epithelial cells in vitro. In contrast, under the same conditions, uptake of anionic
polystyrene nanoparticles was reduced. This phenomenon was observed with
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polystyrene particles of varying diameter and cell type (Fleischer and Payne 2014a;
Fleischer and Payne 2014b). Using competitive assays, protein: particle complexes
were incubated with free BSA and it was revealed that the anionic nanoparticles
competed with the free BSA to bind to the BSA receptor. In contrast, particle uptake of
cationic nanoparticles was unaffected by the presence of free BSA. Further competitive
assays demonstrated that cationic nanoparticles bound to scavenger receptors on the
cell plasma membrane.
1.6 The use of biomimetic systems to determine the effect of
wear particles on the cell plasma membrane
The effect of nanoscale and micron sized alumina and CoCr wear particles on the
plasma membrane can be investigated using biomimetic systems. These systems have
recently been advocated as suitable experimental models to investigate ion transport,
membrane damage, and membrane binding by manufactured nanoparticles. A wide
range of biophysical methods have been reported in the literature to characterise the
interaction of manufactured nanoparticles and these are summarised in Table 1.5.
These techniques often use model membranes, with varying degrees of complexity, to
represent the cell plasma membrane. These include the use of tethered bilayer lipid
membranes (tBLMs) and solid supported bilayer lipid membranes (sBLMs). The
techniques of particular interest to this current study are discussed in detail.
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Table 1.5 – Commonly used techniques to investigate particle interactions with the model
plasma membranes (Mahmoudi et al. 2011; Escorihuela et al. 2015).
Technique Overview of principle
Atomic force microscopy (AFM) Uses a highly sensitive scanning probe
across the sample surface to determine
mechanical and chemical properties of
sample
Dual polarization interferometry (DPI) Uses polarised light from a laser passing
through various waveguides and interacts
with immobilised sample (i.e. the tethered
membrane model). Changes in the resulting
optical interference pattern are caused by
changes in the structure and mass of the
immobilised molecules.
Electro-chemical impedance spectroscopy
(EIS)
Measures particle or ion transport across a
tethered membrane model.
Quartz crystal microbalance with dissipation
(QCM-D)
Measures changes in frequency and
dissipation of an oscillating quartz crystal as
an indicator of particle binding.
Surface plasmon resonance Measures changes in resonating surface
plasmons on metal sensor
Vesicle leakage assays Pore formation of membrane causes release
of dye from fluorescently loaded vesicles.
1.6.1 Surface plasmon resonance
Surface plasmon resonance (SPR) can be used to measure the adsorption of
substances onto the a planar gold or silver sensor by detecting changes in the
refractive index of the surface layer of a solution in contact with the sensor. The change
in the refractive index causes a change in the reflected intensity angle and a
sensorgram can plot this angle against time (Figure 1.4). When light is emitted from a
light source, at a certain incidence angle, light is adsorbed by the electrons at the
surface boundary between the sensor and the contact solution. This causes the
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electrons, also referred to as surface plasmons, to resonate. The resonating surface
plasmons are sensitive to the environment including the refractive index and the film
thickness of an adsorbed layer. These then change the intensity of the reflected light,
which can be measured. The binding kinetics of a material onto the sensor can also be
investigated by observing the sensorgram as a function of time (Mahmoudi et al. 2011).
Figure 1.4 – The principle of surface plasmon resonance. 1 – Light is emitted from light
source and hits the underside of the sensor chip. 2 – At a certain incidence angle (resonance
angle), light is adsorbed by the electrons in the metal sensor, causing them to resonate. 3 –
These resonating electrons (surface plasmons) are sensitive to the refractive index of the
surrounding medium and the thickness of the sensor. 4 – The resulting electrons appear as a
dark band by the detector. (Mahmoudi et al. 2011).
1.6.2 Vesicle leakage assays
In order to study the effect of particles on the cell membrane integrity, simple vesicle
leakage assays have previously been used. Unlike techniques such as TEM analysis,
vesicle leakage assays allow the quantification of the ability of particles to form
membrane pores and thus damage the membrane. This method is based upon lipid
vesicles being loaded with an auto-quenching fluorescent dye. Upon damage to the
vesicle membrane, the dye is released, reducing auto-quenching and the increase in
fluorescent intensity can be measured using a fluorometer (Naumann et al. 2011).
Studies have revealed that silica and zinc oxide nanoparticles can induce membrane
damage to model membrane vesicles in a dose dependent manner. However this was
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only observed at the higher particle concentrations, which were equal or greater than
10 µg.ml-1 (Mu et al. 2012; Mu et al. 2014).
1.6.3 Quartz crystal microbalance with dissipation
The interactions and binding of nanoparticles or wear particles to a model membrane
can also be measured using quartz crystal microbalance (QCM) systems with or
without dissipation. This is a highly sensitive technique and can be modified to increase
the complexity of the membrane model. Therefore the effect of specific factors on wear
particle interactions with the cell plasma membrane can be investigated.
1.6.3.1 Principle of quartz crystal microbalance with dissipation
Quartz crystal microbalance measures changes in mass (Δm) per unit area by
monitoring the change in frequency (Δf) of a resonating quartz crystal (Dixon 2008).
The unique structure of the quartz crystal allows it to exhibit a piezoelectric effect (i.e.
can produce an electrical current via pressure). Sandwiched between a pair of
electrodes, when an alternating current is applied to a quartz crystal, it will oscillate at
its resonant frequency of 4 – 6 MHz (Dixon 2008). The frequency of the oscillating
crystal is dependent on the thickness of the crystal and therefore binding of materials to
the sensor increases the thickness and in turn reduces the oscillating frequency. A
change in the frequency of a rigid layer formed on the sensor surface directly
corresponds to a change in mass as shown in the Sauerbrey equation below
(Sauerbrey 1959).
∆ = − 1 ∆
c = constant of quartz crystal properties (in this case 17.7 ng.cm-2.s-1)
m = mass
n = overtone
f = frequency
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Since the introduction of QCM, the applications of the technology have continued to
expand such as solid supported bilayer lipid membranes (sBLMs) (Cho et al. 2010).
For non-rigid layers, QCM can be combined to quantify the change in dissipation of the
system, known as QCM with dissipation (QCM-D). The dissipation measures the loss
of energy in the system from each oscillation divided by the total energy stored in the
system. This can also be monitored alongside the change in frequency in real-time
(Dixon 2008). When a soft layer is bound to the quartz crystal, it is deformed during
oscillation and therefore a high dissipation is measured (ΔD > 0). In contrast a rigid
layer will mirror the crystal oscillation without being deformed (ΔD = 0). During the
formation of a sBLM, the lipid vesicles bind onto the surface of the crystal until
saturation and burst to form a planar bilayer. Due to the hydrophobic and hydrophilic
properties of phospholipids, the vesicles will arrange themselves to form a bilayer with
a layer of polar head groups orientated towards the liquid interface and a second layer
towards the solid surface (Kunze et al. 2011).
The inclusion of dissipation measurements allows structural information, binding
strength and the swelling or hydration of the bound layers to be monitored in real-time.
Multiple overtones (n) of the resonant frequency are also measured. Only the odd
overtones (n = 3 – 13) can be excited electrically as these harmonics induce charges of
the opposite sign at each end of the crystal surface (Kunze et al. 2011).
1.6.3.2 Nanoparticle interactions with a plasma membrane using quartz crystal
microbalance with dissipation techniques
The advantage of the QCM-D is that it is high sensitivity and is able to measure
changes in masses as low as 100 pg.cm-2 of the crystal area (Dixon 2008). This
method has been used successfully to measure membrane binding of synthetic
nanoparticles onto a model membrane, including silica, copper, and zinc oxide
nanoparticles (Mu et al. 2012; Karlsson et al. 2013; Mu et al. 2014). A typical example
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was reported by Mu et al. (2012) whereby the binding of silica nanoparticles onto a
sBLM, was measured using QCM–D (Figure 1.5). A reduction in the oscillating
frequency was measured as the nanoparticles bound to the membrane. The change in
the dissipation of oscillation was minimal, thus indicating a tight interaction between the
particles and the membrane. Interestingly, it was observed that the introduction of
washing steps did not alter the frequency or dissipation, thus indicating that the
particles were irreversibly bound to the membrane. Furthermore, the addition of more
nanoparticles did not alter the frequency, suggesting that particle binding onto the
membrane had reached saturation point. Therefore this technique is highly
advantageous in assessing particle and membrane interactions and could potentially
be used for THR wear particles.
Figure 1.5 – Silica nanoparticles binding to a model membrane using quartz crystal
microbalance with dissipation. An example of particle binding to a sBLM, using QCM-D,
whereby a reduction in frequency (black) of approximately 90 Hz was measured upon the
addition of the 10 μg.ml-1 of 14nm silica nanoparticles. A small increase in dissipation (blue) of
approximately 3 x 10-6 was also measured, indicating a tight interaction (Mu et al. 2012;
copyright right permission granted by publisher).
Due to the sensitivity of QCM-D, factors effecting particle and model membrane
interactions can be investigated, including particle morphology, size, and particle
coating (Karlsson et al. 2013; Mu et al. 2014). Furthermore, the effect of protein
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coronae can also be explored (Lesniak et al. 2012; Lesniak et al. 2013). Lesniak et al.
(2013) reported that the addition of BSA to polystyrene particles reduced the binding of
the particles to sBLM using QCM-D. The model membranes can also be tailored to
each experiment and proteins can be incorporated into the membrane to investigate
particle: protein interactions (Kunze et al. 2011).
The effects of albumin and endothelial cell attachment on to UHMWPE and CoCr
substrates have previously been investigated by QCM-D, whereby the crystal surface
was coated with the biomaterial of choice and the binding of substrate was measured
(Serro et al. 2010; Castellanos et al. 2015). Castellanos et al. (2015) demonstrated that
the addition of surface coatings on a CoCr alloy surface could improve cell binding for
cardiovascular applications. However, at present the binding of wear particles from
THRs to a model lipid membrane has not been investigated using QCM-D techniques.
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1.7 Project aim
Currently little is known about the precise response mechanisms of cells to CoCr and,
in particular, alumina particles. Specifically, how do the effects described above caused
by alumina and CoCr particles manifest into the larger scale problems observed in
patients? Studies published to date have failed to analyse the effects of CoCr and
alumina wear particles interactions with the plasma membrane. Furthermore, it is not
known if the passing of the particles through the membrane induces cytotoxic effects,
or whether a reduction in the cell viability occurs once the particles are internalised.
Furthermore it is not known what factors influence particle: membrane interactions and
subsequent cellular responses, such as the formation of protein corona or the presence
of specific membrane proteins. Large gaps in the knowledge about CoCr and alumina
particles remain. Therefore, research into the fundamentals of particle: membrane
interactions will provide an insight into the biocompatibility of alumina and CoCr
particles.
This project aims to determine if nanoscale and micron sized alumina and CoCr
particles are able to damage or passively pass the cell membrane with adverse
consequences.
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1.7.1 Specific objectives
The main objectives of this study are listed below and are summarised in Figure 1.6.
 To generate nanoscale CoCr particles using simple configuration wear
simulator.
 To characterise nanoscale CoCr particles alongside commercially available
micron sized CoCr wear particles using SEM image analysis. To characterise
nanoscale and micron sized alumina particles, isolated from an alumina
powder.
 To determine the effects of nanoscale and micron sized alumina and CoCr
particles on primary HFBs and U937 histiocytes in terms of cell viability.
 To study the effect of nanoscale and micron sized alumina and CoCr particles
on membrane integrity and binding using model membrane systems.
 To study the effect of nanoscale and micron sized alumina and CoCr particles
on membrane integrity and binding using a model lipid membrane (a sBLM)
with incorporated fibroblast membrane proteins.
 To study the effect of nanoscale and micron sized alumina and CoCr particles
on fibroblast cell viability and particle uptake in the presence of FBS.
 To study the effect of nanoscale and micron sized alumina and CoCr particles
on membrane integrity and binding using a model lipid membrane (a sBLM) in
the presence of FBS.
 To study the effect of nanoscale and micron sized alumina and CoCr particles
on membrane integrity and binding using a model lipid membrane (a sBLM)
with incorporated fibroblast membrane proteins, in the presence of FBS.
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Figure 1.6 – Flow diagram of project objectives and experimental methods.
Chapter 2
50
Chapter 2
Materials & Methods
2.1 Materials
2.1.1 Nanoscale and micron sized cobalt chromium and
alumina particles
Commercially available particles of alumina ceramic (nanoscale and micron sized)
and micron sized CoCr particles were used throughout the study (Table 2.1).
Nanoscale CoCr particles were generated in house (Section 2.2.1).
Table 2.1 – Alumina and cobalt chromium particles used during the project
2.1.2 Cobalt chromium pins and plates
Six CoCr pins were machined from a high carbon > 0.2% (w/w) CoCrMo alloy
(ASTM F1537). The pins were polished in house by Mrs. Jane Cardie (Technician,
School of Mechanical Engineering) with a radius of curvature of 100° and finished
Particle Type Composition Supplier
Micron sized CoCr particles 62.2% Co
28.7% Cr
0.71% Ni
Sandvik Osprey Ltd, Neath, U.K.
Nanoscale CoCr particles ASTM F1537 Generated in house from
supplier Depuy, Leeds, U.K
Micron sized alumina
particles
Zirconia toughened
Al2O3
BIOLOX forte, manufactured by
Ceramtec AG, Plochingen,
Germany
Nanoscale alumina
particles
Al2O3 PlasmaChem, Berlin, Germany
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to a surface roughness (Ra) of 0.02 – 0.04 µm (Figure 2.1). Smooth CoCr plates
used in the 6 station wear rig were also machined from the same high carbon CoCr
alloy, with a Ra of 0.01 – 0.02 µm.
Figure 2.1 – Dimensions of machined cobalt chromium pins used in the pin-on-plate
wear simulators. R – Radius of curvature. Ø – Diameter of pin.
2.1.3 Membrane lipids and cholesterol
A lipid mixture, similar to that found in fibroblast plasma membranes was prepared
from extracted porcine brain lipids (Riordan 1979). The following phospholipid and
cholesterol compounds were used to form the model fibroblast membranes (Table
2.2).
Table 2.2 – Phospholipid and cholesterol compounds used to form the model
fibroblast membranes
Compound Suppliers Product Code
Cholesterol Sigma Aldrich, UK C8667
Porcine brain phosphatidylcholine Avanti Polar Lipids,
Alabaster, USA
840053C
Porcine brain phosphatidylserine Avanti Polar Lipids,
Alabaster, USA
840032C
Porcine  brain
phosphatidylethanolamine
Avanti Polar Lipids,
Alabaster, USA
840022C
Chapter 2
52
2.1.4 Cells
The cells used throughout this study are listed in Table 2.3.
Table 2.3 – Cells used throughout this study and suppliers
Cell line Type Species Supplier
L929 Fibroblast Murine European Collection of Animal Cell
Culture
U937 Histiocyte Human European Collection of Animal Cell
Culture
Primary dermal
fibroblasts
Fibroblast Human NHS Blood and Transplant
2.1.5 Chemicals
The chemicals used throughout this study are listed in Appendix A, Table 1.
2.1.6 Computer Software
The computer software used throughout this study are listed in Appendix A, Table
2.
2.1.7 Consumables
The general consumables used throughout this study are listed in Appendix A,
Table 3.
2.1.8 Equipment
The equipment used throughout this study is listed in Appendix A, Table 4.
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2.1.9 Glassware
The glassware used throughout this project is listed in Appendix A, Table 5.
2.1.10 Stock solutions
2.1.10.1 3-(N-morpholino)propanesulfonic acid (MOPS) buffer for
membrane and particle experiments
A stock solution of 20mM 3-(N-morpholino)propanesulfonic acid (MOPS) with 30
mM sodium sulphate (Na2SO4) was prepared in ultrapure distilled water. Once in
solution, the pH was adjusted to pH 7.4 and stored at room temperature for
approximately one month.
2.1.10.2 Cell culture medium and supplements
The cell culture medium for both L929 and primary human fibroblast (HFB) cells
was Dulbecco’s Modified Eagles Medium (DMEM), without L-glutamine. U937 cells
were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium. Both types
of medium were supplemented with 10% (v/v) foetal bovine serum (FBS), 2 mM L-
glutamine and 100 μg.ml-1 penicillin:streptomycin. Supplemented cell culture
medium was stored at 4°C for a maximum of 4 weeks.
2.1.10.3 Homogenising solution for cell plasma membrane
isolation
The homogenising solution was made fresh on the day of cell plasma membrane
isolation and was stored on ice. Sucrose, at a concentration of 250 mM was
dissolved in 10 mM Tris-HCl, pH 7.5. This was supplemented with one tablet of
Roche “Complete” proteinase inhibitors (containing a broad spectrum of serine,
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cysteine and metalloproteases inhibitors) per 50 ml of the homogenising solution
and 1 mM dithiothreitol (DTT). A 1M solution of phenylmethanesulfonyl fluoride
(PMSF) was prepared in ethanol and added to the homogenising solution at a final
concentration of 0.5 mM.
2.2 Methods
2.2.1 Particle generation using six station pin-on-plate
simple configuration wear simulator
Cobalt chromium particles were generated using the six station pin-on-plate wear
simulator, which was designed and manufactured by the School of Mechanical
Engineering, University of Leeds. Smooth, high carbon, CoCr alloy pins and plates
were used as described in section 2.1.2.
2.2.1.1 Cleaning of rig components
All CoCr pins and plates were cleaned using ultrasonication whilst immersed in
70% (v/v) isopropanol for 10 minutes at room temperature. The six station rig was
cleaned, whereby all the components were washed in household detergent and
immersed in 1 % (v/v) Trigene for 20 minutes. All components were then rinsed in
copious amounts of water, followed by a final rinse in distilled water. Finally all
components were dried using disposable paper towelling before being ready for use
(Figure 2.2).
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Figure 2.2 – Components of the six station pin-on-plate simple configuration wear
simulator. A – Ball bearing assemblies. B – Threaded nut. C – Bridge section. D – Polymer
baffle. E – Connecting rod. F – Collet. G – Toothed rack. H – Pin holder with polymer gear
wheel. I – Plate bath and rubber seal.
2.2.1.2 Assembly of six station pin-on-plate simple configuration
wear simulator
The pins and plates were individually numbered and the pairing of the pin and
plates for each station remained constant throughout the tests. The orientation of
the plate within the bath also remained the same. The components were
assembled, whereby each plate was screwed into a separate bath. A rubber seal
was placed in the groove of the bath and a plastic baffle was secured into position,
covering the top of the bath. The toothed racks were screwed into position on the
side of each bath. Each numbered bath was secured into place on the rig at the
corresponding station number (Figure 2.3A). Each pin was placed in a pin collet,
using metal spacers to ensure that the pin protruded approximately 5 mm from the
collet (Figure 2.3B). The pin and pin collet were placed in the pin holder, which was
then slotted into the corresponding bridge section of the rig (Figure 2.3C). The pin
holder and bridge section were secured into position and the connection between
the pin holder and toothed rack on the bath was checked (Figure 2.3D). Washers
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were then placed on top of the pin holder and a small amount of Vaseline® was put
on the washers to act as a lubricant. One end of the plastic connecting rod was
slotted into the holder at the front of each bath and the other end of the rod was
secured to the scotch yoke mechanism (Figure 2.3E).
Figure 2.3 – Assembly of the six station pin-on-plate simple configuration wear
simulator. A – The bath (1) containing the plate component (2) was secured into position
on the rig with corresponding baffle (3) and toothed rack (4). B - The pin (1) was placed in
the collet and pin holder (2) with plastic gear wheel (3) attached. C – The pin and pin holder
(1) were slotted into the corresponding bridge section (2) and secured into position using a
threaded nut (3). D – The bridge section and pin holder were secured into position over the
bath. E – The plastic connecting rod (1) was slotted into the groove of the bath and screwed
onto the scotch yoke mechanism.
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2.2.1.3 Generation of cobalt chromium particles using six station
pin-on-plate simple configuration wear simulator
The lubricant used was ultrapure deionised water and approximately 30 ml was
added to each bath. The pin holder was lifted slightly to ensure the presence of
lubricant between the pin and plate prior to commencing the operation of the wear
rig. The cantilever arm was secured into position using the pivot pins. Using a spirit
level and spanner, the pin on the cantilever arm was altered to ensure the arm was
level.
The cycle counter on the rig was set to zero and the motor was turned on. The
frequency was recorded and adjusted to 1 Hz or 60 cycles.min-1, with a stroke
length of 28 mm and a rotation ± 30°. A steel weight was then added to each of the
cantilever arms to correspond to 80 N per station (Figure 2.4). The rig was operated
for 2 weeks during the day (approximately 8 hours per day). Before switching off the
rig at the end of each day, the speed was slowly reduced and the weights were
removed. The lubricant was topped up each day to maintain sufficient lubrication.
Upon completion of the pin-on-plate testing, the number of cycles was recorded and
the rig was dismantled. The pin, CoCr plate, bath and lubricant were subjected to
ultrasonication in ultrapure distilled water for short intervals (10 – 15 seconds) to
dislodge any adherent particles. The lubricant containing the particle debris for each
station was transferred into appropriately labelled sterile plastic pots and stored at
-20°C.
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Figure 2.4 – Assembled station of the six station wear rig with cantilever arm (1) and
weight (2).
2.2.1.4 Centrifuging cobalt chromium nanoscale particle stock
The CoCr nanoscale particles in distilled water generated in section 2.2.1, were
defrosted and subjected to sonication for 30 minutes to disperse the particles. In
order to form a more concentrated particle stock to be sterilised, the particle
suspension was transferred to clean polycarbonate centrifuge tubes and placed in a
SS-34 centrifuge rotor. The centrifuge tubes used were appropriate for the SS-34
centrifuge rotar. The particle suspension was centrifuged for 30 minutes at 45 000 g
at 4°C. The supernatant was removed and the particle pellet was suspended in 5
ml of ultrapure distilled water. The particle suspension was subjected to sonication
for 20 minutes and then transferred into a clean glass universal. The particle
suspension was stored at -20°C until required.
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2.2.2 Preparation of particles for cell culture studies
A small sterile glass vial was covered with foil and weighed using the AT21
balance, which is sensitive to 10-6 grams. A reference glass vial was weighed,
followed by the glass vial and the balance was zeroed between each repeat. The
mass of the reference vial and vial were measured until five repeats were within
100 µg of one another. The reference vial was used to account for the changes of
the atmospheric conditions of the measuring environment before and after the
adding of the particles to the glass vial. The particle suspension (section 2.2.1) was
thawed and a small amount (2 – 3 ml) was pipetted into the pre-weighed vial. The
particles were then placed in the oven for 4 hours at 190°C to sterilise the particles
and to remove the water. The vial was weighed again until 5 repeats were within
100 µg of one another were obtained. The mass of the particles was calculated by
subtracting the average weight of the vial from the average weight of the vial plus
the particles. This mass was adjusted according to the changes in the weight of the
reference vial before and after adding the particles to take into account the changes
in the atmospheric conditions. The particles were suspended with the appropriate
volume of sterile ultrapure distilled water to give a stock particle concentration of 1
mg.ml-1, which was stored at -20ºC.
2.2.3 Cell culture
2.2.3.1 Resurrection of L929 and U937 cell lines
A cyrovial of approximately 1 x 106.ml-1 of cells was removed from the liquid
nitrogen dewar and quickly thawed in a water bath at 37°C. Once thawed, the cells
were immediately transferred to a sterile universal containing pre-warmed fresh
culture medium (10ml). The cell suspension was centrifuged (150g) for 10 minutes
at 20°C. For U937 cells the cell suspension was centrifuged at 200g for 10 minutes
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at 20°C. The supernatant was removed and discarded and the pellet was
suspended in 2ml of fresh culture medium. The cell suspension was added to a
sterile culture flask (75 cm2) containing 10 ml of fresh cell culture medium and
incubated at 37oC in 5% (v/v) CO2 in air until approximately 80% confluent.
Confluency was determined using a light microscope and adherent cells which
covered at least 80% of the flask plastic within the field of view were deemed
confluent. For the non-adherent U937 cells, the cells were determined to be
confluent when the field of view, under the light microscope, was occupied by more
than 50 – 60% cells. The cell culture medium was changed every 2-3 days for the
L929 cells until confluent. For the U937 cells, 3 ml of fresh cell culture medium was
added to each flask every 2 days until the cells were confluent. The U937 cells
were incubated in cell culture flasks at a 45° angle at 37oC in 5% (v/v) CO2 in air.
2.2.3.2 Resurrection of human fibroblast cells
A cyrovial of cells was removed from the liquid nitrogen dewar and quickly thawed
in a water bath at 37°C. Once thawed the cell suspension was added to 10 ml of
pre-warmed cell culture medium in a 75 cm2 culture flask. The cells were incubated
at 37°C in 5% (v/v) CO2 in air for 18 hours to allow the cells to adhere to the tissue
culture plastic. Once adhered, the cell culture medium was replaced with 10 ml of
fresh medium. The cell culture medium was changed every 2 – 3 days until the cells
were 80% confluent.
2.2.3.3 Cell culture maintenance of U937 histiocytes and L929 and
human fibroblast cells
Once the cells had achieved 80% confluency the cell culture medium was removed
from the flask and the cells were gently washed twice with 10ml of sterile
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Dulbecco’s phosphate buffer saline (DPBS) (without calcium and magnesium). The
cells were treated with trypsin-ethylenediaminetetraacetic acid (EDTA) (1 ml) for 5 –
10 minutes in 5% (v/v) CO2 in air at 37°C to detach the cells from the flask. The side
of the culture flask was firmly tapped to dislodge the cells from the tissue plastic
and the trypsin-EDTA was inhibited by the addition of fresh cell culture medium
containing 10% (v/v) FBS. The cell suspension was transferred into a sterile
universal and centrifuged (150g) for 10 minutes. The U937 cells are a suspension
cell line and therefore once confluent, the cell suspension was also centrifuged
(150g) for 10 minutes. The following steps of cell maintenance were used for all
cells types. The supernatant was carefully aspirated from the pellet and suspended
in 5 ml of DMEM culture medium. A trypan blue exclusion assay was performed
(section 2.2.3.4) and the cells were seeded into a fresh cell culture flask (75 cm2 or
175 cm2) at a seeding density of (1 x 104 cells per cm2) with either 10 ml or 20 ml of
fresh DMEM cell culture medium, respectively. The cells were incubated in 5% (v/v)
CO2 in air at 37°C and the cell culture medium was replaced every 2 – 3 days until
confluent. Cells were maintained for up to 12 passages before being discarded.
Cells were stored in long term storage by passaging the cells as described above.
The cells were suspended at a density of 1 x 106 cells.ml-1 in DMEM supplemented
with 20 % (v/v) FBS and 10 % (v/v) filter sterilised dimethyl sulphoxide (DMSO). A
volume of 1.5 ml of the cell suspension was transferred into each labelled, sterile
cryovial and placed in a freezing pot containing isopropanol. The cyrovials were
placed at -80oC for 4 hours before being transferred into liquid nitrogen for long-
term storage.
2.2.3.4 Trypan blue exclusion assay
Cell viability was determined by diluting a small aliquot (20 µl) of the suspended cell
pellet with 20 µl of trypan blue. Using a Neubauer haemocytometer and light
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microscope, the total number of cells was counted from a 10 µl aliquot of the trypan
blue: cell suspension mixture. A minimum of 100 cells and a maximum of 300 cells
were counted within the 25 counting squares of the haemocytometer. The number
of non-viable cells was subtracted from the total cell count to give the number of
viable cells. Non-viable cells appeared blue, whereas viable cells were transparent
in appearance. The number of viable cells per ml was calculated using the following
formula: Number of cells. ml-1=(number of viable cells)×2 × 104
2 = dilution factor of the cell suspension within the trypan blue
104 = dilution factor to account for volume of haemocytometer
2.2.4 Culturing cells in the presence of nanoscale and
micron sized alumina and cobalt chromium particles
The effect of nanoscale and micron sized alumina and CoCr particles on the cell
viability of L929, primary HFB and U937 cells was determined using the ATP-lite
and MTT cell viability assays. A flask of L929 and primary HFB cells, which were
greater than 80% confluent, was treated with trypsin-EDTA and a cell count was
performed (section 2.2.3.3 and 2.2.3.4). An appropriate volume of cell culture
medium was added to the cell suspension to give a final cell density of 1x105.ml-1.
For the U937 cells, the cells were not treated with trypsin, but the cell suspension
was centrifuged at 200g for 10 minutes and a cell count was performed (section
2.2.3.4). The volume of the U937 cell suspension was altered to give a final cell
density of 2x105.ml-1. For each well, 100 µl of the cell suspension was added to a
sterile, clear, flat-bottomed 96 well plate and incubated in 5% (v/v) CO2 in air at
37oC. In the case of U937 cells U-shaped 96 well plates were used. A separate
plate was prepared for each time point and each cell viability assay to be
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performed. The cells were incubated for 18 hours to allow the cells to adhere or
form a cell spheroid for non-adherent cells.
The cells were cultured with nanoscale CoCr particles (section 2.2.1) or
commercially available micron sized CoCr particles (section 2.1.1) at particle
volumes per cell of 50 μm3, 5 μm3, 0.5 μm3, 0.05 μm3, 0.005 μm3 and 0.0005 μm3
using the calculation in Appendix B.  For the alumina particles, the cells were
cultured with nanoscale or micron sized particles at particle volumes per cell of 500
µm3, 50 μm3, 5 μm3, 0.5 μm3, 0.05 μm3, 0.005 μm3 and 0.0005μm3 using the
calculation in Appendix B. Particle volume to cell number ratios were used in the
cell viability experiments to allow an accurate comparison between experiments
using different particle sizes (Matthews et al. 2000). Matthews et al. (2000) reported
histological analysis of wear debris to be at a particle volume of approximately 60
μm3 per macrophage. Previous studies have reported alumina and CoCr nanoscale
particles to significantly affect cell viability at particle volumes of at least 5 μm3 and
50 μm3, respectively. Therefore, whilst the range of particle volumes used were
greater than what would be expected from the wear volumes produced in vivo, the
main aim of this study was to compare the cell viability results against the published
literature. Hence, the particle volumes used reflected previously published literature
(Germain et al. 2003; Papageorgiou et al. 2007). Each particle suspension was
sonicated for 5 minutes before 100 µl of each particle suspension was added to the
cells. The negative control was cells in 200μl of medium and the positive control
was camptothecin at a final concentration of 2 µg.ml-1. A particle only control was
included which was the highest particle dose in medium in the absence of cells. A
blank was also included which was 200 µl of medium only. Each treatment was
repeated six times and the cells were cultured with the particles in 5% (v/v) CO2 in
air at 37oC. The cell viability was assessed over 5 days at specific time points of
day 0, 1, 3 and 5. Each experiment was repeated at least twice.
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2.2.5 Determination of cell viability
Cell viability was determined using two different assays, the ATP-lite and MTT
assay. Nanoscale particles have been reported to directly interfere with a number of
cell viability assays and generate misleading results (Monteiro-Riviere et al. 2009).
Therefore the combination of using two assays was used to provide a better
understanding of how the particles affect cell viability. The ATP-lite assay is highly
sensitive and can measure ATP levels in as few as ten cells. Upon cell death, a
reduction in cellular ATP will occur, and can be used as an indicator of cytotoxicity
(Crouch et al. 1993). The MTT assay measured the reduction of a yellow tetrazole
to a purple formazan by dehydrogenase activity of viable, metabolising cells.
Consequently this assay measures the effect of cell metabolism (Stockert et al.
2012).
2.2.5.1 Determination of the cell viability using the ATP-lite assay
The ATP detection kit assay (ATP-lite™ assay), which measures the levels of ATP
present within the cells by the reaction of ATP with D-luciferin and is outlined in the
following reaction (Crouch et al. 1993). Based on this reaction, the amount of ATP
present can be determined by measuring the emission of light from the sample.
ATP + D-Luciferin + oxygen Oxyluciferin + adenosine monophosphate +
inorganic pyrophosphate + CO2 + Light
The culture medium was removed from each well of the 96-well plate and replaced
with 100 µl of fresh cell culture medium before commencing the assay. For U937
cells, the plate were centrifuged at 200g for 1 minute at 20°C prior to 100 µl of
medium being removed from each well. Mammalian cell lysis solution was added to
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each well (50 µl) and the plate was shaken (80g) for 5 minutes. Reconstituted
lyophilised substrate was then added at a volume of 50 µl per well and again the
plate was shaken (80g) for 5 minutes. The cell suspension in each well was
transferred to the corresponding well of a 96-well Optiplate® and an adhesive clear
film lid was placed over the plate to prevent contamination. The plate was read
using a luminescence reader, which dark-adapted the plate for 10 minutes and
measured the luminescence of each well for 10 seconds using MikroWin 2000
software. The output was presented as counts per second (CPS) and was exported
to the Excel computer software (2010 version). The average of the blank readout
was subtracted from all the results except for the cells which were cultured with the
highest particle volume, whereby the particle only control was subtracted instead.
This was to ensure that the particles did not directly interfere with the assay and
produce “false positive” or “false negative” results.
2.2.5.2 Determining cell metabolism using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay
Cell metabolism was also determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay, which is a yellow tetrazole and is
reduced to a purple formazan by viable, metabolising cells (Figure 2.5) (Stockert et
al. 2012). The absorbance reading of the formazan can be measured as an
indicator of cell metabolism. The formazan is water insoluble and must be liberated
from the cells using acidified sodium dodecyl sulphate (SDS-HCl) to lyse the cells.
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Figure 2.5 – Reduction of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide, (MTT) to a purple formazan.
For L929 and primary HFB cells, 200 µl of the culture medium was removed from
each well of the 96-well plate before commencing the assay and replaced with 100
µl of fresh medium. For U937 cells, the plates were centrifuged at 200g for 1 minute
at 20°C prior to 100 µl of medium being removed from each well. The MTT solution
(5 mg.ml-1 diluted in PBS) was added to each well (20 µl) for 4 hours. The MTT
product was released from the cells using SDS-HCl, whereby 10 g of SDS was
dissolved in 100 ml of distilled water. Once dissolved, 1 ml of 1M of HCl was added.
The solution was filter sterilised using a 0.2 μm pore size filter and 100 µl of SDS-
HCl was added to each well and incubated in 5% (v/v) CO2 in air at 37oC for 18
hours. The absorbance was read at 570 nm using the MultiScan plate reader and
ScanIt MSS software (version 2). The average absorbance measurements for the
blank were subtracted from all the absorbance values of the treatment groups.
However, for the cells cultured in the presence of the highest particle volume, the
average absorbance for the particle only control was subtracted instead.
2.2.6 Determination of the effects of nanoscale and micron
sized alumina and cobalt chromium particles on
model membranes
In order to determine the effect of nanoscale and micron sized alumina and cobalt
chromium particles on the cell plasma membrane, a series of experiments using a
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model membrane have been used. This model membrane mimics the composition
of the plasma membrane of human fibroblast cells. The model membrane has
various degrees of complexity, with some experiments including the addition of
isolated membrane proteins into the model membrane. Furthermore this series of
model membrane experiments used vesicle leakage assays and QCM-D
techniques. Vesicle leakage assays involved the formation of lipid vesicles loaded
with an auto-quenching fluorescent dye. When incubated with particles, if the
particles induced membrane damage, the fluorescent dye was released from the
vesicles and the fluorescence of the released dye was measured using a
fluorescent spectrometer. Particle binding to the model membrane was also
determined using the QCM-D technique, whereby a planar bilayer of the lipids was
formed on an oscillating quartz crystal. Upon the binding of the particles to the
membrane, a change in the frequency and dissipation of the crystal and
surrounding environment could be measured in real-time. These parameters were
analysed to determine if binding had occurred.
2.2.6.1 Formation of phospholipid: cholesterol membrane mixture
A lipid mixture, similar to the composition of the plasma membrane of human
fibroblast cells was prepared from extracted porcine lipids (Riordan 1979).
Cholesterol, phosphatidylcholine, phosphatidylserine, and
phosphatidylethanolamine were combined at a weight ratio of 5:10:2:3, respectively
(section 2.1.3). The lipid mixture was dissolved in chloroform: methanol (1:1) and 5
mg aliquots of the lipid mixture were transferred into sterile 1.5 ml glass vials. The
chloroform: methanol solution was removed by drying the glass vial aliquots in a
desiccator, under vacuum, for at least 2 hours. The lid of each vial was slightly
loosened and stored in a round bottom, short neck flask with stopcock adaptor
under nitrogen, at -20°C until required.
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2.2.6.2 Formation of lipid vesicles for vesicle leakage and quartz
crystal microbalance with dissipation experiments
Lipid vesicles were formed by suspending a 5 mg vial of the lipid mixture prepared
in section 2.2.6.1 in 1 ml of 20 mM MOPS with 30 mM sodium sulphate, pH 7.4.
The lipids were dispersed in the solution by vortexing at 30 second intervals until
the lipid mixture was cloudy and no precipitate on the bottom of the vial was
observed. In order to form the vesicles the lipid mixture was passed through a
track-etched polycarbonate filter with a pore size of 100nm, using an extruder
(Figure 2.6).
Figure 2.6 – Components of the vesicle extruder. A – Extruder holder. B – Large
extruder outer casing. C – Teflon bearing. D – Internal membrane supports. E – Small
extruder outer casing. F – Filter supports. G – O-rings. H – Glass syringes.
The extruder was assembled by placing each O-ring onto the two internal
membrane supports. Two pre-wetted filter supports were placed on to each internal
membrane support with the O-rings facing up (Figure 2.7A). The Teflon bearing
was placed into the smaller extruder casing component, followed by one of the
internal membrane supports (Figure 2.7B). Using tweezers a track-etched
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polycarbonate filter with a pore size of 100nm was placed over the filter support of
the internal membrane support. The second plastic holder (O-ring facing down) was
placed on top of the filter and the second larger extruder outer casing was placed
over the internal membrane supports and screwed tight to secure the components
into position (Figure 2.7C & D).
Figure 2.7 – Assembling vesicle extruder. A – The internal membrane supports with O
rings and filter supports. B – Teflon bearing is placed in the smaller extruder casing,
followed by one of the internal membrane supports. C – The polycarbonate filter is placed
on top of one of the internal membrane supports. The second internal membrane support is
placed face down on top on the membrane. D – The larger outer extruder casing is screwed
into position to secure the components together.
To ensure there were no leakages, 1 ml of 20 mM MOPS with 30 mM sodium
sulphate, pH 7.4 was passed through the extruder using the glass syringes (Figure
2.8). The solution was removed into a waste pot and replace with the lipid mixture.
The lipid mixture was passed through the membrane at least 11 times to ensure
sufficient vesicle formation. The vesicle mixture was then transferred into a 1.5 ml
Eppendorf and stored at 4°C until required. The vesicle mixture was stored for a
maximum of 3 days before being discarded.
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Figure 2.8 – Assembled extruder with syringes.
2.2.6.3 Determination of vesicle leakage in the presence of
nanoscale and micron sized alumina and cobalt chromium
particles
To measure the potential the of nanoscale and micron sized alumina and CoCr
particles to damage the lipid membrane, a simple vesicle leakage assay was used.
2.2.6.3.1 Preparation of carboxylfluorescein loaded lipid vesicles
Carboxylfluorescein (CF) loaded lipid vesicles were formed by suspending a 5 mg
vial of lipids (section 2.2.6.1) with 1 ml of 50 mM carboxylfluorescein (CF) dye (pH
7.4). After vortexing, the lipid suspension was passed through a track-etched
polycarbonate filter with a pore size of 400nm using an extruder as described in
section 2.2.6.2. The vesicles encapsulated with the dye were separated from the
remaining CF dye using a size exclusion chromatography G-25 column (Nap-5, GE
Healthcare Sciences). The column was placed in a clamp and stand and rinsed
three times with approximately 3 ml of DMEM medium (without phenol red or any L-
glutamine and antibiotic supplements). The vesicle mixture (0.5 ml) was then added
to the column and the vesicles were eluted from the column by adding 1 ml of
DMEM medium (without phenol red) (Figure 2.9). The eluted vesicles were
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collected in a Eppendorf and stored at 4°C until required for a maximum of 3 days
before being discarded.
Figure 2.9 – Separation of fluorescently loaded lipid vesicles from the fluorescent
dye. A – Stand and clamp. B – Size exclusion chromatography G-25 column. C – Band of
vesicles isolated from fluorescent dye.
2.2.6.3.2 Measuring vesicle leakage in the presence of alumina and
cobalt chromium particles using a fluorescence spectrometer
The leakage of fluorescent dye from the vesicles incubated in the presence of
nanoscale and micron sized alumina and CoCr particles was monitored using a
fluorescence spectrometer (LS 55, Perkin-Elmer) and the FL Win Lab computer
software (version 4) in real time. The excitation wavelength of the CF dye was 492
nm with an emission wavelength of 517 nm. A 1:100 dilution of the CF loaded
vesicles in DMEM medium (without phenol red) was placed on ice. A quartz cuvette
was inserted into the cuvette holder of the fluorescence spectrometer and the
diluted CF loaded vesicles were further diluted in 1:100 DMEM medium (without
phenol red) within the cuvette. The fluorescence was monitored for at least 200
seconds prior to the addition of particles. The particles (nanoscale and micron sized
alumina or CoCr particles) were added to the cuvette at incremental concentrations
of 1, 10 and 100 μg.ml-1 for at least 200 seconds for each particle concentration.
Following this, to ensure the vesicles had completely lysed and released any
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encapsulated dye, 6 µl of 10% (w/v) Triton X-100 was added to the sample. An
average fluorescence reading of at least 200 seconds for each particle
concentration and Triton-X 100 was recorded and the values were presented as a
percentage of the Triton X-100 measurements. Each vesicle leakage experiment
was repeated three times. A paired t-test was performed on the measurements
recorded for each particle concentration to determine statistical significance. The
data was found to be normally distributed and 95% confidence limits and statistical
data were performed on the raw data.
2.2.6.3.3 Investigation into the quenching effect of particles on the
vesicle leakage assay
The vesicle leakage assays were performed as described in section 2.2.6.3.2.
However, once the fluorescence of the diluted vesicles had been monitored for at
least 200 seconds, 6 µl of 10% (w/v) Triton X-100 was added prior to the addition of
the particles to the cuvette. This was to ensure that the fluorescent dye had been
completely released from the vesicles in order to determine the effect of the
particles on the absorbance reading of the dye. After at least 200 seconds, the
particles (nanoscale and micron sized alumina or CoCr particles) were added to the
cuvette at incremental final concentrations of 1, 10 and 100 μg.ml-1. An average
fluorescence reading for at least 200 seconds for each particle concentration and
the Triton-X 100 treatment was measured and the values were presented as a
percentage of Triton X-100. Each vesicle leakage experiment was repeated three
times. A paired t-test was performed on the results between each treatment group
to determine statistical significance.
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2.2.6.4 Determining particle binding to a model lipid membrane
using quartz crystal microbalance with dissipation
Particle binding on a planar lipid bilayer was monitored using quartz crystal
microbalance with dissipation. Lipid vesicles were formed from a 5 mg vial
suspended in 20 mM MOPS with 30 mM sodium sulphate, pH 7.4 and kept on ice
until required as previously described in section 2.2.6.1. All solutions used in these
experiments, including; 20 mM MOPS with 30 mM sodium sulphate, pH 7.4, DMEM
cell culture medium, and ultrapure distilled water were degassed using sonication,
whilst under vacuum, for approximately 15 minutes.
2.2.6.4.1 Cleaning of quartz sensors
Silicon dioxide coated quartz sensors were cleaned thoroughly prior to commencing
the experiments. The sensors were placed in a Teflon instrument chamber and
bath-sonicated in 2% (w/v) SDS dissolved in ultrapure distilled water for 10 minutes
at room temperature (Figure 2.10A). The sensors within the Teflon instrument
chamber were then rinsed at least six times in ultrapure distilled water and dried
under a flow of nitrogen gas. The sensors were then transferred, face up, onto a
piece of aluminium foil (approximately 20 cm by 20 cm) and cleaned by placing the
sensors in a UV-Ozone cleaner for 20 minutes (Figure 2.10B). Using a pair of flat
edged tweezers, the sensors were then placed in each of the chambers of the Q
sense machine, sensor face down and in the correct orientation as shown in Figure
2.10C. The chamber lids were placed on top of the chambers and screwed into
position. Each chamber was turned over and locked into position in the machine by
sliding the metal bar at the front of each chamber (Figure 2.10D). The QCM-D
machine and peristaltic pump are shown in Figure 2.10E.
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Figure 2.10 – Cleaning of the sensors and assembly of quartz crystal microbalance
with dissipation machine. A – Silicon dioxide coated quartz sensors (1) were placed in a
Teflon instrument holder (2) and immersed in 2% (v/v) SDS, followed by washing with
ultrapure distilled water. B – Sensors were cleaned in a UV-Ozone cleaner. C – Sensors (1)
were placed, faced down into each of the chambers (2). D – The chamber lids were
screwed into position (1) and the chambers were secured in place. E – QCM-D machine
consisting of four chambers (1), a detector (2) and peristaltic pump (3).
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2.2.6.4.2 Quartz crystal microbalance with dissipation machine set up
Using the QSoft programme (version 4.1), the frequency and dissipation of the
sensors in air was measured to check sensor integrity. The starting solution of
DMEM was flowed through the chambers at an initial flow rate of 0.5 ml per minute
using a peristaltic pump for approximately 5 minutes. The flow rate was then
reduced to 70 µl per minute and remained constant throughout the experiment. The
frequency and dissipation of the sensors was measured in DMEM to check sensor
integrity. Using the QSoft programme, the experiment was then started and the
change in frequency and dissipation were monitored over time until the
measurements stabilised. This was dependent on the presence of air bubbles in the
solution or the sensor age. Once the frequency and dissipation had settled, the
monitoring was restarted and the frequency and dissipation in the starting solution
was automatically set at zero by the software. Changes in the dissipation, ΔD, and
normalised changes in the frequency, Δf (f = fn/n, where n is the number of the
overtone, n = 3 – 13), were monitored in real time. The QCM-D was then ready for
the formation of the lipid bilayer and subsequent exposure to the particles.
2.2.6.4.3 Lipid bilayer formation
Once the starting solution had flowed through the sensor chambers for at least 15
minutes, the solution was changed to 20mM MOPS with 30 mM Na2SO4, pH7.4.
The lipid vesicles (section 2.2.6.1) were diluted in 20mM MOPS with 30 mM
Na2SO4, pH7.4, at a final concentration of 0.5 mg.ml-1 with 10 mM CaCl2. After 10
minutes, the 20mM MOPS with 30 mM Na2SO4, pH7.4 was exchanged for the
diluted lipid vesicles and flowed through the chambers for a minimum of 20
minutes. After 20 minutes, to remove loosely bound vesicles and Ca(II), 1 mM of
EDTA dissolved in ultrapure distilled water was flowed through the chambers for 15
minutes. The solution was then exchanged with DMEM. The formation of a planar
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lipid bilayer on the silicon oxidase surface was confirmed by a change in frequency
of -27 to -30 Hz and a dissipation 0 to 0.5 x106 (Mu et al. 2012).
2.2.6.4.4 Addition of particles to membrane bilayer
Once the lipid bilayer had formed, the particles of choice were added to the
chambers. Particle concentrations of 1 μg.ml-1, 10 μg.ml-1 and 100
μg.ml-1 diluted in DMEM were flowed through the chambers in succession for at
least 25 minutes. DMEM was flowed through the chambers for at least 25 minutes
between the addition of each particle concentration to remove any unbound
particles. Due to the sensitivity of the QCM-D equipment, each experiment was
repeated twice using a different reconstituted lipid vesicle vial. For clarity, only the
overtone 9 (n = 9) of the normalised frequency and dissipation is reported in the
results.
2.2.6.5 Isolation of plasma membrane proteins from fibroblasts
and histiocytes
The presence of membrane proteins within the model lipid membrane and the
subsequent effect on the interactions of alumina and CoCr particles was
determined. In order to perform these experiments, the membrane proteins from
L929, primary HFB and U937 cells were isolated and incorporated into the lipid
vesicles, which were used for the vesicle leakage assays and QCM-D experiments.
2.2.6.5.1 Harvesting adherent L929 cells and primary human fibroblasts
At least 20 confluent T175 cm2 flasks of cells were harvested for each plasma
membrane isolation experiment. Under aseptic conditions, the medium was
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aspirated and discarded from each of the flasks. A volume of 10 ml of sterile
filtered, ice cold DPBS containing 1mM EDTA (DPBS:EDTA solution) was added to
each flask and incubated at room temperature for 10 minutes. The cells were then
detached from the flasks using a cell scraper. The cell suspension was transferred
into a sterile universal and centrifuged at 1000 g for 20 minutes at 4°C. The
supernatant was removed and the cell pellet was suspended in 10 ml of ice cold
DPBS:EDTA solution. The cell suspension was centrifuged again at 1000 g for 20
minutes at 4°C. The supernatant was removed and suspended with the
DPBS:EDTA solution and centrifuged again as previously described. The pellet was
suspended with the DPBS:EDTA solution to give a total volume of 2 ml, also known
as the packed cell volume (PCV).
A cell count was performed on the PCV as described in section 2.2.3.4. At least 1 x
108 cells were required for the subsequent isolation protocol. The PCV was
separated into two labelled cryovials and snap frozen in liquid nitrogen. The vials
were then stored at -80°C until required.
2.2.6.5.2 Harvesting suspension U937 histiocytes
At least 20 confluent T175 flasks of cells (approximately 1 x 108 cells) were required
for each plasma membrane isolation experiment. The cells were removed from
each flask into a sterile universal and centrifuged at 1000 g for 20 minutes at 4°C.
The cell pellet was suspended with 10 ml of DPBS:EDTA and centrifuged at 1000 g
for 20 minutes at 4°C. This centrifugation step was repeated once more and the
pellets were pooled to give a total volume of 2 ml. A cell count was performed
(section 2.2.3.4) and the cells were snap frozen as described in section 2.2.6.5.1.
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2.2.6.5.3 Cell disruption using a ball-bearing homogeniser
All solutions and tubing were placed on ice prior to commencing the procedure. The
PCV was thawed rapidly in a 30°C water bath and transferred into a universal. The
PCV was suspended in 2 ml of homogenising solution (section 2.1.10.3) and placed
immediately on ice. The ball-bearing homogeniser was then used to break the cells.
The ball-bearing homogeniser was assembled by placing the ball bearing into the
central compartment of the homogeniser. The end plates were screwed into
position to secure the ball bearing within the homogeniser. A long metal syringe
needle was attached to a disposable 2.5 ml syringe and 1 ml of the PCV was
transferred into the syringe. The metal needle was removed and the syringe was
connected to the inlet of the homogeniser. A second disposable 2.5 ml syringe was
connected to the outlet of the homogeniser (Figure 2.11). The PCV was then
syringed into the homogeniser and collected in the second syringe. To ensure
complete cell disruption of the PCV, the cell suspension was passed through the
homogeniser ten times. The process was repeated for the entire volume of the
PCV.
Figure 2.11 – Diagram of assembled ball-bearing homogeniser. A – Inlet of
homogeniser. B – 2.5 ml syringe. C – Packed cell volume. D – Outlet of homogeniser. E –
End plate screwed into position. F – Ball bearing in bore of homogeniser.
The homogenate was transferred to a 15 ml Falcon tube and homogenising solution
(section 2.1.10.3) was added to give a final volume of 10 ml. The suspension was
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then centrifuged at 800 g for 10 minutes at 4°C. The supernatant was collected in a
50 ml Falcon tube and homogenising solution was added to give a final volume of
20 ml. The suspension was centrifuged at 6000 g for 10 minutes at 4°C. The
supernatant was then transferred into 14 ml thin walled ultracentrifugation tubes
and using the SW-40 Beckmann rotor, the samples were centrifuged at 100,000 g
for 30 minutes at 4°C. The supernatant was discarded and the pellets were
resuspended and pooled in 500 µl of 10mM Tris-HCl, pH 7.5. To ensure complete
resuspension of the pellets, a long, 1 mm gauge, metal needle attached to a 5 ml
syringe was used to disrupt the pellet.
2.2.6.5.4 Membrane fractionation using a sucrose density gradient
The suspended pellet from section 2.2.6.5.3 was transferred into a 14 ml thin walled
ultracentrifugation tube. A volume of 1.34 ml of 70% (w/v) sucrose diluted in 10 mM
Tris-HCl, pH 7.5 was mixed with the pellet. Using a glass Pasteur pipette, the
following sucrose solutions (dissolved in 10 mM Tris-HCl, pH 7.5) were carefully
added to the sample, layer by layer; 3ml of 44% (w/v) sucrose, 3 ml of 31% sucrose
and 2 ml of 9% (w/v) sucrose. The sucrose gradient was then centrifuged in a
Beckmann SW-40 rotor at 100,000 g, for 90 minutes at 4°C without the brake
applied.
The bands at the interfaces of the 9/31% (w/v) sucrose and the 31/45% (w/v)
sucrose were pooled and collected into a clean 14 ml thin walled ultracentrifugation
tube using a glass Pasteur pipette.
The collected bands were diluted at least 3 fold with 10 mM Tris-HCl, pH 7.5 and
then centrifuged in a Beckmann SW-40 rotor at 100,000 g, for 30 minutes at 4°C.
The pellet was resuspended in 200 µl of 20 mM MOPS with 30 mM sodium
sulphate, pH 7.4 and a 30 µl aliquot was placed in an Eppendorf to perform a
bicinchoninic acid (BCA) assay to determine the concentration of protein recovered
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(section 2.2.6.5.5). The remaining isolated membrane sample were transferred to a
labelled cyrovial and snap frozen in liquid nitrogen before being stored at -80°C.
2.2.6.5.5 Determining the concentration of isolated membrane protein
using the bicinchoninic acid assay
An Eppendorf containing a 30 µl aliquot of the isolated membrane protein sample
isolated in section 2.2.6.5.4 was defrosted in a 30°C water bath. The sample was
separated into three wells of a Nunc® flat-bottom 96 well plate at a volume of 10 µl
per well. A volume of 15 µl of ultrapure distilled water was added to each well to
give a total sample volume of 25 µl per well. A bovine serum albumin (BSA)
standard curve was established using a stock solution of 0.4 mg.ml-1 BSA dissolved
in ultrapure distilled water. A volume of 25 µl of each of the following standard curve
concentrations (0, 2, 4, 6, 8 and 10 µg of BSA per well) was added in triplicate to
the 96 well plate.
The BCA working solution was prepared by diluting one part of 4% (w/v) copper (II)
sulphate pentahydrate solution with 49 parts of the BCA solution A (Pierce®,
Thermo Fisher Scientific), which contains bicinchonia acid, NaCO3, sodium tartrate,
sodium bicarbonate in 0.1M NaOH, pH 11.5. A volume of 200 µl of the BCA
working solution was added to each well of the sample and the BSA standards. The
96 well plate was then covered with a lid and incubated in a 37°C incubator for 30
minutes. After the incubation period, the absorbance of the standards and samples
was read at 562 nm using the MultiScan plate reader and ScanIt MSS software
(version 2). A calibration curve of the BSA concentration (in micrograms) against
the absorbance of the standards was plotted with a linear trend-line. Using the
linear equation of the standard curve, the amount of protein in micrograms for each
sample was calculated. Taking into account the dilution factor, the concentration of
the protein of each sample was calculated in mg.ml-1.
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2.2.6.6 Optimising the concentration of isolated fibroblast plasma
membranes for quartz crystal microbalance with
dissipation
The isolation of cell plasma membranes from fibroblasts and macrophages is
detailed in section 2.2.6.5. In order to form a solid supported planar membrane for
QCM-D analysis, the optimal protein concentration of the isolated membranes was
investigated. The isolated plasma cell membranes of L929 fibroblast were used to
optimise the concentration of protein required to form a solid supported planar
membrane. A 5 mg vial of lipids (section 2.2.6.1) was reconstituted in 1 ml of 20
mM MOPS with 30 mM sodium sulphate, pH 7.4. The concentration of the isolated
L929 fibroblast proteins was determined using the BCA assay (section 2.2.6.5.5). A
range of 0.5 mg.ml-1 protein: lipid mixtures, diluted in 20 mM MOPS with 30 mM
sodium sulphate,  pH 7.4 were prepared containing different amounts of protein
from the membrane extraction at 0.1, 0.2 and 0.3 mg ml-1, to give a ratio of 20%,
40% and 60% (w/w) of protein to lipid. To form the vesicles, each solution was
extruded first through a track-etched polycarbonate filter with a pore size of 200nm
followed by a 100 pore size track-etched polycarbonate filter as described in section
2.2.6.2. The vesicle solutions were kept on ice until required and any remaining
vesicles were discarded after 24 hours.
The QCM-D analysis was performed at described in section 2.2.6.4, whereby each
sensor corresponded to a different concentration of the isolated protein: lipid
solution. In brief, the protein: lipid vesicle solutions were flowed through each
chamber for 10 minutes at a flow rate of 70 µl per minute. This was followed by a
20 minute ultrapure distilled water plus 1 mM EDTA wash. The solution was
changed to DMEM and once the frequency and dissipation had stabilised the
experiment was terminated. The results of the change in frequency and dissipation
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were compared for each protein: lipid solution to establish which concentration
generated the most stable solid supported planar membrane.
2.2.6.7 Formation of protein: lipid vesicles for quartz crystal
microbalance with dissipation and vesicle leakage
analysis.
A protein: lipid solution diluted in 20 mM MOPS with 30 mM sodium sulphate, pH
7.4 was prepared, consisting of 0.1 mg ml-1 protein and 0.4 mg ml-1 lipid (20% (w/w)
protein to lipid ratio) (see section 2.2.6.6 for optimisation of protein concentration).
To form the vesicles, the solution was extruded first through a 200 nm pore size
filter followed by a 100 pore size filter as described in section 2.2.6.2. The vesicle
solutions were kept on ice until required. The vesicle leakage and QCM-D
experiments were performed as described in section 2.2.6.3 and 2.2.6.4,
respectively.
2.2.6.8 Modelling quartz crystal microbalance with dissipation
data
The computer software, QTools (version 3.1) was used to model the QCM-D data,
using the Voight viscoelastic model. The first layer of the model was established to
represent the sBLM. The outputs for layer one were then used to model the second
layer, which represented the bound particles. The outputs of the second layer were
the viscosity, shear modulus and thickness of the particle layer. These outputs
indicated if particle binding occurred and the effect on the viscoelastic sBLM. The
fixed parameters for the densities of each layer are listed in Table 2.4, which were
used for the Voight model.
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Table 2.4 – Fixed parameters used for modelling quartz crystal microbalance with
dissipation Density of alumina from manufacturer’s specifications as described in section
2.1.1 (PlasmaChem, Berlin, Germany). (Behl et al. 2013; Jing et al. 2014; Malmström et al.
2007).
Fixed Parameter Density (kg/m3)
Lipid bilayer 1000
Alumina particles 3900
CoCr particles 7700
2.2.7 Statistical analysis
2.2.7.1 Confidence Levels
Data was analysed using Microsoft Excel (version 2010) and the mean and 95%
confidence levels (CL) were calculated. The 95% confidence levels (α = 0.05) were
calculated using the descriptive statistics of Microsoft Excel.
mean = ∑xn
Standard deviation = ∑x2n-1
Standard error (SE) of the mean = Standard deviation√n95% CL=mean ±t x SE
X = Individual value
n = Sample number
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2.2.7.2 Statistical analysis
Data was analysed by one way analysis of variance (ANOVA) and individual
differences between group means were determined using the Tukey-method to
calculate the minimum significant difference (MSD) (p=0.05). The MSD was
calculated using the following equation:MSD=Q (α[k,v]) X SE
Q = Critical value
α =  p = 0.05
k = number of groups
v = degree of freedom (n-1)
For the vesicle leakage assays, the group means were analysed using a paired t-
test and results with a p< 0.05 were significantly different.
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Chapter 3
Generation, characterisation and biocompatibility of cobalt
chromium alloy and alumina ceramic particles
3.1 Introduction
Total hip replacements have been hugely successful in treating end stage
osteoarthritis of the hip joint, leading to over 83,000 primary hip replacement
operations being performed, in the UK, in 2014 (NJR 2015). However, THRs
consisting of a traditional UHMWPE acetabular cup component were historically
associated with high wear rates and promoting osteolysis, eventually leading to late
stage aseptic loosening (Ingham and Fisher 2000; Caton and Prudhon 2011). In the
1980s, there was a rise in the popularity of CoCr alloy metal-on-metal THRs, which
was shortly followed by alumina-based ceramic prostheses. These bearing
materials were perceived as an attractive alternative for younger and more active
patients (Bessette et al. 2003). This was partly due to the low wear rates of the
THRs and therefore was thought to promote implant survivability, which would
delay or prevent the need for revision surgery (Smith et al. 2001; Dowson et al.
2004a; Dowson et al. 2004b; Dowson and Jin 2006). However, more recently CoCr
alloy metal-on-metal prostheses and the wear particles produced have been
associated with adverse responses in patients including pseudotumours, causing a
rise in revision surgeries. At present it is unclear on the mechanism of these
adverse responses. In addition to this, the popularity of ceramic-on-ceramic THRs
has continued to rise in the UK, although this is not the case in the USA (Berry &
Lieberman 2012). Nevertheless, there are limited relevant cell studies on the
particles generated from these implants.
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3.1.1 Cobalt chromium total hip replacements and resurfacing
implants
The wear of retrieved, second generation CoCr metal-on-metal THRs has been
reported to be 5 µm per year, when the femoral head component is positioned
central to the acetabular cup following the initial running in phase (Sieber et al.
1999). Simulator studies of optimally positioned metal-on-metal implants have
reported wear rates less than 1 mm3 per million cycles (Clarke et al. 2000; Smith et
al. 2001; Dowson et al. 2004a; Dowson et al. 2004b; Vassiliou et al. 2007).
Cobalt chromium wear particles, generated by metal-on-metal prostheses, have
been observed to be predominately nanoscale in size from both retrieval and
simulator studies (Doorn et al. 1998; Firkins et al. 2001b; Brown et al. 2007; Goode
et al. 2012). Doorn et al. (1998) reported that CoCr wear particles isolated from
periprosthetic tissues of patients undergoing revision surgery had a mean diameter
of 81 nm. The morphology of the particles was also observed to be round in
morphology, with some shard-like particles using TEM. Simulator studies of metal-
on-metal THRs have reported CoCr wear particles to be slightly smaller, with a
mean size of 30 – 40 nm (Firkins et al. 2001b; Williams et al. 2003; Brown et al.
2007; Papageorgiou et al. 2007).
Until recently large diameter THRs and hip resurfacing implants were increasing in
popularity, especially with active patients due to a perceived increased range of
motion and low wear (Dowson and Jin 2006; Underwood et al. 2011). However as
described in Chapter one, the wear particles and ion release from these implants
have been associated with adverse reactions in patients including type IV delayed
hypersensitivity reactions and pseudotumours (Pandit et al. 2008; Hart et al. 2009;
Gill et al. 2012). Retrieval studies have reported incidences of high wear rates of 22
mm3 per year of large diameter hip resurfacing implants (Langton et al. 2010; Joyce
et al. 2011; Lord et al. 2011). Furthermore, these implants have been associated
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with elevated corrosive wear at the taper junction due to the combination of a large
femoral head on a small femoral neck component, causing an increased frictional
torque (Langton et al. 2011). Simulator studies have demonstrated that non-
optimum positioning of the implant, such as the introduction of translational or
rotational malpositioning can increase the wear rates in comparison to well
positioned implants (Brown et al. 2007; Williams et al. 2008; Leslie et al. 2009;
Fisher 2011; Leslie et al. 2013; Williams et al. 2013).
3.1.2 Alumina ceramic total hip replacements
The low wear rates of alumina based ceramic-on-ceramic THRs have led to
difficulties in the estimation of the wear rates. Patient retrieval studies have
predicted the wear rates to be less than 0.5 mm3 per year (Esposito et al. 2012).
Simulator studies have also reported wear rates of 0.22 mm3 per million cycles or
less, even under adverse conditions (Nevelos et al. 2001; Stewart et al. 2003; Al-
Hajjar et al. 2010; Al-Hajjar et al. 2013).
Alumina ceramic wear particles from ceramic-on-ceramic THR simulator studies
and retrieval studies were reported to have a wide size distribution with a bimodal
size distribution observed (Hatton et al. 2002; Tipper et al. 2002). Using TEM, a
size range of 5 – 90 nm was reported, whereas when SEM analysis was used a
size distribution of 0.05 – 3.2 µm was observed. It is thought that the wide range of
particle sizes was caused by the introduction of translational malpositioning (Tipper
et al. 2002). Fluoroscopy studies predicted that translational malpositioning
occurred in approximately half of polyethylene-on-metal THRs and the introduction
of these conditions for ceramic-on-ceramic THRs generates a characteristic wear
stripe on the femoral head and cup edge (Lombardi et al. 2000; Stewart et al.
2003). Nevertheless, the introduction of translational malposition has been reported
to not extensively elevate the wear rates of ceramic-on-ceramic THRs, even when
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the acetabular cup in positioned at a high abduction angle (Al-Hajjar et al. 2010; Al-
Hajjar et al. 2013).
3.1.3 Biocompatibility of wear particles from total hip
replacements
3.1.3.1 Particle sources
To determine the biocompatibility of CoCr and alumina particles in vitro, a variety of
particle sources have been used in the reported literature. These include the use of
commercially available particles and particles isolated from joint simulators, excised
tissue or simple pin-on-plate wear simulators. One of the main advantages of using
wear particles from joint and pin-on-plate wear simulators or excised tissue is being
able to use clinically relevant wear particles (Jin et al. 2000; Brown et al. 2007).
However, if proteins are present in the samples, such as in the simulator lubricant, it
is technically difficult to isolate the particles in order to visualise the particles and
determine size distribution accurately. This is especially problematic for CoCr wear
particles, which are susceptible to extremes of pH and high temperatures, which
lead to aggregation, changes in particle size or loss of particles (Catelas et al.
2001a; Catelas et al. 2001b). Isolating CoCr and alumina wear particles from serum
is particularly challenging due to their small particle size and the low wear rates
experienced under standard gait conditions (Brown et al. 2007; Billi et al. 2012b).
Moreover, alkaline digestion methods have been reported to alter the morphology,
shape, and composition of CoCr wear particles (Catelas et al. 2001a; Catelas et al.
2001b). Particle preparation can also have an effect on particle characterisation, for
example the resin embedding and sample preparation for TEM analysis has been
shown to cause aggregation, thus potentially causing particle size inaccuracies
(Doorn et al. 1998).
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Simple configuration pin-on-plate wear simulators mimic the wear mechanisms and
kinematics of the THRs during the normal gait cycle (Jin et al. 2000; Jin et al. 2006).
The advantage of using pin-on-plate simulators is that they have been
demonstrated to generate clinically relevant CoCr wear particles using water as a
lubricant (Jin et al. 2000). This is particularly advantageous as it eliminates the
need for any digestion protocol to isolate the particles, and particles can be
recovered by filtration or centrifugation.
Another factor affecting the use of particles from tissue or joint simulators, which
utilise lubricants containing serum, is the low wear rates. This is particularly
problematic for alumina wear particles as the wear rates of ceramic-on-ceramic
THR are very low (Al-Hajjar et al. 2010; Affatato et al. 2012; Esposito et al. 2012).
At present the isolation methods developed and detailed in the ISO standard 17583
do not allow sufficient volumes of particles to be isolated. Therefore a number of
studies have used commercially available particles, such as particles of alumina
powders used in orthopaedic device manufacturing.
3.1.3.2 Cell studies on wear particles
Hard-on-hard bearings became more popular due to the low wear rates and the
generation of predominately nanoscale wear particles (Dowson and Jin 2006). It
was thought that this would reduce the incidence of osteolysis and aseptic
loosening often associated with higher wearing traditional UHMWPE THRs (Ingham
and Fisher 2000; Brown et al. 2006). However, as previously described, adverse
tissue reactions, associated with CoCr wear particles, have been extensively
reported by patients with metal-on-metal THRs or resurfacing implants, which has
led to the continued monitoring of patients with such devices (Davies et al. 2005;
Pandit et al. 2008; Natu et al. 2012; MHRA 2015). In contrast, alumina wear
particles have only been associated with isolated incidences of tissue necrosis in
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vivo (Niche et al. 2006; Affatato et al. 2012). This lack of obvious adverse
responses to alumina wear particles is partly due to the low wear rates of ceramic-
on-ceramic THRs with in vitro studies only reporting adverse effects at high particle
doses, which would not be observed clinically (Germain et al. 2003; Rose et al.
2012).
A number of in vitro studies have examined the effect of CoCr and alumina wear
particles on a variety of cell types as described in detail in Chapter one. As well as
causing genotoxicity, inflammation and oxidative stress, CoCr wear particles have
been reported to be cytotoxic in a dose- and time-dependent manner (Hatton et al.
2003; Brown et al. 2006; Posada et al. 2014). In contrast alumina nanoscale and
micron sized wear particles have been reported to be cytotoxic only at very high
particle concentrations (Germain et al. 2003; Papageorgiou et al. 2007; Rose et al.
2012). However, limited conclusions can be made as numerous studies do not use
clinically relevant particles (Hallab et al. 2000; Tsaousi et al. 2010; Dalal et al. 2012;
Caicedo et al. 2013). Alongside particle dose and exposure time, wear particle
composition, size and shape are of particular importance in terms of the cellular
response to particles (Yoshida et al. 2003; Kwon et al. 2009; Dalal et al. 2012). The
effect of particle size on cell viability has been widely studied and in general CoCr
micron sized particles are less cytotoxic in comparison to nanoscale CoCr particles
(Germain et al. 2003; Papageorgiou et al. 2007). Although it must be noted that this
does not necessarily mean the micron sized particles do not induce other cell
responses, such as inflammation (Brown et al. 2013). The relationship between
particle size and cell responses is less clear for alumina wear particles with some
studies reporting smaller particles induced a greater effect on cell viability and vice
versa (Catelas et al. 1999; Germain et al. 2003; Gutwein and Webster 2004).
Particle shape has been reported to affect cell viability with a larger aspect ratio of
alumina model particles were associated with a greater effect on cell mortality
(Yoshida et al. 2003). Therefore in order to determine the precise mechanism of
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particle toxicity, particles which are similar in terms of size, composition and shape
to the published literature should be used for cell studies and to produce more
meaningful conclusions.
3.2 Aims and objectives
The aim of the first part of this chapter was to generate and isolate nanoscale and
micron sized alumina ceramic and CoCr particles. Nanoscale CoCr particles were
generated using a six station pin-on-plate wear simulator employing the same alloy
used in the manufacture of metal-on-metal THRs. The lubricant chosen was water,
which removed the need for lubricant digestion. To study the effect of particle size,
CoCr micron sized particles were also used. These were sourced from a
commercially available CoCr powder, which has a similar composition to the CoCr
alloy used for metal-on-metal THRs. For the alumina particles, a powder of alumina,
which is used to manufacture ceramic hip components, was used. By means of
sequential filtration techniques, attempts were made to isolate the nanoscale and
micron particle size fractions. All particle types were characterised in terms of size,
morphology, composition using SEM, EDX analysis and image analysis software
(Image Pro Plus).
The second half of this chapter was concerned with determining if the isolated
particles were comparable to the published literature in terms of their effect on the
cell viability of primary HFBs and a U937 histiocyte cell line. Whilst a number of
studies previously outlined in Chapter one have studied the effect of particles on a
range of cell responses, the most common and simplest method was to investigate
the effect on cell viability. This was determined using two cell viability assays to
ascertain the cytotoxic potential of the isolated particles. After characterisation, the
particle stocks could be used for further cell studies including cell membrane
studies to determine how and if the particle interact and disrupt the cell membrane.
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3.2.1 Objectives
The objectives of this part of the thesis are outlined in Figure 3.1 and included:
 To generate CoCr alloy particles using a six station pin-on-plate simulator
 To sequentially filter an alumina powder to isolate the micron sized alumina
particles
 To optimise the sequential filtration method to isolate the nanoscale alumina
particles from an orthopaedic alumina powder
 To characterise nanoscale and micron sized alumina and CoCr particles
using SEM, EDX analysis and image analysis software, Image Pro Plus
 To investigate the effect of nanoscale and micron sized alumina ceramic
and CoCr particles on the cell viability of primary HFBs and a U937
histiocyte cell line using the ATPlite and MTT assays
Chapter 3
93
Figure 3.1 – Outline of thesis and Chapter three methods
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3.3 Materials and methods
3.3.1 Materials
3.3.1.1 Cobalt chromium and alumina particles
Nanoscale and micron sized alumina and CoCr particles are detailed in section
2.1.1.
3.3.2 Methods
3.3.2.1 Sequential filtration of alumina powder to isolate the nanoscale and
micron sized particle fraction for subsequent particle studies
In order to isolate nanoscale alumina particles, an alumina powder (section 2.1.1)
was sequentially filtered to isolate the micron sized and nanoscale particles.
Pre-weighing of filter membranes to calculate recovery rates of3.3.2.1.1
nanoscale and micron sized particle fractions from an alumina
orthopaedic powder
Before commencing, 5 ml of 70% (v/v) ethanol in water was filtered through a 0.015
µm pore size polycarbonate filter and the filter was dried under an infrared light for
at least 4 hours in a laminar flow hood. The filter was stored in a temperature and
moisture controlled environment of the measurement laboratory (School of
Mechanical Engineering, Faculty of Engineering) for 48 hours before being weighed
using an AT21 microbalance. An average of 5 measurements were recorded, which
were within 10 µg of one another. The mean weight of the filter was recorded.
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Preparation of filtration equipment3.3.2.1.2
The filtration glassware was washed and scrubbed using household detergent and
a bottle brush and rinsed at least three times with distilled water, followed by a final
rinse in ultrapure distilled water. The glassware was wrapped in foil and sterilised in
the oven at 190°C for 4 hours. The polymer part of the filtration unit was washed
and scrubbed using household detergent and rinsed with copious amounts of
distilled water and rinsed three times with distilled water, followed by a final rinse
with ultrapure distilled water. All filtration was performed in a class I laminar flow
hood and all equipment was sterilised in a hot air oven at 190°C for 4 hours. The
sterile glass filtration unit was assembled as described in Figure 3.2.
Figure 3.2 - Assembled filtration unit for isolating nanoscale and micron sized
fraction of orthopaedic powder. 1 – Glass reservoir. 2 – Clamp. 3 – Filter membrane and
polymer filter support. 4 – Collection flask. 5 – Vacuum pump.
Filtration of powder to isolate the nanoscale particle fraction3.3.2.1.3
A small mass of alumina particles (0.1 grams), weighed into a clean 500 ml Duran
glass bottle, was subjected to sonication in 500 ml of 70% (v/v) ethanol for 30
minutes immediately prior to filtration. The particle suspension was subsequently
filtered through varying series of filters with pore sizes ranging from 10 µm to
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0.015 µm in an attempt to isolate a large mass of nanoscale particles (Table 3.1).
Each filter was flushed with at least 20 ml of distilled water to remove any trapped
particles prior to removing the filter from the filtration unit. The filter membrane was
removed and placed in a 250 ml sterile plastic pot with a small amount of ultrapure
water (20 – 30 ml). The filter membrane was then sonicated to remove the collected
particles, which were stored at -20°C. The remaining filtrate was sonicated for 30
minutes and then filtered through the filter with the next smallest pore size. Finally
the filtrate was filtered the through a pre-weighed 0.015 µm filter. The 0.015 µm
filter was dried under an infrared lamp for at least 4 hours and weighed as
described in section 3.3.2.1.1. The recovered particle mass was determined by
subtracting the original mass of the filter.
Table 3.1 – Sequence of filtration steps used to isolate the nanoscale particle fraction
from an alumina powder. The alumina powder of a specified weight was filtered through a
series of filter membranes with different pore sizes.
Method Sequence of filter membrane pore sizes used (µm)
A 10 1 0.1 0.015
B 1 0.1 0.015
C 10 1 0.8 0.015
D 10 0.8 0.015
E 10 0.4 0.015
Filtration of the alumina powder to isolate the micron sized particle3.3.2.1.4
fraction
A small mass of alumina particles (0.1 grams) in a clean 500 ml Duran glass bottle
was subjected to sonication in approximately 500 ml of 70% (v/v) ethanol for 30
minutes immediately prior to filtration. The particle suspension was subsequently
filtered through a filter membrane with a pore size of 10 µm. The filter was flushed
with at least 20 ml of distilled water to remove any trapped particles, prior to
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removing the filter from the filtration unit. The remaining filtrate was sonicated and
then filtered through a 0.1 µm filter membrane. Again this filter was flushed with at
least 20 ml of distilled water to remove any trapped particles prior to removing the
filter from the filtration unit.  The 0.1 µm filter membrane was removed and placed
in a 250 ml sterile plastic pot with a small amount of water (20 – 30 ml). The filter
membrane was sonicated to remove the collected particles. A small aliquot (1 ml) of
this particle suspension was filtered through the pre-weighed 0.015 µm filter in
order to determine the mass of particles recovered. The filter was dried under an
infrared lamp for at least 4 hours and weighed as described in section 3.3.2.1.1.
The recovered particle mass was determined by subtracting the original mass of the
filter. The remaining particle suspension was stored at -20°C for long term storage.
3.3.2.2 Characterisation of nanoscale and micron sized alumina and cobalt
chromium particles
The size, composition and morphology of the particles were determined and
analysed using SEM and EDX analysis
Preparation of particles for scanning electron microscope analysis3.3.2.2.1
Approximately 5 ml of 70% (v/v) ethanol was filtered through a 0.015 µm pore size
filter membrane. A small volume (100 µl) of one of the nanoscale and micron sized
CoCr and alumina particle stocks, described in section 2.1.1 and 3.3.2.1.4 were
diluted 1:10 with 70% (v/v) ethanol. The diluted particle stock was sonicated for 30
minutes before being filtered through a pre-weighed 0.015 µm pore size filter
membrane. The filter was dried under an infrared lamp for 4 hours. A small section
of the dried filter membrane was mounted on to a 2.5 cm aluminium short stub
using an adhesive carbon tab and the edges of the filter were coated with carbon
paste. The CoCr nanoscale, alumina nanoscale and alumina micron sized particle
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samples were sputter coated with a platinum and palladium composite to a
thickness of 3 – 10 nm. The CoCr micron sized particles were coated with a carbon
film at a thickness of 3 – 10 nm.
Imaging and characterisation of particles3.3.2.2.2
The CoCr nanoscale, alumina nanoscale and alumina micron size particles were
visualised using the Leo 1530 FEGSEM at a working distance of 3 – 4 mm and an
acceleration of 3 kV. Images were taken at magnifications of x 60 K, x 90 K, x 150
K and x 300 K. The micron size CoCr particles were visualised using the Hitachi
SU8230 SEM at a working distance of 3 mm and at 1 kV and imaged by Mr Imran
Asif (Faculty of Engineering, University of Leeds). Due to the large size of the
particles, images were taken at lower magnifications of x 1.5 K and x 5 K, The SEM
images were analysed using the image analysis software, Image Pro Plus (version
6.1) to measure the maximum length and area of the particles. Approximately 150
particles were characterised in total and only particles where the entire
circumference could be observed were measured. The results were expressed as
percentage particle size and percentage particle area distribution graphs.
Energy dispersive x-ray spectroscopy analysis of particles3.3.2.2.3
Pin point EDX analysis of nanoscale and micron sized alumina and CoCr particles
was performed using the Gemini EDX analyser at a working distance of 8.5 mm, 10
kV and a magnification of x 10 - 20 K. The EDX spectra were acquired using AZtec
software (version 2). For EDX analysis of alumina nanoscale particles, the sample
was coated with 3 – 10 nm of a palladium: iridium mixture rather than a
platinum:palladium composite, which was used for the SEM images
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3.4 Results
3.4.1 Sequential filtration of alumina orthopaedic powder to
isolate the nanoscale particle fraction for subsequent
particle studies
Initially it was intended for the nanoscale alumina debris to be isolated from an
alumina powder using sequential filtration. However, as shown in Table 3.2 the
recovery of nanoscale debris was relatively low, with method A and B only
recovering 15 – 16 µg of nanoscale particles from a starting weight of 0.1 g of
powder. Optimisation of the filtration process included suspending the particles in
70% (v/v) ethanol instead of water and increasing the particle dilution, however,
these changes did not improve the recovery rates of nanoscale particles. Therefore,
the 0.1 µm filter membrane was omitted and replaced with a 0.8 µm filter
membrane (method C & D) or a 0.4 µm filter membrane (method E). However,
none of the optimisation steps attempted allowed recovery of a sufficient mass for
future cell culture experiments as tens of milligrams was required in total.
Therefore, a commercially available nanoscale alumina powder was purchased and
was used in the cell viability assays and membrane toxicity experiments.
Chapter 3
100
Table 3.2 – Optimisation methods and recovery of isolating alumina nanoscale
particles from an alumina powder. The alumina powder of a specified weight was filtered
through a series of filter membranes with different pore sizes. The recovery weight of the
nanoscale alumina particles is recorded for each method.
Method
Sequence of filter
membrane pore sizes used
(µm)
Starting Weight (g)
Recovery
(µg)
A 10 1 0.1 0.015 0.101 15
B 1 0.1 0.015 0.1 16
C 10 1 0.8 0.015 0.102 13.2
D 10 0.8 0.015 0.1 94.9
E 10 0.4 0.015 0.5 167.2
3.4.2 Characterisation of commercially available nanoscale
alumina particles
The aim of this series of experiments was to characterise commercially available
nanoscale alumina particles which could be used in subsequent cell culture
response assays. A small mass (0.01 g) of alumina particle suspension was
suspended in 70% (v/v) ethanol and subjected to sonication for 30 minutes. The
particle suspension was immediately filtered on to a 0.015 µm filter membrane and
analysed using FEGSEM as described in section 3.3.2.2. The alumina nanoscale
particles formed large aggregates, making characterisation of individual particles
difficult. However, the smaller particles were mostly oval in morphology, whereas
the larger nanoscale particles were observed to be more polygonal in shape as
shown in Figure 3.3.
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Figure 3.3 – Scanning electron microscopy image of nanoscale alumina particles.
Particles were isolated from a commercially available alumina powder and filtered onto a
0.15 µm pore filter membrane.  Particles in this image were observed at 90 K magnification,
3 kV, and working distance of 4 mm.
EDX analysis was performed on the nanoscale alumina particles and an example
EDX spectrum is shown in Figure 3.4. The main peaks detected were aluminium
and oxygen. The iridium peaks within the spectrum were attributed to the coating of
the particle samples.
The nanoscale alumina particles were characterised using the SEM images and the
image analysis software, Image Pro Plus (section 3.3.2.2.2). Particles ranging from
10 – 265 nm were measured. The mode size of the particles was measured at 30 –
39 nm, with a mean particle size of 39.5 nm (± 26.5 nm SD, as shown in Figure
3.5A). The majority of the particles were less than 40nm in size, accounting for
88% of the total sample. Particles sized 30 – 39 nm had the largest particle area,
accounting for 36 % of the particles measured (Figure 3.5B).
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Figure 3.4 – Pin point energy-dispersive X-ray spectroscopy of nanoscale alumina
particles. Nanoscale alumina particles were filtered onto a 0.015 µm pore sized filter
membrane and placed on an aluminium stub. The sample was coated with a palladium:
iridium composite at a thickness of 3 – 10 nm. Pin point EDX analysis was performed at a
working distance of 8.5 mm, 10 kV and a magnification of 20 K. (A) Image of analysed
alumina particles. (B) Example EDX spectrum. Arrows indicate characteristic elements of
particles.
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Figure 3.5 – Percentage size (A) and area (B) distribution of nanoscale alumina
particles. Nanoscale alumina particles were suspended in 70% (v/v) ethanol and collected
onto a 0.015 µm pore size filter. The dried filter was placed on an aluminium platform stub
and coated with platinum. Particles were imaged using FEGSEM analysis and the
percentage distribution of the maximum length and area of the particles was determined
using Image Pro-Plus 6.1 software. At least 150 particles were characterised in total from
approximately 10 images.
Chapter 3
104
3.4.3 Characterisation of micron sized alumina particles
Alumina micron sized particles were isolated from an alumina powder as described
in section 3.3.2.1. The particles were isolated from the powder by filtering the
powder through a 10 µm filter membrane and subsequently collected on to a 0.1
µm filter membrane. An aliquot of the particle suspension was analysed on a 0.015
µm filter membrane and visualised using FEGSEM (section 3.3.2.2). A
representative image of the alumina micron size particles is shown in Figure 3.6.
Figure 3.6 – Scanning electron microscopy image of isolated micron sized alumina
particles. Particles were isolated from an aluminium oxide orthopaedic powder and filtered
through a 10 µm and 1 µm pore filter. Particles in this image were observed at 60 K
magnification, 3 kV, and at a working distance of 3.3 mm.
The micron sized alumina particles had a polygonal shard-like morphology and
similar to the nanoscale alumina particles, the particles had a tendency to
aggregate. EDX analysis was performed on the isolated particles and an example
EDX spectrum is shown in Figure 3.7. The main peaks detected were aluminium
and oxygen. The platinum and palladium peaks within the spectrum are attributed
to the coating of the particle samples. Furthermore, the large peak close to 0 KeV
was a characteristic carbon peak
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Figure 3.7 – Pin point energy-dispersive X-ray spectroscopy of micron sized alumina
particles. Micron sized alumina particles were filtered onto a 0.015 µm pore sized filter
membrane and placed on an aluminium stub. The sample was coated with a platinum:
palladium composite at a thickness of 3 – 10 nm. Pin point EDX analysis was performed at
a working distance of 8.5 mm, 10 kV and a magnification of 20K. (A) Image of analysed
micron sized alumina particles. (B) Example EDX spectrum of micron sized alumina
particles. Arrows indicate characteristic elements of particles.
Characterisation of the imaged particles using Image Pro Plus revealed a wide
distribution of particles sizes from 17 nm to 1464 nm in diameter. The mode particle
size was 400 – 449 nm, making up 19 % of the particle size distribution (Figure
3.8A). Similarly, the particle area distribution also had a wide distribution, with
particles sized 250 – 549 nm making up the majority of the particle area (89% of the
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particle area). The mode of the particle area distribution was also 400 – 449 nm,
comprising of 20 % of the total percentage area distribution (Figure 3.8B).
Figure 3.8 – Percentage size (A) and area (B) distributions of micron sized alumina
particles. Using sequential filtration, micron sized alumina particles were isolated from a
powder. Collected particles were imaged using FEGSEM analysis and the percentage
distribution of the maximum length and area of the particles was determined using Image
Pro-Plus 6.1 software. At least 150 particles were characterised in total.
Chapter 3
107
3.4.4 Characterisation of cobalt chromium particles generated
using a pin-on-plate simulator
The CoCr particles were generated using a six station pin-on-plate rig, (section
2.2.1). An aliquot of the CoCr particle suspension was subjected to sonication,
filtered on to a 0.015 µm filter membrane and analysed using FEGSEM, as
described in section 3.3.2.2. A representative FEGSEM image is shown in Figure
3.9. The CoCr nanoscale particles generated were mostly round to oval in
morphology and occasionally shard-like particles were detected.
Figure 3.9 – Representative scanning electron microscopy image of isolated cobalt
chromium particles. Particles were generated using a six station pin-on-plate wear rig and
isolated by filtration onto a 0.015 µm pore size polycarbonate membrane. Particles in this
image were observed at 90 K magnification, 3 kV, and working distance of 3.0 mm.
Pin point EDX analysis was performed to confirm the composition of the CoCr
particles and an example EDX analysis spectrum and corresponding image is
shown in Figure 3.10. The EDX analysis confirmed that the particles imaged were
indeed CoCr particles, which consisted of cobalt and chromium. Molybdenum was
not detected in any of the EDX spectrums.
The CoCr nanoscale particles were characterised using the FEGSEM images and
the image analysis software, Image Pro Plus (section 3.3.2.2.2). The mode size of
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the particles was measured at 40 – 49 nm; however particles up to 236 nm were
measured (Figure 3.11A). Whilst the majority of the particles were 40 – 49 nm in
size, the particles sized 70 – 79 nm had the largest particle area, making up 18 %
of the particles measured (Figure 3.11B). However, the majority of the particle area
distribution comprised of particles sized 40 – 89 nm (77% of the total particle area).
Figure 3.10 – Pin point energy-dispersive X-ray spectroscopy of nanoscale cobalt
chromium particles. Nanoscale CoCr particles were filtered onto a 0.015 µm pore sized
filter membrane and placed on an aluminium stub. The sample was coated with a
platinum:palladium composite at a thickness of 3 – 10 nm. Pin point EDX analysis was
performed at a working distance of 8.5 mm, 10 kV and a magnification of 20K. (A) Image of
analysed nanoscale CoCr particles. (B) Example EDX spectrum of nanoscale CoCr
particles. Arrows indicate characteristic elements of particles.
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Figure 3.11 – Percentage size (A) and area distribution (B) of nanoscale cobalt
chromium particles. Particles were generated using a six station pin-on-plate wear
simulator. Particles were imaged using FEGSEM analysis and the percentage distribution of
the maximum length and area of the particles was determined using Image Pro-Plus 6.1
software. At least 150 particles were characterised in total.
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3.4.5 Characterisation of commercially available micron sized
cobalt chromium particles
An aliquot of the commercially available micron sized CoCr particle suspension in
70% (v/v) ethanol was subjected to sonication, filtered through a 0.015 µm filter
membrane and analysed using SEM as described in section 3.3.2.2. A
representative FEGSEM image is shown in Figure 3.12. The CoCr micron size
particles were observed to be round in morphology with the occasional oval shaped
particles detected. Whilst some aggregates were observed, this was with much less
frequency than for the nanoscale alumina and CoCr particles.
Figure 3.12 – Representative scanning electron microscopy image of commercially
available micron sized cobalt chromium particles. Particles were isolated from a CoCr
powder and filtered onto a 0.015 µm pore size polycarbonate membrane. Particles in this
image were taken at x5 K magnification, 1 kV, and working distance of 3.0 mm.
EDX analysis was performed to confirm the composition of the CoCr micron size
particles and an example of an EDX analysis spectrum and corresponding image is
shown in Figure 3.13. The EDX analysis confirmed that the particles imaged were
comprised of cobalt and chromium.  Pin point EDX analysis also revealed that the
majority of the CoCr particles consisted of cobalt. The CoCr alloy also contained
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molybdenum, which unlike the CoCr nanoscale particle samples was detected in
some of the EDX spectra.
The CoCr micron particles were characterised using the FEGSEM images and the
image analysis software, Image Pro Plus (section 3.3.2.2.2). A wide distribution of
particle sizes were measured, with particles ranging from 150 nm to 6.95 µm. The
mode size of the particles was measured at 2 – 3 µm with a mean particle size of
3.26 µm (SD ± 1.30 µm) as shown in Figure 3.14A. Whilst the majority of the
particles were 2 – 3 µm in size, the particles sized between 3 – 4 µm had the
largest particle area, contributing up 38 % of the particles measured (Figure 3.14B).
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Figure 3.13 – Pin point energy-dispersive X-ray spectroscopy of micron sized cobalt
chromium particles. Micron sized CoCr particles were filtered onto a 0.015 µm pore sized
filter membrane and placed on an aluminium stub. The sample was coated with a carbon
composite at a thickness of 3 – 10 nm. Pin point EDX analysis was performed at a working
distance of 8.5 mm, 10 kV and a magnification of 10K. (A) Image of analysed of micron
sized CoCr particles. (B) Example EDX spectrum of micron sized CoCr particles. Arrows
indicate characteristic elements of particles.
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Figure 3.14 – Percentage size (A) and area (B) distribution of micron sized cobalt
chromium particles. Micron sized CoCr particles were suspended in 70% (v/v) ethanol and
collected onto a 0.015 µm pore size filter. The dried filter was placed on an aluminium
platform stub and coated with carbon. Particles were imaged using FEGSEM analysis and
the percentage distribution of the maximum length and area of the particles was determined
using Image Pro-Plus 6.1 software. At least 150 particles were characterised in total.
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3.4.6 The effect of nanoscale and micron sized alumina and
cobalt chromium particles on the cell viability of U937
histiocytes and primary human fibroblasts
The aim of this part of the study was to compare the effect of nanoscale and micron
sized alumina and CoCr particles on cell viability with other relevant in vitro studies
within the published literature. The simplest method was to investigate the effect of
the particles on the cell viability on U937 histiocytes and primary HFBs. These cell
types have been previously cultured in the presence of CoCr and alumina particles
in the published literature and therefore the results from this study could be
compared (Matthews et al. 2000; Germain et al. 2003; Brown et al. 2006;
Papageorgiou et al. 2007; Brown et al. 2013). In brief, the U937 histiocytes were
seeded into a 96 well plate at a density of 2 x 105.ml-1. For the primary HFBs, the
cells were seeded at a density of 1 x 105.ml-1.The cell density of the U937
histiocytes and primary HFBs for the cell viability ATPlite and MTT assays were
previously described by Germain et al. (2003) and Papageorgiou et al. (2007),
respectively. Cells were cultured in the presence of nanoscale or micron sized
alumina particles at particle volumes per cell of 0.0005 to 500 µm3 per cell (n = 6).
For the CoCr nanoscale and micron sized particles, the cells were cultured with the
particles at volumes of 0.0005 to 50 µm3 per cell (n = 6).
3.4.6.1 The effect of nanoscale and micron sized alumina and cobalt
chromium particles on the viability of U937 histiocytes
The effect of the nanoscale and micron sized alumina and CoCr particles on the
viability of U937 histiocytes was assessed using the ATPlite and MTT assay. These
results were then compared against the published literature to determine if the
particles induced a similar response.
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The effect of nanoscale and micron sized alumina particles on3.4.6.1.1
histiocyte cell viability using the ATPlite and MTT assay.
U937 histiocytes were cultured in the presence of nanoscale or micron sized
alumina particles at particle volumes of 0.0005 to 500 µm3 per cell. Cell viability was
measured at 0, 1, 3, 5 days after incubation using the ATPlite and MTT assays
(section 2.2.5). The results were expressed as a percentage of the cell only control.
Raw data were analysed using one way ANOVA and individual differences between
the means were determined using the Tukey method to calculate the MSD.
Significant (p < 0.05) adverse effects on cell viability in comparison to the cell only
control are indicated by an asterisk (*) in the subsequent graphs.
The ATPlite assay revealed no significant reduction in the cell viability for all particle
doses in comparison to the cell only negative control for both the nanoscale and
micron sized alumina particles (Figure 3.15A & 3.15B, respectively). Indeed on
occasion, the cell viability in the presence of the nanoscale or micron size particles
was higher than the cell only negative control. However, this difference was not
significant. A significant reduction in cell viability was measured for the positive
control of 2 µg.ml-1 camptothecin. After 24 hours of culture with the positive control,
there was an approximate 90% reduction in cell viability in comparison to the cell
only negative control for both the nanoscale and micron sized particles.
The MTT assay results were comparable to the ATPlite assay results (Figure 3.16).
Again the positive control (2 µg.ml-1 camptothecin) caused a significant reduction in
cell proliferation after 24 hours in comparison to the cell only negative control in all
experiments (Figure 3.16A and 3.16B, respectively). The main difference between
the ATPlite and MTT assays was observed for the nanoscale alumina particles at a
particle volume of 500 µm3 per cell at day 3 and 5. This particle volume had a
significant effect on the cell viability, and at day 3 there was an approximate 50%
reduction in cell viability, however, at day 5 this is reduced slightly to a 45%
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reduction for the MTT assay. Nevertheless this was still a significant reduction in
cell proliferation in comparison to the cell only control.
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Figure 3.15 – The effect of nanoscale alumina particles
(A) and micron sized alumina particles (B) on U937 cell viability using the ATPlite
assay. U937 histiocytes were cultured with nanoscale and micron sized alumina particles
for 5 days. Cell viability was determined using the ATPlite assay and presented as a
percentage viability compared to the cell only negative control. Data was analysed using
one-way analysis of variance (ANOVA) and the MSD was calculated using the Tukey
method. A statistically significant reduction (p<0.05) in the cell viability in comparison to the
cell only control, are indicated by an asterisk (*). Error bars represented ± 95% CI levels, n =
6 (■: 500 µm3 per cell; ●: 50 µm3 per cell; ▲: 5 µm3 per cell; ▼: 0.5 µm3 per cell; ♦: 0.05 µm3
per cell; ◄: 0.005 µm3 per cell; ►: 0.0005 µm3 per cell; ●: cell only control; : 2 µg.ml-1
camptothecin).
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Figure 3.16 – Effect of nanoscale (A) and micron sized (B) alumina particles on U937
cell viability using the MTT assay. U937 histiocytes were cultured with nanoscale and
micron sized alumina particles for 5 days. Cell viability was determined using the MTT assay
and presented as a percentage viability compared to the cell only negative control. Data
was analysed using one-way analysis of variance (ANOVA) and the MSD was calculated
using the Tukey method. A statistically significant reduction (p<0.05) in the cell viability in
comparison to the cell only control, are indicated by an asterisk (*). Error bars represented ±
95% CI levels, n = 6 (■: 500 µm3 per cell; ●: 50 µm3 per cell; ▲: 5 µm3 per cell; ▼: 0.5 µm3
per cell; ♦: 0.05 µm3 per cell; ◄: 0.005 µm3 per cell; ►: 0.0005 µm3 per cell; ●: cell only
control; : 2 µg.ml-1 camptothecin).
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The effect of nanoscale and micron sized cobalt chromium particles3.4.6.1.2
on U937 histiocyte cell viability using the ATPlite and MTT assay.
U937 histiocytes were cultured in the presence of nanoscale or micron sized CoCr
particles at particle volumes per cell of 0.0005 to 50 µm3 per cell. Cell viability was
measured at 0, 1, 3, 5 days after incubation using the ATPlite and MTT assays
(section 2.2.4). The results were expressed as a percentage of the cell only control.
For the ATPlite assay, both the nanoparticle and micron sized CoCr particle
studies, the positive control (2 µg.ml-1 camptothecin), caused a significant reduction
in cell viability in comparison to the cell only negative control (Figure 3.17A & 3.17B,
respectively). The majority of the particle volumes of micron sized CoCr particles
had no significant effect on U937 viability over the five days of culture. The
exception was that after five days an approximate 40% drop in cell viability was
measured for the highest particle volume of 50 µm3 per cell in comparison to the cell
only negative control. In contrast the nanoscale CoCr particles had a greater
detrimental impact on the cell viability. For the ATPlite assay, after one day of
culture, the highest particle volume of 50 µm3 per cell had a significant effect on the
cell viability with a 30% reduction in viability. After five days of culture, this had
increased to at least a 98% drop in viability. Furthermore, particle volumes of 5 µm3
per cell of nanoscale CoCr significantly reduced cell viability in comparison to the
cell only negative control after 3 and 5 days of culture.
Similar results were obtained using the MTT assay to assess cell viability. The
positive control, 2 µg.ml-1 camptothecin, significantly reduced cell viability after one
day of culture (Figure 3.18A and 3.18B, respectively). In contrast to the ATPlite
assay results (Figure 3.17B), no significant drop in cell viability was measured for
any of the particle volumes over the five days of culture with the micron sized CoCr
particles. The nanoscale CoCr particles were also observed to have less of an
effect on the cell viability in comparison to the results obtained with the ATPlite
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assay. Only the highest particle volume of 50 µm3 per cell of nanoscale CoCr
particles produced a reduction in cell viability from day one onwards. However, a
much larger decrease in the cell viability was measured in comparison to the
ATPlite assay results. Cell viability was reduced almost to zero after one day with
50 µm3 per cell of nanoscale CoCr particles, which was greater than the positive
control.
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Figure 3.17 – Effect of nanoscale (A) and micron sized (B) cobalt chromium particles
on U937 cell viability using the ATPlite assay. U937 histiocytes were cultured with
nanoscale and micron sized CoCr particles for 5 days. Cell viability was determined using
the ATPlite assay and presented as a percentage viability compared to the cell only control.
Data was analysed using one-way analysis of variance (ANOVA and the MSD was
calculated using the Tukey method. A statistically significant reduction (p<0.05) in the cell
viability in comparison to the cell only control, are indicated by an asterisk (*). Error bars
represented ± 95% CI levels, n = 6. (●: 50 µm3 per cell; ▲: 5 µm3 per cell; ▼: 0.5 µm3 per
cell; ♦: 0.05 µm3 per cell; ◄: 0.005 µm3 per cell; ►: 0.0005 µm3 per cell; ●: cell only control;
: 2 µg.ml-1 camptothecin).
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Figure 3.18 – Effect of nanoscale (A) and micron sized (B) cobalt chromium particles
on U937 cell viability using the MTT assay. U937 histiocytes were cultured with
nanoscale and micron sized CoCr particles for 5 days. Cell viability was determined using
the MTT assay and presented as a percentage viability compared to the cell only control.
Data was analysed using one-way analysis of variance (ANOVA) and the MSD was
calculated using the Tukey method. A statistically significant reduction (p<0.05) in the cell
viability in comparison to the cell only control, are indicated by an asterisk (*). Error bars
represented ± 95% CI levels, n = 6. (●: 50 µm3 per cell; ▲: 5 µm3 per cell; ▼: 0.5 µm3 per
cell; ♦: 0.05 µm3 per cell; ◄: 0.005 µm3 per cell; ►: 0.0005 µm3 per cell; ●: cell only control;
: 2 µg.ml-1 camptothecin).
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3.4.6.2 The effect of alumina and cobalt chromium nanoscale and micron
size particles on the cell viability on primary human fibroblast cells
The effect of the previously characterised nanoscale and micron sized alumina and
CoCr particles on the viability of HFBs were assessed using the ATPlite and MTT
assay. These results were then compared against the published literature to
determine if a similar response occurred in the presence of the particles.
The effect of nanoscale and micron sized alumina particles on3.4.6.2.1
primary human fibroblast cell viability using the ATPlite and MTT
assays
Primary HFBs were cultured in the presence of nanoscale or micron sized alumina
particles at particle volumes per cell of 0.0005 to 500 µm3 per cell. Cell viability was
measured at 0, 1, 3, 5 days after incubation using the ATPlite and MTT assays
(section 2.2.4). The results were expressed as a percentage of the cell only control.
The nanoscale alumina particles had no effect on cell viability for all the particle
volumes over the five days of culture as determined by the ATPlite assay (Figure
3.19A). The positive control, (2 µg.ml-1 camptothecin) caused a significant reduction
in cell viability, resulting in an approximate 90% reduction after 5 days of culture.
None of the particle volumes of the micron sized alumina particles had any
significant effect on HFB cell viability in comparison to the cell only control. Only the
positive control, (2 µg.ml-1 camptothecin) had a significant effect on viability after
one day of culture (Figure 3.19B).
Similar results were obtained with the MTT assay. Primary HFBs were cultured with
particle volumes per cell of 0.0005 to 500 µm3 per cell of nanoscale alumina
particles over 5 days. The only significant effect on the cell viability was observed
for the positive control (Figure 3.20A). In contrast the micron sized alumina
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particles, at high particle volumes, had a significant effect on fibroblast proliferation
in comparison to the cell only control. The highest particle volume of 500 µm3 per
cell caused a 52% reduction in cell viability after one day of culture, although this
reduced to 29% after 5 days. A 19% reduction in cell viability was also measured
with the micron sized alumina particle volume of 50 µm3 per cell after one day of
culture (Figure 3.20B).
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Figure 3.19 – Effect of nanoscale (A) and micron sized (B) alumina particles on
primary human fibroblast viability using the ATPlite assay. Primary HFBs were cultured
with nanoscale and micron sized alumina particles for 5 days. Cell viability was determined
using the ATPlite assay and presented as percentage viability compared to the cell only
control. Data was analysed using one-way analysis of variance (ANOVA) and the MSD was
calculated using the Tukey method. A statistically significant reduction (p<0.05) in the cell
viability in comparison to the cell only control, are indicated by an asterisk (*). Error bars
represented ± 95% CI levels, n = 6. (■: 500 µm3 per cell; ●: 50 µm3 per cell; ▲: 5 µm3 per
cell; ▼: 0.5 µm3 per cell; ♦: 0.05 µm3 per cell; ◄: 0.005 µm3 per cell; ►: 0.0005 µm3 per
cell; ●: cell only control; : 2 µg.ml-1 camptothecin).
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Figure 3.20 – Effect of nanoscale (A) and micron sized (B) alumina particles on
primary human fibroblast viability using the MTT assay. Primary HFBs were cultured
with nanoscale and micron sized alumina particles for 5 days. Cell viability was determined
using the MTT assay and presented as percentage viability compared to the cell only
control. Data was analysed using one-way analysis of variance (ANOVA) and the MSD was
calculated using the Tukey method. A statistically significant reduction (p<0.05) in the cell
viability in comparison to the cell only control, are indicated by an asterisk (*). Error bars
represented ± 95% CI levels, n = 6. (■: 500 µm3 per cell; ●: 50 µm3 per cell; ▲: 5 µm3 per
cell; ▼: 0.5 µm3 per cell; ♦: 0.05 µm3 per cell; ◄: 0.005 µm3 per cell; ►: 0.0005 µm3 per
cell; ●: cell only control; : 2 µg.ml-1 camptothecin).
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The effect of nanoscale and micron sized cobalt chromium particles3.4.6.2.2
on human fibroblast cell viability using the ATPlite and MTT assay
Primary HFBs were cultured in the presence of nanoscale or micron sized CoCr
particles at particle volumes per cell of 0.0005 to 50 µm3 per cell. Cell viability was
measured at 0, 1, 3, 5 days after incubation using the ATPlite and MTT assays
(section 2.2.4). The results were expressed as a percentage of the cell only control.
A dose- and time-dependent effect of nanoscale CoCr particles on the human
fibroblast viability was observed using the ATPlite assay (Figure 3.21A). After one
day of culture, the particle volume of 50 µm3 per cell, caused a 37% decrease in the
cell viability in comparison to the cell only control. This was further reduced to a
65% drop in cell viability by day 5. At the time points of day 3 and 5, the particle
volume of 5 µm3 per cell also induced a significant reduction in cell viability in
comparison to the cell only control. In contrast, the only significant reduction in the
cell viability for the primary HFBs cultured with micron sized CoCr particles was
measured for the positive control, (2 µg.ml-1 camptothecin, Figure 3.21B).
Large reductions in cell viability in comparison to the cell only control for the highest
nanoscale CoCr particle volume of 50 µm3 per cell was measured using the MTT
assay (Figure 3.22A). Furthermore particle volumes of 5 µm3 per cell also had a
significant effect on cell viability after one day of culture, with an average 13% drop
in viability over day 1, 3 and 5 of culture. After 3 and 5 days of culture, the particle
volume of 0.5 µm3 per cell also reached significance. However, the majority of the
particle volumes of the micron sized CoCr particles had no effect on the cell viability
using the MTT assay (Figure 3.22B). The only exception was the highest particle
volume of 50 µm3 per cell, which had a significant detrimental effect on the cell
viability from one day of culture.
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Figure 3.21 – Effect of nanoscale (A) and micron sized (B) cobalt chromium particles
on primary human fibroblast viability using the ATPlite assay. Primary HFBs were
cultured with nanoscale and micron sized CoCr particles for 5 days. Cell viability was
determined using the ATPlite assay and presented as percentage viability compared to the
cell only control. Data was analysed using one-way analysis of variance (ANOVA) and the
MSD was calculated using the Tukey method. A statistically significant reduction (p<0.05) in
the cell viability in comparison to the cell only control, are indicated by an asterisk (*). Error
bars represented ± 95% CI levels, n = 6. (●: 50 µm3 per cell; ▲: 5 µm3 per cell; ▼: 0.5 µm3
per cell; ♦: 0.05 µm3 per cell; ◄: 0.005 µm3 per cell; ►: 0.0005 µm3 per cell; ●: cell only
control; : 2 µg.ml-1 camptothecin).
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Figure 3.22 – Effect of nanoscale (A) and micron sized (B) cobalt chromium particles
on primary human fibroblast viability using the MTT assay. Primary HFBs were cultured
with nanoscale and micron sized CoCr particles for 5 days. Cell viability was determined
using the MTT assay and presented as percentage viability compared to the cell only
control. Data was analysed using one-way analysis of variance (ANOVA) and the MSD was
calculated using the Tukey method. A statistically significant reduction (p<0.05) in the cell
viability in comparison to the cell only control, are indicated by an asterisk (*). Error bars
represented ± 95% CI levels, n = 6. (●: 50 µm3 per cell; ▲: 5 µm3 per cell; ▼: 0.5 µm3 per
cell; ♦: 0.05 µm3 per cell; ◄: 0.005 µm3 per cell; ►: 0.0005 µm3 per cell; ●: cell only control;
: 2 µg.ml-1 camptothecin).
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3.5 Discussion
The aim of this part of the study was to generate, isolate and characterise
nanoscale and micron sized alumina and CoCr particles. The particles were
characterised in terms of size, morphology, composition and effect on cell viability
in comparison to the published literature on particles prior to them being used for
cell membrane toxicity studies.
3.5.1 Isolation and characterisation of nanoscale and micron
sized alumina particles
The micron sized alumina powder were characterised via SEM and were revealed
to have a wide distribution of particle sizes, ranging from less than 20 nm up to
1464 nm. As the particle size distribution included micron sized particles and to
differentiate from the nanoscale alumina particles, which had a mode particle size
tenfold lower than this particle stock, this particle type was referred to as the micron
sized alumina particles. The morphology of the particles was observed to be
polygonal in shape. This orthopaedic powder has previously been used in the
reported literature to determine the effect of the viability of fibroblasts and
histiocytes and a comparable mode particle size of 0.5 µm, with polygonal shard-
like morphology was previously reported. Furthermore, Hatton et al. (2003) reported
similar findings for micron sized alumina particles isolated from the orthopaedic
powder and particles isolated from joint simulator lubricant in terms of TNF-α
production from PBMNCs. Therefore this particle source was deemed appropriate
for further cell-based experiments.
Alumina particles isolated from periprosthetic tissue during revision surgery have a
wide size distribution, ranging from a few nanometres to less than 5 µm in diameter
(Hatton et al. 2002; Tipper et al. 2002). The large size range is thought to be
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caused by the introduction of translational malpositioning, causing stripe wear and a
bimodal particle size distribution. Indeed, Tipper et al. (2002) observed wear
particles generated under standard gait conditions, to be 2 – 27.5 nm in diameter
when visualised by TEM. However, when microseparation conditions were
introduced, the particle diameter increased to 0.02 – 1 µm. Translational
malpositioning has been reported to occur in all bearing types in vivo and is
characterised by an elliptical stripe on the femoral head and on the rim of the
acetabular cup of ceramic-on-ceramic THRs (Nevelos et al. 1999; Lombardi et al.
2000; Stewart et al. 2003; Glaser et al. 2008). Therefore a wide particle size
distribution and in particular a bimodal particle size distribution is clinically relevant.
Hence the effect of nanoscale alumina particles was also included in this
investigation.
The wear rates of ceramic-on-ceramic THRs have been reported to be as low as
0.1 mm3 per million cycles, with some simulator studies reporting no measurable
wear (Nevelos et al. 2001; Stewart et al. 2003; Vassiliou et al. 2007; Al-Hajjar et al.
2010; Al-Hajjar et al. 2013). Due to the low wear rates and the small size of the
alumina wear particles, methods to isolate ceramic particles from tissues or from
serum lubricants have not been reliably successful for isolating the very small
volumes of particles generated and it was not practical to attempt to recover
particles from serum lubricants from hip simulator studies to use in the cell studies
reported here (Hatton et al. 2002; Tipper et al. 2002). Therefore, an alternative
approach was taken to sequentially filter an alumina powder used in the
manufacture of ceramic THR components and supplied by the manufacturer,
Ceramtec to allow the desired particle size range to be isolated. Nevertheless, the
retrieval of sufficient nanoscale particles was technically very challenging, even with
modifications and optimisation of the filtration method. This included using different
suspension media and using filters of various pore sizes in order to capture as
many nanoscale particles as possible. A large enough volume of particle could not
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be isolated to complete all cell studies using this technique and instead a
commercially available alumina powder was purchased and used for all subsequent
experiments.
The nanoscale alumina particles from this current study were observed to have
formed large aggregates with a mostly oval morphology. The mode size of the
particles was measured at 30 – 39 nm; however particles up to 265 nm were
measured. The majority of the particles were less than 40nm in size, representing
88% of the particles measured. As previously stated, alumina wear particles
isolated from periprosthetic tissues or from simulator studies of hip prostheses have
a bimodal size distribution. The nanoscale fraction of this bimodal size distribution
have been reported to be less than 20 nm (Hatton et al. 2002; Tipper et al. 2002;
Germain et al. 2003). The nanoscale alumina particles used in this study were
larger at 30 – 39 nm, with a mean of 39.5 nm (± SD 26.5 nm), which did not reflect
the published literature. However, the effect of the nanoscale alumina particles can
be compared against the micron sized alumina particles to determine the effect of
particle size on the subsequent membrane studies.
3.5.2 Generation and characterisation of nanoscale and micron
sized cobalt chromium particles
Cobalt chromium nanoscale particles were generated using a six station pin-on-
plate wear simulator as these conditions have been used previously in the literature
for simple pin-on-plate wear studies and represent the loading and kinematic
conditions of a standard gait cycle in the hip (Jin et al. 2000). Clinically relevant
particles have also been generated from hip simulator studies, using 25% (v/v)
bovine serum as the lubricant (Brown et al. 2007). However, the recovery of metal
wear debris from serum has been reported to be difficult, as lubricant proteins and
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other contaminants are challenging to remove and particle loss remains an issue
(Brown et al. 2007; Billi et al. 2012a; Billi et al. 2012b). Furthermore, alkaline
digestion methods have been reported to alter the morphology, shape, and
composition of CoCr wear particles (Catelas et al. 2001a; Catelas et al. 2001b). A
number of isolation methods have been developed, including by Brown et al. (2007)
who developed a multiple step enzymatic digestion protocol. However, enzymatic
digestion has been reported to affect particle size and induce aggregation (Catelas
et al. 2001a; Lu et al. 2012). In addition, Billi et al. (2012b) developed an isolation
method, which deposits the particles onto a silicon wafer using ultracentrifugation
methods. However, the removal of the wear particles from the wafer remains
problematic. Therefore, the use of a simplified pin-on-plate wear simulator was
chosen, as sufficient wear volumes of clinically relevant CoCr debris can be
produced within a short timeframe. Furthermore, water was used as the lubricant,
which can be removed by evaporation (190°C for 4 hours), leaving behind sterile
and endotoxin-free particles (Germain et al. 2003; Brown et al. 2006; Papageorgiou
et al. 2007; Brown et al. 2013).
The CoCr particles were observed to have a mode size of 40 – 49 nm. The particles
were round in morphology with occasional shard-like particles. The particle mode
size was similar to the reported literature for CoCr wear particles isolated from
periprosthetic tissues. Doorn et al. (1998) isolated CoCr wear particles from
periprosthetic tissues of 13 patients undergoing revision surgery of Morris hip
prostheses. The median of the particle sizes from each of the samples ranged from
51 to 116 nm, with an average of 81 nm. The particles were also observed to be
round in morphology, with some shard-like particles. Simulator studies have
reported CoCr wear particles to be slightly smaller, with a mean size of less than 40
nm, with no shard-like particles detected (Firkins et al. 2001b; Brown et al. 2007;
Papageorgiou et al. 2007). One possible explanation for this is the use of wrought
or cast CoCr components in the wear studies, which have been demonstrated to
Chapter 3
134
have varying wear rates (Dowson et al. 2004a). Whilst no shard-like particles were
detected in these studies, they have been detected in ex vivo tissue studies from
hip resurfacing implants (Xia et al. 2011; Goode et al. 2012).
The composition of CoCr particles was confirmed using pin-point EDX analysis, and
cobalt and chromium was detected in the spectrum of the nanoscale CoCr particles.
Wear particles generated from well positioned metal-on-metal THRs have been
reported to be comprised of oxidised chromium with little or no cobalt detected
(Madl et al. 2015). Under normal physiological conditions a passive layer of
oxidised chromium is formed. In stimulator studies, using serum lubricant, this
passive layer is 85 nm thick, whereas using water as the lubricant, the passive layer
is 3 – 3.5 nm thick (Madl et al. 2015). Therefore, in vivo and under optimal
conditions, the wear particles generated are from the passive layer and it is the
oxidised chromium which will interact with the cells. Whilst the passive layer is not
as thick in simulator studies using water as the lubricant, the wear particles still
consist of oxidised chromium, but to a lesser extent (Madl et al. 2015). It is
assumed that the nanoscale CoCr particles generated in this current study
consisted of oxidised chromium. However, further investigation would be required to
confirm this.
Molybdenum makes up 5 – 7% of the overall composition of the bulk alloy,
however, it was rarely detected in any of the samples in this study. Molybdenum
was only detected the EDX spectra of the micron sized CoCr particles. Goode et al.
(2012) also failed to detect molybdenum in CoCr particles isolated from
periprosthetic tissues. The detection of low concentrations of elements via EDX
analysis can cause small peaks within the spectrum to be masked by background
emissions, thus reducing the level of detection (Bell and Garratt-Reed, 2003). Two
different EDX analysers were used to detect the nanoscale and micron sized CoCr
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particles and therefore this may have been a cause for the differences in the
spectra.
The mode particle size of the micron sized CoCr particles was measured at 2 – 3
µm, with a mean particle size of 3.26 µm (± SD 1.30 µm). The particles were round
in shape and had a composition similar to the nanoscale CoCr particles generated
by the wear simulator, with the majority of the particle consisting of cobalt. This
particle stock has been previously characterised in the literature and have been
reported to have a mean particle size of 2.97 µm with a round morphology
(Papageorgiou et al. 2007).
3.5.3 Effect on cell viability of nanoscale and micron sized
alumina and CoCr particles on primary human fibroblasts
and histiocytes
The cell viability of primary HFBs and a U937 human histiocyte cell line in the
presence of nanoscale and micron sized alumina and CoCr particles was
investigated using the MTT and ATPlite assay. The ATPlite assay is highly sensitive
and can measure ATP levels in as few as ten cells. Upon cell death, a reduction in
cellular ATP occurs, and this can be used as an indicator of cytotoxicity (Crouch et
al. 1993). The MTT assay measures the reduction of a yellow tetrazole to a purple
formazan by NAD(P)H-dependent oxidoreductase enzymes and can be used as an
indicator of cell metabolism. Cells which are viable will reduce the tetrazole
substrate more rapidly than cells with reduced metabolism or non-viable cells.
However, the reduction of the tetrazole substrate can be affected if the cells are
subjected to oxidative stress (Stockert et al. 2012). The effect of the particles on the
cell viability was compared against the relevant published literature.
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3.5.3.1 Assay choice and particle interference
An additional control was also included in both assays for all particle types, which
measured the potential interference of the particles with the results. Previous
studies have revealed that the highly reactive surface of nanoparticles can interfere
with biochemical assays and induce false negative or false positive results.
Therefore, it is now common practice within the field of nanotoxicology to use to
different cell assays in order to determine a greater understanding of the particles
on the cells (Monteiro-Riviere et al. 2009). To investigate the potential effect of
alumina and CoCr particles on the ATPlite and MTT assay, the highest particle
volume (500 µm3 per cell and 50 µm3 per cell, respectively) were incubated in cell
culture medium in the absence of cells. The readouts were subtracted from the
absorbance or luminescence readings for the cells cultured in the presence of the
corresponding highest particle volume.
During this study it was noted that the nanoscale and micron sized alumina
particles, at the highest particle volumes, had a positive effect on the absorbance
readings of the MTT assay. However not all of the reported literature has taken the
impact of particle interference with cell viability assays into consideration.  Indeed,
Roualdes et al. (2010) and Dalal et al. (2012) both stated that alumina particles
tested had a significantly positive effect on the cell viability at high particle
concentrations. However, these findings are likely to be caused by the particles
inducing a higher than expected assay readout rather than the particles effecting
cell viability. An extreme example was noted by Granchi et al. (2004) whereby the
alumina particles interfered with the alamar blue assay performed and the results
for highest particle concentrations of 0.1 and 1 mg.ml-1 had to be disregarded.
Unlike the nanoparticles and micron sized alumina particles, no detrimental effect
was observed for the CoCr particle only control for both assays. However, Dalal et
al. (2012) and Papageorgiou et al. (2007) noted that CoCr wear particles
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significantly increased cell viability using an LDH assay at high particle
concentrations. Nevertheless, it was not apparent whether particle only controls
was used and whether these results reflected the actual effects of the particle on
the cells. Therefore the approach of this study was to use two assays in conjunction
with two different cell types in order to gain a better understanding on the effects of
the particles.
3.5.3.2 The effect of nanoscale and micron sized alumina particles on U937
histiocytes and human fibroblasts using the ATPlite and MTT assay
The results from this study demonstrated that nanoscale and micron sized alumina
particles had a limited effect on the cell viability for both U937 histiocytes and
primary HFBs. No significant effects were observed for the nanoscale and micron
sized alumina particles on the U937 histiocytes and primary HFBs using both the
ATPlite and MTT assay. Only the nanoscale alumina particles had a statistically
significant effect on the U937 histiocyte viability at the highest particle volume of
500 µm3 per cell after 3 days of culture when assessed using the MTT assay. In
contrast, significant effects of micron sized alumina particles on viability were
observed for the primary HFBs at particle volumes of 50 and 500 µm3 per cell, after
one day of culture, when assessed using the MTT assay. The ATPlite assay
measure ATP levels in cells, whereby viable cells will have a greater ATP
concentration. The MTT assay is a measure of cell metabolism and detects the
reduction of MTT by NAD(P)H-dependent oxidoreductase enzymes. As previously
described, the reduction of the tetrazole substrate is greater in viable, metabolising
cells in comparison to cells with a reduced metabolism. Hence, the decrease in
formazan formation can be caused by a reduction in cell metabolism rather than cell
number and is why the MTT assay is not a direct measure of cell proliferation. In
addition to this, a reduction in the tetrazole substrate can occur when the cells are
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subjected to oxidative stress. Therefore the differences in the ATPlite and MTT
assay results may be caused other factors rather than just a reduction in cell
number. Without further investigation it is difficult to ascertain the exact cause,
however the results highlight the need to use more than one assay to gain a better
understanding of particle toxicity.
At present there is limited published literature on the cytotoxic effects of clinically
relevant alumina wear particles. From the data available, a number of these studies
did not use clinically relevant particles, making direct comparisons to the literature
difficult (Yoshida et al. 2003; Granchi et al. 2004; Gutwein and Webster 2004;
Yamamoto et al. 2004). However, Germain et al. (2003) and Hatton et al. (2003)
used alumina wear particles from ceramic-on-ceramic hip joint simulators, and
compared the effects with particles isolated from the same orthopaedic powder
used in this current study. Hatton et al. (2003) reported that both particle sources
had no significant effect on the cell viability of PBMNCs after 24 hours using the
MTT assay. Germain et al. (2003) also reported a limited effect of the alumina
particles on U937 histiocytes and L929 murine fibroblasts over 5 days using the
ATPlite assay. The only significant reduction in the cell viability was observed for
the predominately nanoscale (5 – 30 nm) alumina particles isolated from the hip
joint simulator after three days of culture with U937 histiocytes at a particle volume
of 50 µm3 per cell.  However, the current study did not observe any significant effect
on cell viability of U937 histiocytes incubated with the alumina nanoscale particles
at the same particle volumes. This small discrepancy between the current study
and  results from Germain et al. (2003) could be caused by the differences in the
particle source, leading to small differences in the particles size and composition.
Interestingly Germain et al. (2003) also observed that differences in the effect of
alumina particles were dependent on the cell type as no significant reduction in cell
viability was observed for the L929 fibroblasts cultured in the presence of alumina
wear particles.
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Studies using commercially available alumina particles have also reported the effect
of alumina particles on the viability of a number of cell types, with most studies only
reporting cytotoxic effects at high particle concentrations (Catelas et al. 1999;
Germain et al. 2003; Hatton et al. 2003; Granchi et al. 2004; Gutwein and Webster
2004; Dalal et al. 2012). However, there are inconsistencies in the literature with
respect to the effect of alumina particle size on cell viability. The present study
revealed that minor differences between the cytotoxicity of the nanoscale and
micron sized alumina particles was dependent on cell type and assay choice.
Germain et al. (2003) also noted a moderate difference between nanoscale and
micron sized alumina particles with an 18% reduction in U937 histiocyte viability
after 3 days. In contrast, Catelas et al. (1999) and Gutwein & Webster (2004)
reported an increase in cell death with increasing particle size. This could be
caused by different cell types used or alternatively the methods employed. The
interference of the particles with the assays used or the presence of endotoxins
could have impacted the results. Unfortunately neither Catelas et al. (1999) and
Gutwein & Webster (2004) state if appropriate particle controls nor methods to
remove endotoxins from the particles were used and therefore it is not known if
these affected the outcomes of the studies.
Overall the results from this present study suggest that the nanoscale and micron
sized alumina particles are significantly cytotoxic at high particle doses. However,
as previously described the low wear rates of ceramic-on-ceramic THRs mean that
the likelihood of cells in periprosthetic tissues encountering these particle doses is
rare. Indeed the incidences of any biological adverse tissue reactions, such as
osteolysis have only been described in extreme cases (Morlock et al. 2001; Jarrett
et al. 2009; D'Antonio et al. 2012). These incidences were attributed to severe
malpositioning of the implant or mismatching of the femoral head and acetabular
cup component. Therefore it can be concluded that alumina based ceramic
particles are relatively bioinert.
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3.5.3.3 The effect of nanoscale and micron sized cobalt chromium particles
on U937 histiocytes and human fibroblasts using the ATPlite and
MTT assay
The results from this study revealed that nanoscale and micron sized CoCr particles
induced a significant reduction in U937 histiocytes and human fibroblast viability in
a time- and dose-dependent manner. The nanoscale CoCr particles significantly
reduced the viability at the particle volumes of 50 µm3 per cell or greater for both
U937 histiocytes and primary HFBs using the ATPlite assay. The highest particle
volume of 500 µm3 per cell had a significant effect on the viability of U937
histiocytes after one day when assessed using the MTT assay. The greatest effect
on cell viability was measured for the primary HFBs cultured with the nanoscale
CoCr particles. A significant reduction in the cell viability was measured, using the
MTT assay, for particle volumes of 0.5, 5 and 50 µm3 per cell after three days in
culture. Whilst the general trend between the two assays was similar, small
differences between the assays and cell types were observed, suggesting CoCr
cytotoxicity is sensitive to the assay and cell type used. In particular differences in
the response of cell lines in comparison to primary cells have been reported
(Geraghty et al. 2014). For instance immortalised endothelial cell lines have been
demonstrated to express different cell markers and receptors in comparison to
primary cells (Unger et al. 2002). Immortalised cell lines have been reported to lose
the characteristics of the original tissue they were isolated from and to be
susceptible to genetic drift and contamination as they divide (Geraghty et al. 2014).
Therefore the greater responses of the HFBs in comparison to the U937 cell line, in
the presence of alumina and CoCr particles, may be caused by this.
Studies using the same pin-on-plate simulator method to generate CoCr particles
reported very similar results to this current study (Germain et al. 2003; Brown et al.
2006; Papageorgiou et al. 2007; Bhabra et al. 2009; Papageorgiou et al. 2014).
Indeed some of these studies have used cell types also employed in this present
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study. Papageorgiou et al. (2007) observed a significant reduction in human
fibroblast viability after 1 day using the MTT assay. Furthermore, Germain et al.
(2003) reported that nanoscale CoCr wear particles at a particle volume of 50 µm3
per cell reduced U937 histiocyte and L929 fibroblast cell viability in comparison to
the cell only control after 5 days. This was also observed in this current study at the
equivalent particle volumes after 5 days of culture with U937 histiocytes using both
the MTT and ATPlite assay.
Particle size was observed to affect cell viability of U937 histiocytes and primary
HFBs. The micron sized CoCr particles had no effect on the viability of U937
histiocytes and primary HFBs when assessed using the ATPlite assay. In contrast,
the MTT assay revealed that the highest particle volume dose of 50 µm3 per cell
reduced the viability of primary HFBs in comparison to the cell only control after 1
day. Similarly, a significant effect on the viability was measured for U937 histiocytes
cultured with micron sized CoCr particles at a particle volume of 50 µm3 per cell
after five days using the MTT assay. Germain et al. (2003) also reported micron
sized CoCr wear particles (9.87 µm) were observed not to be cytotoxic to U937
histiocytes and L929 fibroblasts. Papageorgiou et al. (2007) reported that micron
sized CoCr particles, also sourced from the same manufacturer as the particles
used in the present study, were less cytotoxic than nanoscale CoCr wear particles
(29.5 ± 6.3 nm) in primary HFBs. A significant reduction in the cell viability was only
observed after 4 days of culture.
A limitation of the cell viability assays is that the effect of Co and Cr ions was not
separately investigated. Ions are known to be released from the bearing surface
and have been reported to be cytotoxic, even at physiologically relevant levels
(Andrews et al. 2011; Posada et al. 2014). However the current study only
investigated CoCr particles and the subsequent release of the ions over the time
the particles are cultured with the cells. Therefore it cannot be determined if the
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reduction in cell viability was caused by the particles, the release of ions into the
surrounding culture medium, or a combination of both.
3.6 Conclusion
This part of the study aimed to generate, isolate and characterise alumina and
nanoscale and micron sized CoCr particles. The nanoscale CoCr particles were
revealed to be comparable to particles isolated from hip simulator studies and
periprosthetic tissues from around hip prostheses in terms of size, morphology and
composition. Furthermore the micron sized CoCr particles, used to investigate the
role of particle size, were demonstrated to have a similar composition to the CoCr
alloy used in THR manufacture. Alumina particles from THRs have been reported to
have a bimodal size distribution and therefore nanoscale and micron sized alumina
particles were obtained for the present study. Unfortunately the nanoscale particle
fraction could not be successfully isolated from an alumina powder and a
commercially available nanoscale alumina powder was used instead. The
commercially available nanoscale alumina particles were larger in size in
comparison to the published literature on wear particles. Nevertheless, the effect of
particle size on the cell membrane can still be determined in the following chapters,
which is an important factor in particle toxicity (as described in section 1.5.3.1.1).
The biocompatibility of the particles was determined by investigating the effect of
the particles on the viability of U937 histiocytes and primary HFBs. The particles
were revealed to have a similar effect to previous reports in the literature with
nanoscale CoCr particles reducing the cell viability to a greater extent than the
micron sized CoCr particles. Furthermore, the nanoscale and micron sized alumina
particles only induced a statistically significant reduction in the viability of primary
HFB and U937 histiocytes at very high particle doses, which was dependent on cell
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type and viability assay used. Interestingly, due to the low wear rates of ceramic-on-
ceramic THRs, this is unlikely to occur in a clinical situation.
The nanoscale and micron sized alumina and CoCr particles have been
characterised in terms of particle size, morphology and cytotoxicity and with the
exception of the nanoscale alumina particles, are comparable with results from the
literature. All four particle types were deemed suitable for use in the cell membrane
toxicity experiments in the subsequent sections of this study.
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Chapter 4
The effect of nanoscale and micron sized alumina and
cobalt chromium particles on the cell plasma membrane
4.1 Introduction
A variety of techniques have been used to investigate the role of particles on the
cell plasma membrane within the field of nanotoxicology. These include the use of
SPR, vesicle leakage studies and QCM-D (Green et al. 2000; Mu et al. 2012b;
Karlsson et al. 2013). As described in Chapter one, the sensitivity of QCM-D allows
potential factors affecting particle and model membrane interactions to be
investigated, including particle morphology, size and composition (Mu et al. 2012a;
Mu et al. 2014). The model membrane can also be tailored to each experiment and
proteins can be incorporated into the membrane to investigate particle: protein
interactions (Lesniak et al. 2013). QCM-D can be used to investigate the effect of
nanoscale and micron sized alumina and CoCr particles with model membranes
and to provide an insight into cellular uptake mechanisms of the particles, such as
whether the particles bind non-specifically to the membrane or are receptor
mediated.
4.1.1 Aims and objectives
This part of the study aimed to investigate the effect of nanoscale and micron sized
alumina and CoCr particles on a model lipid membrane using vesicle leakage,
QCM-D and SPR techniques. Furthermore, the effect of size and composition of the
particles were investigated by comparing the outcomes for nanoscale and micron
sized alumina and CoCr particles (previously characterised in Chapter three). In this
first instance, a simple model membrane consisting of extracted phosphocholine,
phosphoserine, and phosphoethanolamine, with cholesterol has been used, which
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is similar to the lipid composition of plasma membranes of human fibroblast cells.
Finally the incorporation of membrane proteins from primary HFBs into the model
lipid membrane was also implemented. This was to determine more accurately the
factors involved in particle: membrane interactions.
4.1.1.1 Objectives
The specific objectives of this part of the study were as follows and outlined in
Figure 4.1:
 To assess the effect of nanoscale and micron sized alumina and CoCr
particles on simple model membranes using vesicle leakage assays
 To investigate the binding of nanoscale and micron sized alumina and CoCr
particles to a simple sBLM using QCM-D
 To model QCM-D data to ascertain if nanoscale and micron sized alumina
and CoCr particles bind to a sBLM using the Voight model
 To investigate the binding of nanoscale and micron sized alumina and CoCr
particles to a model membrane using surface plasmon resonance
techniques
 To explore the effect of incorporating fibroblast and histiocyte membrane
proteins into the sBLM on nanoscale and micron sized alumina and CoCr
particle induced membrane damage
 To study the effect of incorporating of fibroblast membrane proteins into the
sBLM on nanoscale and micron sized alumina and CoCr particle binding to
the model membrane
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Figure 4.1 – Overall project aim and experimental work. Chapter four aims are outlined
in red.
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4.2 Material and methods
4.2.1 Materials
4.2.1.1 Surface plasmon resonance analysis
The materials used for the SPR analysis are listed in Table 4.1.
Table 4.1 – Materials used for surface plasmon resonance analysis
Material Model Supplier
Biacore®  SPR machine 2000
GE Healthcare Life
Sciences,
Buckinghamshire, U.K.
BIAdesorb solution 1 (0.5% w/v SDS) 193606
GE Healthcare Life
Sciences,
Buckinghamshire, U.K.
BIAdesorb solution 2 (50 mM glycine, pH 9.5)
193607
GE Healthcare Life
Sciences,
Buckinghamshire, U.K.
BIAdisinfectant solution (sodium hypochlorite)
BR100666
GE Healthcare Life
Sciences,
Buckinghamshire, U.K.
BIAevaluation computer software Version 3.1
GE Healthcare Life
Sciences,
Buckinghamshire, U.K.
HPA sensor chip consisting of alkane thiol
molecules attached to a gold film.
BR100406
GE Healthcare Life
Sciences,
Buckinghamshire, U.K.
Octeyl glucoside
29836-26-8
Melford Laboratories
Ltd., Ipswich, U.K.
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4.2.2 Methods
4.2.2.1 Investigation into the effect of particles in membrane integrity using a
simple vesicle leakage assay
The materials and methods for the simple vesicle leakage assay are outlined in
section 2.2.6.3.
4.2.2.2 Investigation into the binding of particles using quartz crystal
microbalance with dissipation
The method for using QCM-D is outlined in section 2.2.6.4.
4.2.2.3 Surface plasmon resonance analysis of nanoscale cobalt chromium
particles binding to a model lipid membrane
Using the nanoscale CoCr particles as an example, the binding of the particles to a
monolayer of the model lipid membrane was investigated.
4.2.2.3.1 Desorbing and sanitising the surface plasmon resonance machine
The Biacore® 2000 SPR machine was kept on standby and the machine tubing
was cleaned thoroughly prior to testing. All reagents were degassed under vacuum
and filtered through a 0.22 µm pore size filter. The running buffer of the machine
was replaced with degassed ultrapure distilled water. Using the BIAevaluation
(version 3.1) computer programme, the machine command “desorb” was selected
and the chip in the machine was removed and replaced with a standard sensor
chip, whilst the tubing was cleaned. Once docked, the chip and tubing was primed
using degassed ultrapure distilled water. A volume of 3 ml of each of the
BIAdesorb solutions 1 (0.5% w/v SDS) and 2 (50 mM glycine, pH 9.5) were placed
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in glass vials and placed on the sample rack of the SPR machine. The position of
the samples was entered into the computer programme and the desorb process
was initiated, whereby solutions 1 and 2 were flowed through the machine tubing.
Once the desorb process was completed, the Biacore machine went into standby
mode. Approximately 10 ml of the BIAdisinfectant solution (sodium hypochlorite)
was placed in a measuring cylinder and placed onto the sample rack of the SPR
machine. The sanitise function was selected on the computer programme which
flowed the disinfectant solution though the tubing of the machine. Once completed
the resting buffer was changed to ultrapure distilled water and placed on standby
for approximately 18 hours.
4.2.2.3.2 The formation of a monolayer of a model lipid membrane onto the
sensor chip
The sensor chip within the machine was replaced with the test HPA chip (Table
4.1), which was docked into the machine and primed using the running solution (20
mM MOPS with 30 mM Na2SO4, pH 7.4). Once primed, the sensorgram, which
measured resonance units (RU), was run until the readout had settled
(approximately 1 hour). A 5 minute injection of 40 mM octyl glucoside in ultrapure
distilled water was used to wash the surface of the chip, followed by rinsing with the
running solution of 20 mM MOPS with 30 mM Na2SO4, pH 7.4. The lipid vesicles
(prepared as described in section 2.2.6.2) at a final concentration of 0.5 mM in 20
mM MOPS with 30 mM Na2SO4 and 10 mM CaCl2, pH7.4 were injected across the
sensors of the chip at a rate of 5 µl per minute for at least 3 hours or until the
readout had stabilised. The monolayer of the model lipid membrane was washed
with three 5 minute injections of ultrapure distilled water with 1 mM EDTA to remove
any unbound vesicles.
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4.2.2.3.3 The addition of nanoscale cobalt chromium particles to the model
lipid membrane
The running solution of 20 mM MOPS with 30 mM Na2SO4, pH 7.4 was changed to
DMEM without any supplements. Once the readout had settled, a blank control of
the equivalent volume of ultrapure water in DMEM of the highest particle
concentration was injected across the sensor chip at a flow rate of 5 µl per minute
for 30 minutes. DMEM were then flowed across the chip for another 30 minutes at a
flow rate of 5 µl per minute. Nanoscale CoCr particles, at a concentration of 100
µg.ml-1 in DMEM was flowed across the chip for 30 minutes at a flow rate of 5 µl per
minute. DMEM was then flowed across the chip for 30 minutes at a flow rate of 5 µl
per minute. Once completed, the chip was either placed on standby or cleaned
according to section 4.2.2.3.1. The experiment was repeated twice.
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4.3 Results
4.3.1 The effect of nanoscale and micron sized alumina and
cobalt chromium particles on the integrity of a model
lipid membrane using a simple vesicle leakage assay
In order to assess the effects of nanoscale and micron sized alumina and CoCr
particles on plasma membrane integrity, a simple vesicle leakage assay was used
as described in section 2.2.6.2 and 2.2.6.3.
4.3.1.1 The effect of nanoscale and micron sized alumina particles on the
integrity of a model lipid membrane
Nanoscale and micron sized alumina particles induced vesicle leakage in a dose
dependent manner as presented in Figure 4.2A and 4.2B, respectively. However, at
the particle concentration of 1 µg.ml-1, the mean vesicle leakage was barely above
the baseline for both nanoscale and micron sized alumina particles. At the highest
particle concentration of 100 µg.ml-1, the nanoscale alumina particles caused an
average 16% increase in vesicle leakage, which was statistically significant in
comparison to the particle concentration of 1 µg.ml-1. The nanoscale alumina
particles, at a particle concentration of 10 µg.ml-1 also induced statistically
significant vesicle leakage in comparison to the lowest particle concentration of 1
µg.ml-1. Significant increases of 3% and 20% in vesicle leakage were observed for
micron sized alumina particles compared to the baseline at particle concentrations
of 10 and 100 µg.ml-1, respectively. These results were statistically significant in
comparison to the lowest particle concentration of 1 µg.ml-1.
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Figure 4.2 – The effect of nanoscale (A) and micron sized (B) alumina particles on the
vesicle leakage of a model lipid membrane. Vesicles loaded with an autoquenching
fluorescent dye were formed from lipid membranes and exposed to increasing
concentrations (1 – 100 µg.ml-1) of nanoscale or micron sized alumina particles. The release
of fluorescent dye was measured, in real-time, using a fluorometer. Afterwards, Triton-X 100
(0.1% v/v) was added to samples to ensure complete vesicle lysis. Vesicle leakage was
expressed as a percentage of the absorbance reading for the detergent Triton-X 100
sample. Raw data were analysed using paired t-test and statistically significant results (p<
0.05) are indicated by an asterisk (*). Error bars represented 95% confidence levels (n = 3).
4.3.1.2 The effect of nanoscale and micron sized cobalt chromium particles
on the integrity of a model lipid membrane
The effect of nanoscale and micron sized CoCr particles on the fluorescent dye
encapsulated vesicles was also investigated as described in section 2.2.6.3. Both
nanoscale and micron sized CoCr particles also induced a dose dependent
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increase in vesicle leakage. However the percentage leakage was much less than
the results measured for the nanoscale and micron sized alumina particles. Even at
the highest particle concentration of 100 µg.ml-1, the nanoscale CoCr particles only
marginally induced vesicle leakage of 4%, in comparison to the baseline levels
(Figure 4.3A). Nevertheless this result was statistically significant in comparison to
the lowest particle concentration of 1 µg.ml-1, which only induced a 0.3% increase in
the vesicle leakage. Similarly, the micron sized CoCr particles only induced 3%
vesicle leakage at the highest particle concentration of 100 µg.ml-1, however due to
increased sample variability, this was not statistically significant in comparison to
the lowest particle concentration (Figure 4.3B).
Chapter 4
154
Figure 4.3 – The effect of nanoscale (A) and micron sized (B) cobalt chromium
particles on the vesicle leakage of a model lipid membrane. Vesicles loaded with an
autoquenching fluorescent dye were formed from lipid membranes and exposed to
increasing concentrations (1 – 100 µg.ml-1) of nanoscale or micron sized CoCr particles.
The release of fluorescent dye was measured, in real-time, using a fluorometer. Afterwards,
Triton-X 100 (0.1% v/v) was added to samples to ensure complete vesicle lysis. Vesicle
leakage was expressed as a percentage of the absorbance reading for the Triton-X 100
sample. Raw data were analysed using paired t-test and statistically significant results (p<
0.05) are indicated by an asterisk (*). Error bars represented 95% confidence levels (n = 3).
4.3.1.3 Investigation into the potential quenching effects of nanoscale and
micron sized alumina and cobalt chromium particles on the vesicle
leakage assay
The potential for nanoparticles to quench light emitting assays has been extensively
reported (Raikar et al. 2011). This may have an effect on the results obtained for
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the vesicle leakage assays and must be investigated. To assess whether the
nanoscale and micron sized alumina and CoCr particles could quench the
excitation wavelength from the fluorescent dye, the vesicles, which encapsulated an
autoquenching fluorescent dye, were formed as stated in section 2.2.6.3.3.
4.3.1.3.1 Quenching effects of nanoscale and micron sized alumina particles
on the vesicle leakage assay
No overall quenching of the fluorescent dye was observed for the vesicles
incubated with nanoscale alumina particles as shown in Figure 4.4A. Indeed a
marginally positive effect (106% leakage) was observed, in comparison to the
Triton-X 100 control for the highest particle concentration of 100 µg.ml-1. This result
was considered statistically significant in comparison to the lowest particle
concentration of 1 µg.ml-1. Again no overall quenching of the fluorescence dye was
observed for the vesicles incubated with micron sized alumina particles (Figure
4.4B). At all the particle concentrations tested, the mean vesicle leakage was close
to 100%.
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Figure 4.4 – The effect of nanoscale (A) and micron size (B) alumina particles on the
quenching of the fluorescent dye. Vesicles loaded with an autoquenching fluorescent dye
were formed from lipid membranes. The vesicles were then lysed with Triton-X 100 followed
by the addition of increasing alumina particle concentrations (1 – 100 µg.ml-1). The release
of fluorescent dye was measured in real-time, using a fluorometer and vesicle leakage was
expressed as a percentage of the detergent Triton-X 100. Raw data were analysed using
paired t-test and statistically significant results (p< 0.05) are indicated by an asterisk (*).
Error bars represented 95% confidence levels (n = 3).
4.3.1.3.2 Quenching effects of nanoscale and micron sized cobalt chromium
particles on the vesicle leakage assay
The nanoscale CoCr particles induced a quenching effect on the fluorescent dye.
The highest particle concentration of 100 µg.ml-1 induced a 17% reduction in the
absorbance readings. This was significantly larger than the quenching effects of the
particle concentrations of 1 and 10 µg.ml-1 (Figure 4.5A). No quenching effect was
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observed for the micron sized CoCr particles at all the particle concentrations tested
(Figure 4.5B). The highest particle concentration of 100 µg.ml-1, with a mean vesicle
leakage of 104% was significantly higher than the lowest particle concentration of 1
µg.ml-1 with a mean vesicle leakage of 100%.
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Figure 4.5 – The effect of nanoscale (A) and micron sized (B) cobalt chromium
particles on the quenching of the fluorescent dye. Vesicles loaded with an
autoquenching fluorescent dye were formed from lipid membranes. The vesicles were then
lysed with Triton-X 100 followed by the addition of increasing CoCr particle concentrations
(1 – 100 µg.ml-1). The release of fluorescent dye was measured in real-time, using a
fluorometer and vesicle leakage was expressed as a percentage of the detergent Triton-X
100. Raw data were analysed using paired t-test and statistically significant results (p< 0.05)
are indicated by an asterisk (*). Error bars represented 95% confidence levels (n = 3).
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4.3.2 Investigation into the binding of nanoscale and micron
sized alumina and cobalt chromium particles to a
model lipid membrane using quartz crystal
microbalance with dissipation
In order to investigate the mechanism of particle internalisation, the ability of the
nanoscale and micron sized alumina and CoCr particles to bind to the cell plasma
membrane was assessed. In this series of experiments, the model lipid membrane
described in section 2.2.6.1 was used, which mimics the lipid and cholesterol
composition of a typical human fibroblast plasma membrane. To measure particle
binding, the technique QCM-D was used.
4.3.2.1 The interaction of nanoscale and micron sized alumina particles on a
model lipid membrane
A planar sBLM was established on the surface of the oscillating quartz crystal for
both the nanoscale and micron sized alumina particles as observed in Figures 4.6A
and 4.6B, respectively. No change in the frequency and dissipation was observed
when the nanoscale alumina particles were flowed across the membrane at particle
concentrations of 1 and 10 µg.ml-1. However, at the highest particle concentration of
100 µg.ml-1 there was a slight increase in the frequency. Most notable was the
change in dissipation at the highest particle concentration of 100 µg.ml-1. This effect
stabilised when the membrane was washed with DMEM, although the change in
dissipation was not reversed.
The micron sized alumina particles had an effect on both the frequency and
dissipation change. The lowest particle concentration of 1 µg.ml-1 had no effect on
the frequency or dissipation, but when the next highest concentration of 10 µg.ml-1
was added, a minor decrease in the frequency change of 1 Hz was observed.
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Alongside this, the dissipation also increased from 0 to 1.5 x 10-6. At the highest
particle concentration, a minor change in the frequency was observed with a
decrease of 3 Hz. Again, the largest effect was measured for the dissipation with an
increase to approximately 8 x 10-6 at the highest particle concentration. The particle
induced effects on both the frequency and dissipation stabilised upon the addition
of the DMEM washes.
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Figure 4.6 – Quartz crystal microbalance with dissipation plot of a solid supported
bilayer lipid membrane in the presence of nanoscale (A) and micron sized (B) alumina
particles. A sBLM formed from model lipid vesicles was generated onto an oscillating
quartz crystal (not shown), resulting in a Δf of -27Hz and a Δd of < 0.5 x 10-6. Commencing
in DMEM, incremental concentrations (1 – 100 µg.ml-1) of alumina particles followed by
DMEM washes were added at times indicated by the arrows. Changes in the frequency
(blue) and dissipation (red) were measured (the ninth overtone is displayed). Each
experiment was repeated twice.
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4.3.2.2 The interaction of nanoscale and micron sized cobalt chromium
particles on a model lipid membrane
The ability of nanoscale and micron sized CoCr particles to bind to a model lipid
membrane was assessed using QCM-D techniques (Figures 4.7A and 4.7B,
respectively). For both series of experiments, a planar sBLM was formed on the
surface of the oscillating quartz crystal with the characteristic frequency change of
-27 Hz and a dissipation of approximately 0.
The nanoscale CoCr particles did not have an effect on the change in frequency
and dissipation until the highest particle concentration of 100 µg.ml-1 was added.
Upon the addition of 100 µg.ml-1 of CoCr particles a small change in the frequency
was observed from -27 Hz to -26 Hz. The greatest effect was observed for the
dissipation with a change from 0 to 2 x10-6, which stabilised upon the addition of
DMEM. These results were similar to the results for the nanoscale alumina
particles.
The smallest effect on the frequency and dissipation change of the all the particle
types tested (including the nanoscale and micron sized alumina particles) was
observed for the CoCr micron sized particles. A small change in the frequency of 1
Hz was measured and an increase in the dissipation from 0 to 1.0 x10-6 was
measured. However, this change was only observed at the highest particle
concentration of 100 µg.ml-1. As observed with all the other particle types, this effect
stabilised on the addition of DMEM.
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Figure 4.7 – Quartz crystal microbalance with dissipation plot of a solid supported
bilayer lipid membrane in the presence of nanoscale (A) and micron sized (B) CoCr
particles. A sBLM formed from model lipid vesicles was generated onto an oscillating
quartz crystal (not shown). Commencing in DMEM, incremental concentrations (1 – 100
µg.ml-1) of CoCr particles followed by DMEM washes were added at times indicated by the
arrows. Changes in the frequency (blue) and dissipation (red) were measured (the ninth
overtone is displayed). Each experiment was repeated twice.
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4.3.2.3 Modelling quartz microbalance with dissipation data to determine
particle binding using the Voight model
The frequency and dissipation data from the QCM-D experiments can be modelled
to establish if particle binding has occurred and what effect this had on the sBLM.
The results observed were greater for the dissipation compared to the frequency
and it was unclear from the measured data if particle binding had occurred.
Therefore, modelling method of the Voight model, described in Chapter one was
used. The computer software, QTools was implemented to model the data, using
the Voight viscoelastic model. This model allows the bound layers on the quartz
crystal to be represented as a viscous dashpot and elastic spring connected in
parallel, which is more suited for viscoelastic soft layers such as the formation of
sBLM and particle binding.
The first layer of the model was established to represent the sBLM. The sBLM was
modelled using the data before the addition of the particles. The parameters for
layer one (shear modulus, viscosity and thickness) were then fixed and the second
layer was modelled, which represents the bound particles to the sBLM. The outputs
of the second layer were the layer viscosity, shear modulus and thickness. These
outputs indicate if binding occurred (i.e. high shear modulus, low viscosity).
However, it is noted that this model assumes that the sBLM itself is unperturbed by
the addition of particles.
4.3.2.3.1 Modelling of nanoscale and micron sized alumina particles
The fixed parameters for the densities of each layer are listed in Table 4.2, which
were used for the Voight model. For the nanoscale alumina particles, the fitted
parameters (viscosity, shear modulus, and layer thickness) of layer one are detailed
in Table 4.3 and were fixed when modelling layer two. The output of the fitted
parameters for layer two indicated that the shear modulus and the viscosity were
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small. The thickness of layer two was only 7.76 nm which is much smaller than the
average diameter of the nanoscale alumina particles (40 nm). Therefore the outputs
of layer 2 did not reflect the expected properties of nanoscale alumina particles of a
high viscosity, high shear modulus and a representative thickness equal or greater
to the mean particle diameter and thus indicate interactions between layer one and
two was very weak.
A similar result was also observed for the modelling of the QCM-D data of the
micron sized alumina particles and the model lipid membrane. The properties of
layer one (the sBLM) were used to subsequently model the second layer of the
micron sized alumina particles as detailed in Table 4.4. Again, the results were not
characteristic of a layer of micron sized alumina particles, with small values for the
viscosity. Furthermore the thickness of layer two in the model was only 4.6 nm,
which was almost 100 times smaller than the mode size of the micron sized
alumina particles (450 nm).
Table 4.2 – Fixed parameters used for the Voight model for nanoscale and micron
sized alumina particles. The densities of layer one (sBLM) and layer two (the bound
particle layer) are listed, which were used to calculate the fitted parameters of the Voight
model (Jing et al. 2014; Malmström et al. 2007). Density of alumina from manufacturer’s
specifications as described in section 2.1.1 (PlasmaChem, Berlin, Germany)
Fixed Parameter Density (kg/m3)
Layer 1 (sBLM) 1000
Layer 2 (particles) 3900
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Table 4.3 – Fitted parameter outputs using the Voight model for nanoscale alumina
particles. Using the fixed parameters outlined in Table 4.2, Voight analysis was performed
using multiple harmonics (n = 3 - 13). The shear modulus, viscosity, and thickness of layer
one (sBLM) was first modelled and these fitted parameters were used to model layer two
(particle layer).
Fitted Parameter
Shear Modulus
(Pa)
Viscosity (kg/ms) Thickness (nm)
Layer 1 (sBLM) 5.05 x 105 0.013 5.12
Layer 2 (particles) 2.12 x 103 2.6 x 10-4 7.76
Table 4.4 – Fitted parameter outputs using the Voight model for micron sized alumina
particles. Using the fixed parameters outlined in Table 4.2, Voight analysis was performed
using multiple harmonics (n = 3 - 13). The shear modulus, viscosity, and thickness of layer
one (sBLM) was first modelled and these fitted parameters were used to model layer two
(particle layer).
Fitted Parameter Shear Modulus
(Pa)
Viscosity (kg/ms) Thickness (nm)
Layer 1 (sBLM) 3.42 x 104 5.0 x 10-3 5.70
Layer 2 (particles) 1.58 x 104 2.7 x 10-4 4.60
4.3.2.3.2 Modelling of nanoscale and micron sized cobalt chromium particles
The effect of nanoscale and micron sized CoCr particles on the model lipid
membrane were also modelled using the Voight model. The densities used to
model both layer one and two are described in Table 4.5. The outputs of the model
for the nanoscale and micron sized CoCr particles are detailed in Table 4.6 and 4.7,
respectively. The model outputs for the nanoscale CoCr particles revealed that the
shear modulus was low and had a layer thickness of 0.65 nm. This indicated that
CoCr particles did not bind to the sBLM and only weakly interacted. Similarly, the
model predicted that the micron sized CoCr particles had a low shear modulus.
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Furthermore, the thickness of layer two, 0.01 nm, was much smaller than the mean
particle size of approximately 3.26 µm. Again, the model outputs suggested
extremely weak interactions between the sBLM and the CoCr particles.
Table 4.5 – Fixed parameters used for the Voight model for nanoscale and micron
sized cobalt chromium particles. The fixed parameters of layer one (sBLM) and layer two
(the bound particle layer) are listed, which were used to calculate the fitted parameters of
the Voight model (Behl et al. 2013; Jing et al. 2014).
Fixed Parameter Density (kg/m3)
Layer 1 (sBLM) 1000
Layer 2 (particles) 7700
Table 4.6 – Fitted parameter outputs using Voight model for nanoscale cobalt
chromium particles. Using the fixed parameters outlined in Table 4.5, Voight analysis was
performed using multiple harmonics (n = 3 - 13). The shear modulus, viscosity, and
thickness of layer one (sBLM) was first modelled and these fitted parameters were used to
model layer two (particle layer).
Fitted Parameter Shear Modulus
(Pa)
Viscosity (kg/ms) Thickness (nm)
Layer 1 (sBLM) 1.03 x 107 4.29 x 10-3 4.53
Layer 2 (particles) 985.33 1.30 x 10-4 0.65
Table 4.7 – Fitted parameter outputs using Voight model for micron sized cobalt
chromium particles. Using the fixed parameters outlined in Table 4.5, Voight analysis was
performed using multiple harmonics (n = 3 - 13). The shear modulus, viscosity, and
thickness of layer one (sBLM) was first modelled and these fitted parameters were used to
model layer two (particle layer).
Fitted Parameter Shear Modulus
(Pa)
Viscosity (kg/ms) Thickness (nm)
Layer 1 (sBLM) 1.06 x 107 6.41 x 10-3 4.51
Layer 2 (particles) 8581.5 1.94 x 10-4 0.01
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4.3.2.3.3 Summary of quartz crystal microbalance with dissipation results for
nanoscale and micron sized alumina and cobalt chromium particles
The data from the QCM-D results were modelled using the Voight model and the
results from section 4.3.2.2 suggested that overall no particle binding occurred for
all particle types tested. This was based upon the predicted thickness of the particle
layer being too small alongside the low shear moduli and viscosity, which did not
correspond to particles being tightly bound to the sBLM.
4.3.3 Investigation into the binding of particles to a model
lipid membrane using surface plasmon resonance
techniques
The QCM-D data from section 4.3.2 described a large change in the dissipation in
the absence of any large changes in the frequency. This phenomenon is
uncommon in QCM-D and further to this, the model used assumed that the particles
had not perturbed the sBLM. Therefore this part of the study aimed to confirm if
particle binding occurred using the alternative technique of SPR analysis. This
technique measures changes in the angle of incidence of surface plasmon
electrons at the surface of a metal sensor. These surface plasmons are sensitive to
changes in the refractive index and film thickness and therefore can be used to
ascertain if particle binding had occurred. For this part of the study, nanoscale CoCr
particles were used as an example. The sensor consisted of long-chain alkane thiol
molecules bound to a gold film. A planar monolayer of the model lipid membrane
was formed across the sensor in 20 mM MOPS with 30 mM Na2SO4, pH 7.4, which
together with the alkane thiol layer on the sensor chip, forms a hybrid bilayer. The
membrane was subsequently washed three times with ultrapure distilled water to
remove any unbound lipids (section 4.2.2.1.2). Using DMEM, without any
supplements, as the running solution, the blank was flowed across the membrane
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at a rate of 40 µl per minute. The blank was then exchanged to DMEM and once
the readout had stabilised, 100 µg.ml-1 of CoCr particles were flowed across the
membrane and the association kinetics were measured as described in section
4.2.2.1.3.
The resonance units (RU) were plotted against time to ascertain the association
kinetics of the CoCr particles with the membrane monolayer, as shown in Figure
4.8. A sharp reduction of approximately 250 RU was observed immediately after the
blank sample was injected into the sensor cell. However, upon the addition of the
DMEM running buffer, the RU baseline immediately returned to the pre-blank level.
This phenomenon was also observed when the sample of 100 µg.ml-1 nanoscale
CoCr particles was injected into the sensor cell and thus clearly reflects the change
in the refractive index of the solution. Despite the initial drop of the RU baseline, no
association kinetics of the CoCr particles interacting with the membrane was
measured with the data being comparable to the blank sample.
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Figure 4.8 – Surface plasmon resonance analysis of nanoscale cobalt chromium
particles bound to model lipid membrane. A planar, monolayer of the model lipid
membrane was formed on a gold sensor coated with long-chain alkane thiol molecules (not
shown). Using DMEM as the running buffer the blank of DMEM plus 10% (v/v) of ultrapure
distilled water was added. After the DMEM wash, 100 µg.ml-1 of CoCr particles were added
to the membrane and the association curve was measured. The experiment was repeated
twice.
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4.3.4 The incorporation of plasma membrane proteins into
the model lipid membrane
In order to explore the interaction of nanoscale and micron sized alumina and CoCr
particles with the cell plasma membrane, the complexity of the model lipid
membrane was further increased to promote the clinical relevance of the model.
Therefore the effect of the presence of plasma membrane proteins isolated from
primary HFBs on particle interactions with the model lipid membrane was
investigated. The membrane proteins from U937 histiocytes were also isolated as
described in section 2.2.6.5. Due to sample shortage, these samples were only
used in vesicle leakage assays.
4.3.4.1 Optimisation of isolated membrane protein concentration for the
formation of a solid supported bilayer lipid membrane
In order to form a stable sBLM, for the QCM-D studies, the concentration of the
isolated protein within the membrane was optimised, as high concentrations can
inhibit planar bilayer formation (Dodd et al. 2008). For continuity this concentration
would also be used for the vesicle leakage assays. For the optimisation studies, the
membrane proteins isolated from L929 fibroblasts were used as a large amount of
isolated proteins were required for the optimisation studies. As described in Chapter
two, approximately 1 x 108 cells were required to isolate sufficient amounts of
isolated membrane proteins. Therefore plasma membrane isolated from L929
fibroblasts were used as these cells are more readily available and large cell stocks
can be acquired quickly. The membrane proteins were incorporated with the
phospholipid:cholesterol mixture previously used in this chapter for the model lipid
membrane. Lipid vesicles with 20%, 40% or 60% (w/w) of isolated membrane
proteins to lipid were investigated. Mixing plasma membranes with lipids and sBLM
formation are described in section 2.2.6.6, whereby the vesicles (0.5 mg.ml-1) were
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formed in 20 mM MOPS with 30 mM Na2SO4, pH 7.4 and flowed across the surface
of the quartz crystal. The bursting of the vesicles to form a bilayer was induced by
the addition of ultrapure distilled water, followed by the addition of the starting
solution DMEM.
The changes in frequency and dissipation over time for the different protein
concentrations are shown in Figure 4.9A and 4.9B, respectively. Upon the addition
of the vesicles, for all three protein concentrations, there was a sharp decrease in
the frequency, indicating rapid binding of the vesicles to the silicon dioxide coated
QCM-D crystal surface. However, the vesicles formed with 20% (w/w) isolated
membrane protein, burst spontaneously and formed a planar sBLM just before the
ultrapure distilled water wash. Nevertheless the frequency was lower and the
dissipation was higher than expected for a completely planar plasma membrane
and therefore suggested that some of the adsorbed vesicles remained intact. For
the vesicles with 40% (w/w) and 60% (w/w) isolated membrane proteins, the
frequency continued to fall and did not recover significantly after the addition of the
ultrapure distilled water and DMEM wash. This indicated that the vesicles continued
to bind to the surface of the crystal, forming a layer of vesicles, rather than bursting
to form a stable sBLM. This was also reflected in the dissipation results (Figure
4.9B), whereby a large reduction in the dissipation was observed for the sBLM
formed from 20% (w/w) isolated membrane proteins just before the ultrapure
distilled water wash was added. In contrast, the dissipation values for the sBLMs
formed with 40% (w/w) and 60% (w/w) isolated membrane proteins were much
higher. This suggested that a more planar sBLM was formed from vesicles
containing 20% (w/w) isolated membrane proteins. Planar sBLMs are characterised
by dissipation values of less than 2 x 10-6 (Richter et al. 2006). Therefore, all future
QCM-D and vesicle leakage experiments would incorporate 20% (w/w) of the
isolated membrane proteins into the lipid membrane.
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Figure 4.9 – Optimisation of isolated membrane protein concentration for the
formation of a stable solid supported bilayer lipid membrane. Model lipid vesicles with
20%, 40% or 60% (w/w) proteins isolated from L929 fibroblasts were formed in MOPS. The
vesicles were added to SiO2-coated crystals and the frequency (A) and dissipation (B) were
measured in real time. The ninth overtone is displayed. Key – 20% protein; – 40% protein; –
60% protein.
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4.3.5 The effect of the incorporation of fibroblast and
histiocyte membrane proteins into the model lipid
membrane on membrane integrity in the presence of
nanoscale and micron sized alumina and cobalt
chromium particles
The effect of incorporating membrane proteins isolated from primary HFBs and
U937 histiocytes on the membrane integrity in the presence of nanoscale and
micron sized alumina and CoCr particles was investigated. The vesicle leakage
studies were performed as described in section 2.2.6.3, however the major
difference was the incorporation of 20% (w/w) isolated membrane proteins from
primary HFBs or U937 histiocytes into the model lipid vesicles (previously optimised
in section 4.3.4.1).
4.3.5.1 The effect of the incorporation of fibroblast and histiocyte membrane
proteins into the model lipid membrane on membrane integrity in the
presence of nanoscale and micron sized alumina particles
In the presence of nanoscale alumina particles, no release of the fluorescent dye
from the vesicles containing isolated human fibroblast proteins was observed at the
particle concentrations of 1 and 10 µg.ml-1 (Figure 4.10A). At the highest particle
concentration of 100 µg.ml-1, a small increase of 3% in the vesicle leakage was
measured, which was significantly greater than the vesicle leakage at the lower
particle concentrations. Similar results were also measured for vesicles containing
U937 histiocyte proteins in the presence of nanoscale alumina particles. Only a
small vesicle leakage of 6% was observed at the particle concentration of 100
µg.ml-1 (Figure 4.10B).
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A dose dependent increase in the vesicle leakage was measured for the vesicles
containing human fibroblast isolated proteins in the presence of micron sized
alumina particles (Figure 4.10C). No vesicle leakage was observed at the lowest
particle concentration of 1 µg.ml-1. However at the highest particle concentration of
100 µg.ml-1 the mean vesicle leakage had increased to 15%, which was statistically
significant in comparison to the vesicle leakage at 1 and 10 µg.ml-1. In the presence
of micron sized alumina particles, a dose dependent increase in the vesicle leakage
was observed for the vesicles containing U937 isolated proteins. Nevertheless the
amount of released fluorescent dye was less than observed for the vesicles
containing isolated primary HFBs proteins, with the highest particle concentration of
100 µg.ml-1 only inducing a 8% vesicle leakage (Figure 4.10D). This result was
significantly higher than the lower particle concentrations of 1 and 10 µg.ml-1.
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Figure 4.10 – The effect of nanoscale and micron sized alumina particles on vesicle
leakage of a lipid membrane with isolated membrane proteins from human fibroblasts
and U937 histiocytes. Nanoscale alumina particles were incubated with lipid vesicles
consisting of 20% (w/w) isolated proteins from human fibroblast membranes (A) or isolated
U937 histiocytes (B). Micron sized alumina particles were incubated with lipid vesicles
consisting of 20% (w/w) isolated human fibroblast membrane proteins (C) or isolated U937
histiocytes (D). Data (n=3) is expressed as a percentage vesicle leakage of the detergent
Triton-X 100. Vesicle leakage of fluorescent dye encapsulated vesicles was measured in
real time and subsequent increasing particle concentrations (1, 10 and 100 µg.ml-1). A
paired t-test was performed in comparison to FBS only control and statistically significant
results (p< 0.05) are indicated by an asterisk. Error bars represent 95% confidence levels.
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4.3.5.2 The effect of the incorporation of fibroblast and histiocyte membrane
proteins into the model lipid membrane on membrane integrity in the
presence of nanoscale and micron sized cobalt chromium particles
In the presence of nanoscale CoCr particles, no vesicle leakage was observed for
vesicles containing isolated primary HFBs proteins at the particle concentrations of
1 and 10 µg.ml-1. Only at the highest particle concentration of 100 µg.ml-1, a mean
of 3% vesicle leakage was observed (Figure 4.11A). No vesicle leakage was
observed for the vesicle containing isolated U937 proteins incubated with
nanoscale CoCr particles, whereby the vesicle leakage was less than the baseline
for all particle concentrations (Figure 4.11B). This suggested that the CoCr particles
induced a quenching effect.
In the presence of micron sized CoCr particles, a small amount of vesicle leakage
of 6% was observed at the particle concentration of 100 µg.ml-1 for vesicles
containing isolated primary HFBs proteins (Figure 4.11C). Similarly, at the highest
particle concentration of 100 µg.ml-1, the micron sized CoCr particles only induced a
mean 8% vesicle leakage when incubated with vesicles containing U937 isolated
proteins (Figure 4.11D).
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Figure 4.11 – The effect of nanoscale and micron sized cobalt chromium particles on
vesicle leakage of a lipid membrane with isolated membrane proteins from human
fibroblasts and U937 histiocytes. Nanoscale CoCr particles were incubated with lipid
vesicles consisting of 20% (w/w) isolated proteins from human fibroblast membrane (A) or
isolated U937 histiocytes (B). Micron sized CoCr particles were incubated with lipid vesicles
consisting of 20% (w/w) isolated human fibroblast membrane proteins (C) or isolated U937
histiocytes (D). Data (n=3) is expressed as a percentage vesicle leakage of the detergent
Triton-X 100. Vesicle leakage of fluorescent dye encapsulated around vesicles was
measured in real time and subsequent increasing particle concentrations (1, 10 and 100
µg.ml-1). A paired t-test was performed in comparison to FBS only control and statistically
significant results (p< 0.05) is indicated by an asterisk (*). Error bars represented 95%
confidence levels (n = 3).
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4.3.6 The effect of the incorporation of fibroblast membrane
proteins into the model lipid membrane on the binding
of particles
The effect of incorporating membrane proteins isolated from primary HFBs on the
interactions of particles was investigated using QCM-D. The QCM-D studies were
performed as described in section 2.2.6.4, however the major difference was the
incorporation of 20% (w/w) isolated membrane proteins from primary HFBs into the
sBLM (previously optimised in section 4.3.4.1). Upon the formation of a stable
sBLM, nanoscale and micron sized alumina or CoCr particles, diluted in DMEM at
concentrations of 1, 10 and 100 µg.ml-1, were flowed across the sBLM at a flow rate
of 70 µl per minute for 30 minutes. The change in frequency and dissipation over
time were monitored and for clarity, the ninth overtone is only shown for the QCM-D
plots.
4.3.6.1 The effect of the incorporation of fibroblast membrane proteins into
the model lipid membrane on the binding of nanoscale and micron
sized alumina particles
The change in frequency and dissipation over time at the ninth overtone for the
alumina nanoscale and micron sized particle QCM-D experiments are shown in
Figure 4.12A and Figure 4.12B, respectively. A stable sBLM consisting of 20%
(w/w) isolated membrane proteins from primary HFBs was formed for both the
nanoscale and micron sized alumina particle QCM-D studies. No overall effect on
the frequency was observed upon the addition of nanoscale alumina particles to the
sBLM at particle concentrations equal to or less than 100 µg.ml-1. No change in the
frequency was observed for all the concentrations of micron sized alumina particles
tested. For both the nanoscale and micron sized alumina particle experiments, the
greatest change was observed for the dissipation at particle concentrations of 10
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µg.ml-1 or higher. For example, upon the addition of 100 µg.ml-1 of nanoscale
alumina particles, the dissipation increased to 8 x 10-6. This change in dissipation
stabilised upon the addition of DMEM.
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Figure 4.12 – QCM-D plot of a solid supported bilayer lipid membrane containing 20%
isolated human fibroblast plasma membrane in the presence of nanoscale alumina
(A) and micron sized (B) particles. A sBLM of the mixed lipid vesicles was formed onto an
oscillating quartz crystal (not shown). Commencing in DMEM, incremental concentrations (1
– 100 µg.ml-1) of nanoscale or micron sized alumina particles followed by DMEM washes
were added at times indicated by the arrows. Changes in the frequency (blue) and
dissipation (red) were measured (the ninth overtone is displayed).
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4.3.6.2 The effect of the incorporation of fibroblast membrane proteins into
the model lipid membrane on the binding of nanoscale and micron
sized cobalt chromium particles
A stable sBLM, consisting of 20% (w/w) isolated proteins from primary HFBs, was
formed for both the nanoscale and micron sized CoCr particle QCM-D studies
(Figure 4.13A and 4.13B, respectively). For both the nanoscale and micron sized
CoCr particle experiments, no change in the frequency was observed for all particle
concentrations, which remained constant throughout the testing. A minor increase
in the dissipation from 5 x 10-6 to 6.5 x 10-6 was measured when 100 µg.ml-1 of CoCr
nanoscale particles were flowed across the sBLM. However, this increase was less
than the dissipation change observed in the alumina nanoscale and micron sized
particle experiments. No change in the dissipation was measured upon the addition
of micron sized CoCr particles at all the particle concentrations tested.
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Figure 4.13 – QCM-D plot of a solid supported bilayer lipid membrane containing 20%
isolated human fibroblast plasma membrane in the presence of nanoscale CoCr (A)
and micron sized (B) particles. A sBLM of the mixed lipid vesicles was formed onto an
oscillating quartz crystal (not shown). Commencing in DMEM, incremental concentrations (1
– 100 µg.ml-1) of nanoscale or micron sized CoCr particles followed by DMEM washes were
added at times indicated by the arrows. Changes in the frequency (blue) and dissipation
(red) were measured (The ninth overtone is displayed).
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4.4 Discussion
The aim of this part of the study was to investigate the effect of nanoscale and
micron sized alumina and CoCr particles on the cell plasma membrane. Whilst a
number of in vitro studies have explored the effect of alumina and CoCr particles on
a variety of cell types, currently there are limited studies exploring the effect of
these particles on the cell plasma membrane (Lewis et al. 2007; Goode et al. 2012).
The plasma membrane is important for overall cell function by providing a
selectively permeable barrier and structural support for the cell (Voet et al. 2013).
Therefore the effect of particles on the cell plasma membrane integrity, binding and
subsequent uptake may influence the cellular responses to the particles (Canton
and Battaglia 2012). This study focused on the effect of nanoscale and micron
sized alumina and CoCr particles on the cell plasma membrane and the potential
impact on the cell viability.
Studies which have explored the effect of particles on the cell plasma membrane
lack specificity (Lewis et al. 2007; Goode et al. 2012). These studies tend to only
report particle uptake and localisation within the cells. However, these studies do
not determine the factors affecting particle interactions with the cell membrane or
the possible damage caused by the particles. Furthermore a large proportion of in
vitro studies on the effect of alumina and CoCr particles on the cell viability have
used model particles which are not clinically relevant in terms of particle size
(Yoshida et al. 2003; Hallab et al. 2010; Dalal et al. 2012). As previously described
in Chapter 1, particle size, composition and morphology can have an influencing
effect on particle: membrane interactions and on the cell viability (Canton and
Battaglia 2012). Therefore this part of the study aimed to use nanoscale and micron
sized alumina and CoCr particles described in Chapter three.
In order to investigate the effect of nanoscale and micron sized alumina and CoCr
particles on the cell plasma membrane, recently developed methods within the field
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of nanotoxicology were implemented. These included the use of simple vesicle
leakage assays, QCM-D and SPR techniques (Green et al. 2000; Cho et al. 2010;
Mu et al. 2014). The advantage of using these techniques allows the environment in
which particle: membrane interactions occur to be highly controlled. Furthermore,
influencing factors, such as the presence of serum or membrane proteins can be
investigated (Cho et al. 2010). Moreover, a number of studies investigating the
effect of nanoparticles on the cell plasma membrane have used simplified model
membranes, often only consisting of one type of phospholipid (Lesniak et al. 2012;
Lesniak et al. 2013). However the cell plasma membrane comprises of multiple
phospholipids and cholesterol (Voet et al. 2013). Therefore to make the model
membrane more clinically relevant, the composition of the model lipid membrane
employed in this study consisted of a phospholipid: cholesterol mixture similar to
the composition of primary HFBs (Schroeder et al. 1984; Mahadik et al. 1994). At
present this is the first instance where a model fibroblast membrane has been used
to investigate particle: membrane interactions.
4.4.1 The effect of nanoscale and micron sized alumina and
cobalt chromium particles on the integrity of a model
lipid cell plasma membrane
The effect of nanoscale and micron sized alumina and CoCr particles on membrane
integrity and the ability to damage the membrane was investigated, initially using a
simple vesicle leakage assay. This vesicle leakage assay has previously been used
in the published literature with alternative nanoparticles. Similar results have also
been reported for silica nanoparticles whereby the particles only induced a
moderate increase of up to 20% vesicle leakage, even at high particle
concentrations of 100 µg.ml-1 (Mu et al. 2012a).
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The results revealed that both the nanoscale and micron sized alumina and CoCr
particles induced vesicle leakage of the model lipid membrane in a dose dependent
response. Surprisingly the nanoscale and micron sized alumina particles induced a
larger vesicle leakage than the nanoscale and micron sized CoCr particles. Indeed
at the highest particle concentration of 100 µg.ml-1, the nanoscale alumina particles
caused a 16% increase in vesicle leakage, whereas the nanoscale CoCr particles
only induced 4% vesicle leakage at the equivalent particle concentration.
Nanoscale CoCr particles were revealed to have a quenching effect on the
florescent dye released from the vesicles. Nanoparticles have previously been
reported to have a quenching effect on colorimetric assays and therefore this must
be considered (Raikar et al. 2011).
Whilst the results from the chapter demonstrated that the vesicle leakage in the
presence of particles was statistically significant, particularly with membrane
proteins incorporated into the vesicles, this does not necessarily correlate with
biological significance. Membrane pores caused by silica nanoparticles have been
demonstrated to form transient pores in the membrane which may have limited
effect on viability of a cell (Mu et al. 2012; Zhang et al. 2012). Furthermore the
particle concentrations used in the vesicle leakage assays (up to and including 100
µg.ml-1) were much higher than the concentrations used in the cell viability assays
described in Chapter three and would not be observed within a clinical scenario.
Therefore it is unlikely that the main mode of toxicity for nanoscale and micron
sized alumina and CoCr particles is direct damage to the plasma membrane.
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4.4.2 Binding of nanoscale and micron sized alumina and
cobalt chromium particles to a model lipid membrane
The binding of nanoscale and micron sized alumina and CoCr particles to a model
lipid membrane were also investigated using QCM-D. As outlined previously, QCM-
D has been used to explore the effect of a variety nanoparticles on a sBLM,
including silica and copper particles (Karlsson et al. 2013; Lesniak et al. 2013). The
advantage of using QCM-D is that it is highly sensitive and can measure changes in
mass as low as 100 pg.cm-2 over the crystal area. Furthermore, due to its sensitivity
this technique provides an opportunity to isolate and examine which factors are
critical for particle binding to a model lipid membrane such as the presence of
membrane proteins (Cho et al. 2010). A stable sBLM was formed using the
optimised methods described by Mu et al.(2012; 2104). Upon the formation of the
sBLM, nanoscale and micron sized alumina and CoCr particles were flowed across
the membrane and the frequency and dissipation were measured. A decrease in
the frequency indicated particle binding and the dissipation also provided
information on the viscoelasticity of the nanoparticle layer. Due to the nature of the
QCM-D method, a positive control of membrane binding was not used with each
experiment in this current study. However, an example of silica nanoparticle binding
to a sBLM from the literature is shown in Figure 1.5 and was used as a point of
reference. Furthermore, Appendix C reveals that 10% (v/v) FBS was able to bind to
the sBLM used in this current study, thus demonstrating the potential for binding to
the model membrane to occur.
The results for the QCM-D experiments from this part of the study revealed that
none of the nanoscale and micron sized alumina and CoCr particles caused a
significant reduction in the frequency at any particle concentration tested. Indeed a
minor increase in the frequency was observed for the nanoscale alumina and CoCr
particles and micron sized CoCr particles. A small reduction in the frequency was
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measured in the presence of the micron sized alumina particles; however this
decrease of 3 Hz was very minor and did not indicate significant particle binding.
Moreover, for all particle types, a rise in the dissipation was observed with
increasing particle concentration. These results were unexpected. However, the
changes in dissipation were measured consistently across the different types of
particles and between repeats, suggesting that a degree of precision of the QCM-D
method. As previously mentioned nanoparticle binding to sBLMs have be reported
in the literature using QCM-D. However Mu et al. (2012) measured approximately a
90 Hz reduction in the frequency upon the addition of 10 μg.ml-1 of 14 nm silica
nanoparticles to the sBLM. Similarly Lesniak et al. (2013) reported a strong
interaction with the model membrane with a reduction in the frequency of
approximately 60 Hz after the addition of 100 nm polystyrene nanoparticles to a
POPC sBLM. Mu et al. (2014) also reported an increase in the dissipation (7 x 10-6)
as well as a reduction in the frequency (less than 10 Hz) after the addition of
polymer coated zinc oxide nanoparticles to a sBLM, suggesting a weaker
interaction with the membrane.
Interestingly, Karlsson et al. (2013) also reported copper nanoparticles in the
presence of a sBLM induced a large increase in the dissipation alongside a small
increase in the frequency. Nevertheless the authors failed to explain why this
occurred. Olsson et al. (2012) hypothesised that the increase in frequency can be
caused by the particles binding to the sBLM via small contact points and oscillating
at their own resonant frequency. The authors hypothesised a coupled resonance
model whereby the particle formed resonators themselves which was dependent on
the overtone number. However, the data from the present study did not fit this
model and therefore this theory was unlikely to explain the results obtained in this
present study.
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To quantify the binding of the nanoscale and micron sized alumina and CoCr
particles to the sBLM, the frequency and dissipation data at all overtones was
modelled using the Voight model. The Voight model is commonly used for QCM-D
studies which implement non-rigid structures on the surface of the quartz crystal.
This model is able to model non-rigid layers unlike the traditionally used Saurbrey
equation, which assumes a rigid layer has been formed on the surface of the crystal
(Voinova et al. 1999). The Saurbrey equation does not take into account the
dissipation and therefore can underestimate the mass bound to the quartz crystal.
Instead the Voight model represents the sBLM and the layer of bound particles as a
viscous dashpot and elastic spring connected in parallel. It can be used to
determine the viscosity, shear modulus and thickness of each layer formed on the
crystal surface (Voinova et al. 1999).
The modelling outputs for the nanoscale and micron sized alumina and CoCr
particles revealed that stable sBLMs had been formed. However the second layer
of the model was not characteristic of either alumina or CoCr particles. Therefore it
was hypothesised that the increase in dissipation may have been caused by an
intermediate layer being formed between the sBLM and the particles, known as a
slippage layer (Daikhin et al. 2000). The presence of the slippage layer would have
caused no overall change in the frequency but may have increased the dissipation
outputs. Nevertheless, it was not possible to model this as the Voight model
assumes that only two layers can be modelled, rather than three. Therefore, an
alternative binding technique of SPR was used to confirm whether or not particles
bound to the model lipid membrane.
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4.4.3 Binding of particles to a model lipid membrane using
surface plasmon resonance techniques
Surface plasmon resonance was used in conjunction with the QCM-D results to
determine if particle binding to the model lipid model had occurred. This technique
measures the adsorption of substances onto a planar gold or silver sensor by
detecting changes in the film thickness of the sensor (Green et al. 2000). The
binding of nanoscale CoCr particles was used as an example particle for the SPR
experiments. The SPR results revealed that no binding was observed upon the
addition of nanoscale CoCr particles to the model lipid membrane. Therefore it was
concluded that no or very little particle binding had occurred for the QCM-D
experiments. These results highlight the sensitivity of the QCM-D technique and
suggest that the change in dissipation may have been caused by very weak
interactions between particles and sBLM or, alternatively, a minor disrupting effect
on the sBLM without permanent adherence of the particles.
4.4.4 The incorporation of fibroblast membrane proteins into
the model lipid membrane on the binding of particles
To further increase the complexity and clinical relevance of the model lipid
membrane, nanoscale and micron sized alumina and CoCr particles interactions to
membrane proteins was also investigated. The presence of membrane proteins
may also be an essential part of particle recognition and cellular internalisation.
Following the optimisation studies, proteins were isolated from the plasma
membranes of U937 histiocytes and primary HFBs using a sucrose gradient. This
method was optimised in order to only isolate the proteins of the plasma membrane
and structurally similar endosomal vesicles of the cytoplasm. This method removed
the membranes of other organelles, such as mitochondria, which were considered
structurally very different and may have influenced the results.
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In order to form a stable sBLM for the QCM-D studies, the concentration of
membrane proteins incorporated within the model lipid membrane was optimised.
This is because high concentrations of proteins can inhibit bursting of the
membrane vesicles once bound to the quartz crystal to form a sBLM. The formation
of a sBLM was measured using 20% (w/w), 40% (w/w) and 60% (w/w) proteins
isolated from L929 fibroblasts. This cell type was used as a large number of cells
were required to isolate sufficient concentration of membrane proteins for the
optimisation experiments. L929 cells were more readily available than the primary
HFBs and U937 histiocytes and hence were used for this experiment. The results
demonstrated that the optimal protein concentration was 20% to form a solid
supported planar membrane. This finding was in good agreement with the results
published by Dodd et al. (2008), where the inner membrane was isolated from E.
coli and incorporated into a phosphatidylcholine sBLM. Using QCM-D techniques,
Dodd et al. (2008) revealed that a protein concentration of 20% (w/w) formed a
stable sBLM. Therefore a protein concentration of 20% (w/w) was incorporated into
the model lipid membrane for all future experiments investigating effect of the
presence of membrane proteins. The more complex model membrane has not been
used in literature and was considered a novel, clinically relevant model.
The effect of nanoscale and micron sized alumina and CoCr particles on membrane
integrity in the presence of membrane proteins was investigated using the vesicle
leakage assay. The membrane proteins isolated from U937 histiocytes and primary
HFBs were used in these experiments. For both types of isolated proteins, no
extensive vesicle leakage was observed for the nanoscale and micron sized
alumina and CoCr particles. However the vesicle leakage for the alumina particles
was less than results for the vesicles without membrane proteins incorporated into
them. For instance, 100 μg.ml-1 of micron sized alumina particles induced 20%
leakage for the vesicles without any membrane protein incorporated into them.
When the membrane proteins were incorporated into the vesicles, the vesicle
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leakage reduced to 7.5%. This difference may be caused by the presence of the
proteins within the vesicles reducing the number of particle: membrane interactions
to occur and thus fewer pores within the membrane were formed. Alternatively, the
presence of proteins in the vesicles may alter the vesicle stability, making them less
susceptible to pore formation. Nevertheless, these results suggest that pore
formation within the cell membrane is not the main mode of particle toxicity.
Nanoscale and micron sized alumina and CoCr particle interactions with the sBLM
containing 20% (w/w) isolated membrane proteins was also explored. Due to low
recovery rates from U937 histiocytes, only the proteins isolated from primary HFBs
were tested. Again the results for the nanoscale and micron sized alumina and
CoCr particles demonstrated no overall decrease in the frequency. Instead an
increase in the dissipation was observed. As described above, these results were
considered negative, with no or weak particle binding occurring in the presence of
membrane proteins. The binding of particles, from THRs or commercially available
nanoparticles, to a model membrane containing isolated primary HFBs has not
been investigated in the literature, making comparisons difficult. As previously
described, this phenomenon of an increase of dissipation observed in this current
study has been reported by Karlsson et al. (2013). Using QCM-D, copper
nanoparticles were washed across a simple lipid membrane, in the absence of
membrane proteins, which caused an increase in dissipation. The authors did not
explain why this occurred, but as described in this present study, concluded that
particle binding had not occurred. Therefore other factors must be considered to
determine the effect of alumina and CoCr particles on the cell plasma membrane.
4.4.5 Conclusion
This part of the study aimed to investigate the effect of nanoscale and micron sized
alumina and CoCr particles on the cell plasma membrane. In vitro studies on the
Chapter 4
191
effect of CoCr and alumina particles have failed to investigate the potential effects
on the cell plasma membrane. This is particularly important as the interactions with
the plasma membrane can determine downstream effects such as cell viability.
Using a novel model lipid membrane, which was similar in composition to primary
HFBs, it was revealed that the nanoscale and micron sized alumina and CoCr
particles did not directly damage the model membrane, even in the presence of
isolated membrane proteins from U937 histiocytes and primary HFBs.
Furthermore, using the highly sensitivity technique of QCM-D, the nanoscale and
micron sized alumina and CoCr particles induced an increase in the dissipation.
Modelling of the frequency and dissipation using the Voight model did not reveal
characteristic results for particles bound to the sBLM. These results were confirmed
by SPR and the increases in dissipation for the QCM-D experiments were likely to
be non-specific artefacts due to the sensitivity of QCM-D or minor alterations of the
sBLM layer. Moreover, the incorporation of membrane proteins from primary HFBs
into the model membrane also demonstrated that no particle binding occurred.
Therefore this series of experiments have revealed that the particles did not bind to
the sBLM or induce membrane damage detectable by these methods under the
conditions used.
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Chapter 5
The effect of serum proteins on the interaction of
nanoscale and micron sized alumina and cobalt chromium
particles with a model lipid membrane
5.1 Introduction
This part of the present study focused on the effect of serum proteins on particle
interactions with a model lipid membrane. The results from the previous chapter
demonstrated no or a weak interaction of the particles to a sBLM, even in the
presence of isolated membrane proteins from primary HFBs or U937 histiocytes. To
investigate further the effects of nanoscale and micron sized alumina and CoCr
particles on the cell plasma membrane, other factors need to be considered. One
such factor is the formation of a protein corona on the surface of the particles and its
influence on particle toxicity. A protein corona is formed when proteins from the
surrounding biological medium adhere to the particles (Rauch et al. 2013). The
particles can potentially interact with a diverse range of biological molecules
including proteins, receptors and glycoproteins. The bound proteins on the particle
surface change the surface characteristics and in turn can alter the cellular
response to the particles, such as cell viability, oxidative stress and genotoxic
effects (Rauch et al. 2013).
The formation of a protein corona is likely to happen immediately after the release of
the wear particles from the bearing surface and into the joint capsule (Catalani et al.
2011). Catalani et al. (2011) confirmed that chromium ions bind to human serum
albumin (HSA) from patients with CoCr alloy THRs. Chromium (Cr3+) and aluminium
ions (Al3+) have also been demonstrated to bind to transferrin (Vincent and Love
2012). Hence investigation into the effect of protein coronae on particle toxicity is
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particularly relevant and further provides a greater understanding of in vitro cell
viability studies on wear particles.
As yet, very few studies have investigated the role of proteins adsorbed on the
surface of alumina and CoCr particles on the cell membrane and subsequent
particle biocompatibility (Hallab et al. 2000; Lewis et al. 2007; Potnis et al. 2013).
Lewis et al. (2007) compared the uptake of model CoCr particles into fibroblasts
which had either been pre-incubated with HSA for 5 days or were pre-incubated for
1 hour in MEM only. After 48 hours, the particles incubated in MEM, prior to
exposure to fibroblasts, were more likely to be internalised and induce single
stranded DNA breaks. Hallab et al. (2000) demonstrated in vitro that CoCr model
particles bound to high molecular weight proteins within human serum were more
likely to induce lymphocyte proliferation in comparison to cells exposed to CoCr
particles in the absence of serum. However, both these studies used micron sized
model particles and therefore it is not known if this would occur for more clinically
relevant nanoscale CoCr wear particles.
The occurrence of protein coronae is an area of interest within the field of
nanotechnology (Dai et al. 2015). In order to improve the therapeutic effects of
nanoparticles, particularly those used in medical applications, a number of studies
have reported the role of protein coronae on particle toxicity which can reduce or
increase potential particle toxicity. In addition these types of studies can provide
useful indications on the potential cellular effects of protein coronae formed on the
surface of the particles (Dai et al. 2015; Mirshafiee et al. 2015; Shang and Nienhaus
2015).
The formation of a protein corona on the particle surface is determined by a number
of factors. These include the characteristics of the particles such as size, charge,
shape and the proteins within the biological medium that the particles are exposed
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to (Hu et al. 2014; Pozzi et al. 2015). Albumin is the most abundant protein in serum
(55%) and in vitro cell studies on particle toxicity often use medium supplemented
with 10% (v/v) FBS. Bovine serum albumin (BSA) has been reported to bind to
model CoCr particles (Smith et al. 2004; Lewis et al. 2007; Vidal and Muñoz 2011).
Alongside albumin, less abundant proteins such as immunoglobulins and growth
factors are present within the serum (Rauch et al. 2013). Therefore, unless a free
serum environment is specifically used for cell studies, it is presumed that the
particles cultured with cells are coated with proteins. However this process is often
not considered when determining mechanisms of particle toxicity on cells.
In vitro studies on the formation of a protein corona, using manufactured
nanoparticles, have demonstrated a diverse range of cell responses (Deng et al.
2011; Fleischer and Payne 2014b; Hu et al. 2014; Borgognoni et al. 2015; Cheng et
al. 2015; Duan et al. 2015; Landgraf et al. 2015; Mirshafiee et al. 2015). Indeed, the
protein corona can influence particle uptake, for example the binding of BSA to
graphene oxide nanoparticles has been reported to reduce the physical interaction
and entry into A549 lung epithelial cells (Duan et al. 2015). However, the coating of
serum albumin onto carbon nanoribbons was demonstrated to increase particle
uptake into A549 lung epithelial cells (Mbeh et al. 2014). Other studies have
demonstrated that protein coronae on titanium dioxide and gold nanoparticles can
induce a greater detrimental effect on cell viability (Borgognoni et al. 2015; Cheng et
al. 2015). In contrast, other studies have reported a reduced effect on cell viability of
a variety of cell types cultured with metal nanoclusters, graphene oxide and iron
oxide nanoparticles with bound proteins on the particle surface (Duan et al. 2015;
Landgraf et al. 2015; Shang and Nienhaus 2015).
More specifically, studies investigating the effect of protein coronae on particle:
membrane binding have reported conflicting results (Nel et al. 2009; Deng et al.
2011; Vincent and Love 2012; Lesniak et al. 2013; Fleischer and Payne 2014b; Hu
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et al. 2014; Cheng et al. 2015; Duan et al. 2015; Mirshafiee et al. 2015). For
example Lesniak et al. (2013) reported reduced binding of carboxylated polystyrene
nanoparticles to a POPC sBLM in the presence of serum, using QCM-D techniques.
The authors proposed that the formation of a protein corona shielded the binding
sites in the membrane, thus reducing membrane: particle interactions. In contrast,
fibrinogen coated gold nanoparticles were reported to increase the binding of
particles to the integrin receptor Mac-1 in human promyelocytic leukaemia (HL-60),
embryonic kidney (HEK293) and monocyte (THP-1) cell lines. It was suggested that
the fibrinogen denatured onto the particle surface and increased the binding affinity
to the Mac-1 receptor in the cell membrane (Deng et al. 2011).
The discrepancies between these studies mean forming conclusions about the
influencing factors of particle binding and subsequent effects on cells is difficult.
Especially as there is no standardisation of methods and it is unknown how much of
an influence the use of different cell types and the formation of different protein
coronae can have on particle interactions with the membrane and particle
biocompatibility (Horie et al. 2009). Within the field of wear particle toxicity, the lack
of evidence means that the effect of different joint replacement materials is unclear.
Furthermore, current published literature on particle binding to the cell membrane
using QCM-D techniques have used simple phospholipid membrane model (Lesniak
et al. 2013). These membranes often only contain one type of phospholipid (usually
POPC), which does not reflect the composition of a typical human cell plasma
membrane. As previously described a plasma membrane contains multiple types of
phospholipids and cholesterol as well as integrated membrane proteins (Voet et al.
2013). Therefore this part of the study aimed to use a model lipid membrane, also
used in chapter four, to closely represent the structure of human fibroblast
membranes (Schroeder et al. 1984; Mahadik et al. 1994). Furthermore, the
integration of membrane plasma proteins isolated from primary HFBs would allow
Chapter 5
196
the investigation into the role of membrane proteins on particle binding in the
presence of FBS.
5.1.1 Aims and Objectives
The aim of this part of the study was to investigate if the addition of FBS with the
nanoscale and micron sized alumina and cobalt chromium particles influences
particle cytotoxicity and membrane interactions. In the first instance the effect of the
presence or absence of 10% (v/v) FBS in the cell culture medium on L929 fibroblast
viability was explored. Further the internalisation and localisation of alumina and
CoCr in the presence or absence of FBS was investigated using TEM techniques.
These experiments aimed to determine if the particles were internalised and if the
particles are actively taken up within vesicles or distributed throughout the
cytoplasm. More specifically the effect of the formation of a protein corona on
particle interactions with a lipid model membrane, also used in Chapter four, was
investigated. The effects of membrane proteins and protein corona formation on
particle membrane binding were also explored. These experiments were designed
to provide an insight into the factors influencing particle binding and uptake into
cells, specifically fibroblasts, using a model of a human fibroblast cell.
5.1.2 Objectives
The specific objectives of this part of the study were as follows and are outlined in
Figure 5.1:
 To investigate the effect of 10% (v/v) FBS on L929 fibroblast cell viability in the
presence of nanoscale and micron sized alumina and CoCr particles
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 To explore nanoscale alumina and CoCr particle uptake into L929 fibroblasts in
the presence or absence of 10% (v/v) FBS using TEM techniques
 To assess the effects of nanoscale and micron sized alumina and CoCr particles
on membrane integrity in the presence of 10% (v/v) FBS.
 To investigate the binding of nanoscale and micron sized alumina and CoCr
particles to a model plasma membrane, in the presence of FBS, using QCM-D
 To explore the effect of incorporating of isolated membrane proteins into the
model membrane on membrane damage caused by nanoscale and micron
sized alumina and CoCr particles using vesicle leakage assays in the presence
of 10% (v/v) FBS
 To explore the effect of incorporating isolated membrane proteins of primary
HFBs into model membranes on nanoscale and micron sized alumina and CoCr
particle binding using QCM-D in the presence of FBS
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Figure 5.1 – Overview of project and outline of chapter five methods
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5.2 Material and methods
5.2.1 Materials
Materials and equipment required for sample preparation for TEM analysis are listed
in Table 5.1.
Table 5.1 – Materials and equipment used to prepare cell samples for transmission
electron microscopy analysis
Chemical/ Material Supplier
2, 4, 6-Tris (dimethylaminomethyl) phenol (DMP30)
(R1065)
Agar Scientific, Stansted, U.K.
24 well flat cell culture plate (142475) Thermofisher Scientific,
Langenselbold, Germany.
Araldite resin (R1042)
Agar Scientific, Stansted, U.K.
Copper grids (200 nm grids) (AGG2710C) Agar Scientific, Stansted, U.K.
Dental wax strips (AGG381) Agar Scientific, Stansted, U.K.
Diamond blade (DiATOME 45° AGG339-8) Agar Scientific, Stansted, U.K.
Dodecenylsuccinic anhydride (DDSA) (R1053) Agar Scientific, Stansted, U.K.
EDX analysis system and software (Inca version 4.1)
Oxford Instruments, Abington,
U.K.
Eppendorf centrifuge (5415R) Eppendorf, Stevenage, U.K.
Ethanol (absolute) (64-17-5) Sigma-Aldrich, Irvine, U.K.
Filter paper (1001090) Whatman, Maidstone, U.K.
Glutaraldehyde (AGR1009) Agar Scientific, Stansted, U.K.
Osmium tetraoxide (AGR1015) Agar Scientific, Stansted, U.K.
Plate heater (AGG3328) Agar Scientific, Stansted, U.K.
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Chemical/ Material Supplier
Polypropene oxide (R1080) Sigma-Aldrich, Irvine, U.K.
Reynold’s lead citrate (AGR1210) Agar Scientific, Stansted, U.K.
Sodium hydroxide 1M (S/4920/60)
Fisher Scientific,
Loughborough, U.K.
TEM (JEOL 1400) Jeol, Peabody, U.S.A.
TEM for EDX analysis (Tecnai F20 TEM) FEI, Hillsboro, USA.
Trichloroethylene (GPR 30497)
VWR Chemicals, Lutterworth,
U.K.
Ultramicrotome  (Reicher-Jung Microtome  Ultracut E)
Leica Microsystems, Milton
Keynes, U.K.
Ultramicrotome glass (for glass blades)  (B329) Agar Scientific, Stansted, U.K.
Uranyl acetate   (AGR1260A) Agar Scientific, Stansted, U.K.
5.2.1.1 Araldite resin for embedding of cell samples for transmission
electron microscopy imaging
A volume of 27 ml of Araldite was added to 23 ml of dodecenylsuccinic anhydride
(DDSA) in a clean 150 plastic pot and stirred carefully with a glass stirrer to avoid
bubble formation. Once mixed, 1 ml of 2, 4, 6-Tris (dimethylaminomethyl) phenol
(DMP30) was added and the resin was mixed thoroughly using a glass stirrer. The
resin was placed into 20 ml glass vials and stored at 4°C for a maximum of 24 hours.
5.2.2 Methods
5.2.2.1 The effect of particles on L929 fibroblast cell viability in the absence
or presence of 10% (v/v) foetal bovine serum
L929 fibroblasts were passaged and seeded into flat bottomed 96 well plates at a
cell density of 1x105.ml-1 as described in section 2.2.4. After 16 hours, the cell
culture medium was replaced with either DMEM with 10% (v/v) FBS or DMEM
Chapter 5
201
without FBS. Two sets of each particle volume were made up in either DMEM with
10% (v/v) FBS or DMEM without FBS. The cells, with six replicates, were cultured
with nanoscale or micron sized CoCr particles at particle volumes per cell of 50 μm3,
5 μm3, 0.5 μm3, 0.05 μm3 and 0.005 μm3.  For the nanoscale and micron sized
alumina particles, the cells were cultured with particles at a particle volume per cell
of 500 µm3 50 μm3, 5 μm3, 0.5 μm3 and 0.05 μm3. Each particle suspension was
sonicated immediately before 100 µl of the particle suspension was added to the
cells. The negative control was cells in 200μl of the corresponding medium (DMEM
with or without 10% (v/v) FBS) and the positive control was camptothecin at a final
concentration of 2 µg.ml-1. A particle only control was included which was the
highest particle dose in the corresponding medium (DMEM with or without 10% (v/v)
FBS) in the absence of cells. A blank was also included which was 200 µl of
corresponding medium only (DMEM with or without 10% (v/v) FBS). Each treatment
was repeated six times and the cells were cultured with the particles in 5% (v/v) CO2
in air at 37oC. The cell viability was assessed over 5 days at specific time points of
day 0, 1, 2, 3 and 5. The cell viability was assessed using the MTT assay (section
2.2.5) and the experiment was repeated twice, with 6 replicates, to ensure
repeatability.
5.2.2.2 Transmission electron microscopy analysis of L929 fibroblasts
cultured with nanoscale alumina and cobalt chromium particles in the
absence or presence of 10% (v/v) foetal bovine serum
The internalisation of nanoscale alumina and CoCr particles into L929 fibroblast
cells was analysed using TEM techniques.
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5.2.2.2.1 Culturing L929 fibroblasts with nanoscale alumina and CoCr
particles in the absence or presence of 10% (v/v) foetal bovine
serum
L929 fibroblasts were treated with trypsin and seeded onto a 24 well culture plate at
a density of 2 x 104 cells.ml-1 as described in section 2.2.4. For each well, 500 µl of
the cell suspension was added and were incubated at 37°C, 5% (v/v) CO2 for 16
hours to allow the cells to adhere. The medium was then replaced with fresh DMEM
medium either with or without 10% (v/v) FBS. Two sets of each particle volume
were diluted in either DMEM supplemented with 10% (v/v) FBS or DMEM without
FBS. The cells were cultured with nanoscale CoCr particles at a particle volume per
cell of 50 μm3, 5 μm3 and 0.5 μm3.  For the nanoscale alumina particles, the cells
were cultured with particles at a particle volume per cell of 50 μm3 and 5 μm3. Each
particle suspension was sonicated immediately before 500 µl of the appropriate
particle suspension was added to the corresponding wells.
Based upon the cell viability results, after 48 hours, the cells cultured with nanoscale
CoCr particles were treated with trypsin. After 5 days, cells cultured with nanoscale
alumina particles were treated with trypsin to remove the cells from the cell culture
plate. The medium from all wells were removed and discarded and the cells were
washed twice with 500 µl of DPBS before being incubated with 250 µl of trypsin.
The plates were incubated at 5% (v/v) CO2 in air at 37oC for ten minutes. DMEM
was then added to each well (750 µl) and the cell suspension of each well was
transferred to separately labelled, sterile 1.5 ml Eppendorfs and centrifuged at 200 g
for 10 minutes at room temperature. A volume of 500 µl of DPBS was carefully
added to each Eppendorf in order to not disturb the pellet prior to fixation.
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5.2.2.2.2 Fixation of L929 fibroblasts cultured with nanoscale alumina and
cobalt chromium particles
The samples from section 5.2.2.2.1 were fixed with 2.5% (v/v) glutaraldehyde in
0.1M phosphate buffer for 2.5 hours at room temperature. Using a glass pipette, the
glutaraldehyde was removed and discarded and the pellets were incubated with
0.1M phosphate buffer for 30 minutes. The pellets were then centrifuged at 200 g
for 2 minutes before 0.5 ml of 1% osmium tetraoxide in 0.1M phosphate buffer was
added to each sample (made in house by Mr. M. Fuller, Faculty of Biological
Sciences). After 1 hour, the cells were centrifuged at 200 g for 2 minutes and the
osmium tetraoxide solution was replaced with 0.5 ml of 0.1M phosphate buffer. After
20 minutes, the phosphate buffer was removed and discarded and the samples
were dehydrated by incubating the samples with 0.5 ml of increasing concentrations
of ethanol; 20%, 40%, 60%, 80% and 100% (v/v) for 20 minutes each. The 100%
(v/v) ethanol wash was repeated to ensure complete sample dehydration.
The samples were then embedded in an Araldite resin (section 5.2.1.1). Each
sample was incubated with 0.5 ml of 50:50 Araldite: propylene oxide mixture and
incubated for 16 hours at room temperature. The 50:50 resin was then removed,
using a glass Pasteur pipette and replaced with 0.5 ml of 75:25 Araldite: propylene
oxide solution for 3 hours. The 75:25 Araldite: propylene oxide solution was
carefully removed by pouring off the excess and replaced with approximately 1 ml of
neat Araldite resin. Leaving the lids of the Eppendorfs open, the samples were
incubated for 3 hours at room temperature. The excess resin was poured off each
sample and replaced with fresh Araldite resin. The samples were placed in a 60°C
oven for 16 hours to fix the samples.
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5.2.2.2.3 Sectioning of fixed L929 fibroblasts cultured with nanoscale alumina
and cobalt chromium particles
The resin embedded samples (section 5.2.2.2.2) were then sectioned and placed
onto copper grids for TEM analysis. The samples were prepared using a saw and
filed to fit into the nuck of the microtome and were secured into position using a
screw (Figure 5.2). A glass blade with a 45° angle blade (made in house by Mr. M.
Fuller, Faculty of Biological Sciences) was secured into position in the blade holder
of the microtome and thin sections, 0.5 µm thick, were cut until the sample within
the resin was exposed (Figure 5.3A). Using a glass blade, with an attached boat to
collect the sections, the sample was aligned with the blade and the boat was filled
level with distilled water (Figure 5.3B).
Figure 5.2 – Resin embedded sample secured into the nuck of microtome for
sectioning. 1 – Resin embedded sample. 2 – Screw to secure sample to nuck. 3 – Nuck of
the microtome. 4 – Nuck holder.
The automatic sectioning dial was selected and approximately 15 sections, 90 nm
thick were cut. To reduce wrinkling of the sections a wooden dowel rod was soaked
in trichloroethylene and the dowel rod was gently wafted over the samples in the
boat. Using a pair of tweezers, a 5 mm round copper grid (200 nm grid size) was
placed on to the surface of the water in the boat and the sections transferred from
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the water to the grid. The grid was then placed sample side up onto a piece of filter
paper. The samples were stored in a sample holder, at room temperature until
required
Figure 5.3 – Resin embedded sample in microtome with glass blade (A) and glass
blade with attached boat (B). 1 – Secured sample in nuck of microtome. 2 – Glass blade in
knife holder. 3 – Glass blade with boat to collect samples.
5.2.2.2.4 Contrast staining of transmission electron microscopy samples
To prepare the samples for TEM analysis, the sample grids were contrast stained
with uranyl acetate and lead citrate. On the designated radiation bench, a drop of
saturated uranyl acetate (made in house by Mr. M. Fuller, Faculty of Biological
Sciences) per sample grid was placed onto a piece of dental wax strip. Using
tweezers, each sample grid was placed on the uranyl acetate drop with the sample
side in contact with the drop. After 2 hours, the grids were gently rinsed in distilled
water and placed face down, on a drop of Reynold’s lead citrate on a piece of wax
in a glass petri dish (made in house by Mr. M. Fuller, Faculty of Biological Sciences).
To reduce the lead citrate deposits, a small volume of 1M NaOH was added to the
petri dish to surround the piece of wax. After 20 minutes, the sample grids were
rinsed with 0.2M NaOH, followed by a final rinse in distilled water. The excess water
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was blotted onto a small piece of filter paper and the samples were stored in a
sample holder until required.
5.2.2.2.5 Transmission electron microscopy imaging and energy-dispersive
X-ray spectroscopy analysis of L929 fibroblasts cultured with
nanoscale alumina and cobalt chromium particles
The samples were visualised using a JEOL 1400 TEM at 120 kV at magnifications
ranging from 1K to 5.5K. To differentiate between staining artefacts and particles,
pin point EDX analysis was performed using a Tecnai F20 TEM and Oxford
Instrument EDX system with the sample grid placed at a 15° tilt. The TEM images
were used to size the particle agglomerates within the cells. The computer software,
Image Pro Plus (version 6.1) was used. The means of the particle agglomerate at
different concentrations, in the presence or absence of 10% (v/v) FBS were
analysed using a one-tailed student’s t-test.
5.2.2.3 The effect of particles on the vesicle leakage of a model lipid plasma
membrane in the presence of 10% (v/v) foetal bovine serum
Vesicle leakage assays in the presence of 10% (v/v) FBS were performed. The 400
nm carboxylfluorescein loaded lipid vesicles were prepared as described in chapter
2, section 2.2.6.3. The leakage of the vesicles over time was monitored using a
fluorometer as described in section 2.2.6.3 except that prior to the addition of the
particles, 10% (v/v) FBS was added to the cuvette and the fluorescence was
measured. Each vesicle leakage experiment was repeated three times. A paired t-
test was performed on the results between each treatment group and 10% (v/v)
FBS only to determine statistical significance (p<0.05).
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5.2.2.4 The effect of particles on the vesicle leakage of a model lipid plasma
membrane containing isolated plasma membrane proteins in the
presence of 10% (v/v) foetal bovine serum
Plasma membrane proteins from primary HFBs and U937 histiocytes were isolated
as described in section 2.2.6.5. Optimisation experiments from section 4.3.4.1
determined that a concentration of 20% (w/w) protein within the lipid membrane
formed a stable bilayer for QCM-D experiments and was used for all subsequent
studies, including the vesicle leakage assays performed here. The vesicle leakage
assays were performed as described in section 5.2.2.3; however the vesicles
consisted of phospholipids, cholesterol and 20% (w/w) of the isolated membrane
proteins as described in section 2.2.6.2.
5.2.2.5 Quenching effect of particles on the vesicle leakage assay in the
presence of 10% (v/v) serum
The vesicle leakage assays were performed as described in section 2.2.6.3.
However, once the fluorescence of the diluted vesicles had been monitored for at
least 200 seconds, 10% (v/v) of FBS diluted in DMEM without phenol red was
added and the fluorescence was measured. An average absorbance reading over at
least 200 seconds for each particle concentration was calculated and presented as
a percentage of the reading for the Triton X-100.
5.2.2.6 Investigation into the binding of particles to a solid supported bilayer
lipid membrane using quartz crystal microbalance with dissipation in
the presence of foetal bovine serum
The binding of nanoscale and micron sized alumina and CoCr particles to a lipid
membrane (used in Chapter four) in the presence of FBS was measured using
Chapter 5
208
QCM-D. Foetal bovine serum was demonstrated to have a high binding affinity to
the sBLM. Therefore, in order to measure any small interactions of the particles to
the sBLM, the concentration of FBS diluted in DMEM was optimised.
5.2.2.7 Optimising the concentration of foetal bovine serum for quartz crystal
microbalance with dissipation
The vesicles and QCM-D crystals were prepared as described in section 2.2.6.3
and 2.2.6.4, respectively. Upon the formation of a sBLM, as described in section
2.2.6.4, the starting solution of DMEM was replaced with DMEM supplemented with
0.1% (v/v) or 10% (v/v) FBS. The change in the frequency and dissipation were
measured to determine if the measurements stabilised.
5.2.2.8 The binding of particles to a solid supported bilayer lipid membrane
in the presence of 0.1% (v/v) foetal bovine serum
Prior to the QCM-D experiment the particles of choice were incubated with DMEM
supplemented with 0.1% (v/v) FBS at particle concentrations of 1 μg.ml-1, 10 μg.ml-1
and 100 μg.ml-1. These solutions were then incubated at 37°C for 16 hours. The
sBLM was formed for the QCM-D experiment as described in section 2.2.6.4. Once
the bilayer had been formed, the starting solution of DMEM was replaced with
DMEM supplemented with 0.1% (v/v) FBS. Once the readout had stabilised, the
particles were added. The particle concentrations of 1, 10 and 100 μg.ml-1 diluted in
DMEM supplemented with 0.1% (v/v) FBS was flowed across the sBLM for at least
25 minutes. Following this, DMEM supplemented with 0.1% (v/v) FBS was flowed
across the sBLM for at least 25 minutes to wash away any unbound particles.
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5.2.2.9 The binding of particles to a solid supported bilayer lipid membrane
containing isolated plasma membrane proteins in the presence of 0.1%
(v/v) foetal bovine serum
Plasma membrane proteins from primary HFBs were isolated as described in
section 2.2.6.5. Optimisation experiments from section 4.3.4.1 determined that a
concentration of 20% (w/w) of the protein within the lipid membrane formed a stable
bilayer for QCM-D and was used for all studies. The QCM-D experiments were
performed as described in section 2.2.6.4; however the vesicles, which formed the
sBLM, consisted of lipids, cholesterol and 20% (w/w) of the isolated membrane
proteins as described in section 2.2.6.7.
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5.3 Results
5.3.1 The effect of the presence of foetal bovine serum on
particle cell viability
The aim of this part of the study was to investigate the role of proteins within FBS on
the effect of nanoscale and micron sized alumina and CoCr particles on the cell
viability of L929 fibroblasts. This work followed on from an undergraduate student
final year project (Moisley 2014).
.
5.3.1.1 The effect of nanoscale and micron sized alumina particles on L929
fibroblast cell viability in the absence or presence of foetal bovine
serum
In the presence of 10% (v/v) FBS, only the nanoscale alumina particles at a particle
volume of 500 µm3 per cell caused a significant reduction in the cell viability at day 2
and 5 in the presence of FBS in comparison to the cell only control (Figure 5.4A).
No other particle volume induced a significant effect on cell viability. In contrast, in
the absence of 10% (v/v) FBS, by day 5 of culture, the nanoscale alumina particles
induced a significant decrease in cell viability at the highest particle volumes of 500
and 50 µm3 per cell in comparison to the cell only control (Figure 5.4B).
Comparisons of the cell viability results in the absence or presence of 10% (v/v)
FBS was performed (Table 5.2). The analysis revealed that in the absence of 10%
(v/v) FBS the particle volumes of 500 and 50 µm3 per cell significantly reduced the
cell viability in comparison to cells cultured in the presence of FBS at equivalent
particle doses after 3 days of culture. A statistically significant difference was
measured for the particle volume of 500 µm3 per cell after 2 days of culture.
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After 5 days of culture, the micron sized alumina particles significantly reduced cell
viability, in the presence of 10% (v/v) FBS at particle volumes of 500 and 50 µm3
per cell in comparison to the cell only control (Figure 5.5A). A 15% and 18% loss in
cell viability in comparison to the cell only control was measured at day 5 for the
particle volumes of 500 and 50 µm3 per cell, respectively. In the absence of 10%
(v/v) FBS, the micron sized alumina particles had a larger effect on the cell viability
in comparison to the cell only control. At the particle volumes of 500 and 50 µm3 per
cell, a 42% and 35% reduction in cell viability was observed after day 1, respectively
(Figure 5.5B). The cell viability results in the presence or absence of 10% (v/v) FBS
were compared (Table 5.3). After 1 day of culture the particle volumes of 500 and
50 µm3 per cell significantly reduced the cell viability in the absence of FBS in
comparison to cells cultured in the presence of FBS with the corresponding particle
doses. This significant difference was observed over the 5 days of culture.
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Figure 5.4 - The effect of nanoscale alumina particles on L929 cell viability in the
presence (A) or absence (B) of 10% (v/v) foetal bovine serum using the MTT assay.
Cell viability is presented as percentage viability in comparison to the cell only control. One-
way ANOVA tests were performed and the MSD was calculated using the Tukey method.
The mean (+/- 95% CL) was plotted (n=6) and statistically significant results (p<0.05) are
indicated by an asterisk (*). (■: 500 µm3 per cell; ●: 50 µm3 per cell; ▲: 5 µm3 per cell; ▼:
0.5 µm3 per cell; ♦: 0.05 µm3 per cell; ●: cell only control; : 2 µg.ml-1 camptothecin).
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Figure 5.5 - The effect of micron sized alumina particles on L929 cell viability in the
presence (A) or absence (B) of 10% (v/v) foetal bovine serum using the MTT assay.
Cell viability is presented as percentage viability in comparison to the cell only control. One-
way ANOVA tests were performed and the MSD was calculated using the Tukey method.
The mean (+/- 95% CL) was plotted (n=6) and statistically significant results (p<0.05) are
indicated by an asterisk (*). (■: 500 µm3 per cell; ●: 50 µm3 per cell; ▲: 5 µm3 per cell; ▼:
0.5 µm3 per cell; ♦: 0.05 µm3 per cell; ●: cell only control; : 2 µg.ml-1 camptothecin).
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Particle volume (µm3 per cell)
Time (day) 500 50 5 0.5 0.05
0 - - - - -
1 - - - - -
2 + - - - -
3 + + - - -
5 + + - - -
Table 5.2 – Statistical analysis on the effect of nanoscale alumina particles on L929
cell viability in the presence or absence of 10% (v/v) foetal bovine serum. A two way
ANOVA were performed and the MSD was calculated using the Tukey method. Statistically
significant results (p<0.05) are indicated by a plus sign (+). A red plus sign (+) indicated that
the results in the presence of 10% (v/v) FBS induced a statistically significant reduction in
the cell viability in comparison to the cells in the absence of FBS. A green plus sign (+)
indicated that the results in the absence of 10% (v/v) FBS induced a statistically significant
reduction in the cell viability in comparison to the cells in the presence of FBS.
Particle volume (µm3 per cell)
Time (day) 500 50 5 0.5 0.05
0 - - - - -
1 + + - - -
2 + + - - -
3 + + - - -
5 + + - - -
Table 5.3 – Statistical analysis on the effect of micron size alumina particles on L929
cell viability in the presence or absence of 10% (v/v) foetal bovine serum. A two way
ANOVA were performed and the MSD was calculated using the Tukey method. Statistically
significant results (p<0.05) are indicated by a plus sign (+). A red plus sign (+) indicated that
the results in the presence of 10% (v/v) FBS induced a statistically significant reduction in
the cell viability in comparison to the cells in the absence of FBS. A green plus sign (+)
indicated that the results in the absence of 10% (v/v) FBS induced a statistically significant
reduction in the cell viability in comparison to the cells in the presence of FBS.
5.3.1.2 The effect of nanoscale and micron sized cobalt chromium particles
on L929 fibroblast cell viability in the absence or presence of foetal
bovine serum
In the presence of 10% (v/v) FBS, the nanoscale CoCr particle volumes of 50, 5 and
0.5 µm3 per cell had a significant effect on the cell viability after 2 days of culture in
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comparison to the cell only control (Figure 5.6A). After 5 days of culture only the
highest particle volume of 50 µm3 per cell induced a statistically significant reduction
in the cell viability in comparison to the cell only control. In the absence of 10% (v/v)
FBS, only the particle volume of 50 µm3 per cell caused a significant reduction in the
cell viability in comparison to the cell only control, with an average 25% loss in cell
viability over the 5 days of culture (Figure 5.6B). A statistically significant difference
between cells cultured with nanoscale CoCr particles in the presence of 10% (v/v)
FBS in comparison to cells cultured with the CoCr particles in the absence of FBS
was measured. After 1 day of culture the particle volume of 5 µm3 per cell, in the
presence of FBS induced a significant reduction in cell viability in comparison to
cells cultured in the absence of FBS. After 2 days of culture the particle volume of
50 µm3 per cell significantly reduced the cell viability in the presence of FBS in
comparison to cells cultured in the absence of FBS at the corresponding particle
doses. The difference between the cell viability results in the presence or absence
of 10% (v/v) FBS was not statistically significant after 2 days of culture (Table 5.4).
There was minimal difference in the results for L929 fibroblasts cultured with CoCr
micron sized particles in the presence or absence of 10% (v/v) FBS. In the presence
of 10% (v/v) FBS, only the highest particle volume of 50 µm3 per cell induced a 35%
reduction in the cell viability after 2 days in comparison to the cell only control
(Figure 5.7A). However by day 3, no significant difference was measured. Similarly,
in the absence of 10% (v/v) FBS the only particle volume of 50 µm3 per cell caused
a 40% loss in the cell viability by day 2. Again, by day 3 this particle volume had no
significant effect on the cell viability (Figure 5.7B). No statistical difference between
cells cultured with the micron CoCr particles in the presence or absence of 10% (v/v)
FBS was observed at any time point (Table 5.5).
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Figure 5.6 - The effect of nanoscale CoCr particles on L929 cell viability in the
presence (A) or absence (B) of 10% (v/v) foetal bovine serum using the MTT assay.
Cell viability is presented as percentage viability in comparison to the cell only control. One-
way ANOVA tests were performed and the MSD was calculated using the Tukey method.
The mean (+/- 95% CL) was plotted (n=6) and statistically significant results (p<0.05) are
indicated by an asterisk (*). (●: 50 µm3 per cell; ▲: 5 µm3 per cell; ▼: 0.5 µm3 per cell; ♦:
0.05 µm3 per cell; ◄: 0.005 µm3 per cell; ●: cell only control; : 2 µg.ml-1 camptothecin).
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Figure 5.7 - The effect of micron sized CoCr particles on L929 cell viability in the
presence (A) or absence (B) of 10% (v/v) foetal bovine serum using the MTT assay.
Cell viability is presented as percentage viability in comparison to the cell only control. One-
way ANOVA tests were performed and the MSD was calculated using the Tukey method.
The mean (+/- 95% CL) was plotted (n=6) and statistically significant results (p<0.05) are
indicated by an asterisk (*). (●: 50 µm3 per cell; ▲: 5 µm3 per cell; ▼: 0.5 µm3 per cell; ♦:
0.05 µm3 per cell; ◄: 0.005 µm3 per cell; ●: cell only control; : 2 µg.ml-1 camptothecin).
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Particle volume (µm3 per cell)
Time (day) 50 5 0.5 0.05 0.005
0 - - - - -
1 - + - - -
2 + - - - -
3 - - - - -
5 - - - - -
Table 5.4 – Statistical analysis on the effect of nanoscale cobalt chromium particles
on L929 cell viability in the presence or absence of 10% (v/v) foetal bovine serum. A
two way ANOVA were performed and the MSD was calculated using the Tukey method.
Statistically significant results (p<0.05) are indicated by a plus sign (+). A red plus sign (+)
indicated that the results in the presence of 10% (v/v) FBS induced a statistically significant
reduction in the cell viability in comparison to the cells in the absence of FBS. A green plus
sign (+) indicated that the results in the absence of 10% (v/v) FBS induced a statistically
significant reduction in the cell viability in comparison to the cells in the presence of FBS.
Particle volume (µm3 per cell)
Time (day) 50 5 0.5 0.05 0.005
0 - - - - -
1 - - - - -
2 - - - - -
3 - - - - -
5 - - - - -
Table 5.5 – Statistical analysis on the effect of micron sized cobalt chromium particles
on L929 cell viability in the presence or absence of 10% (v/v) foetal bovine serum. A
two way ANOVA were performed and the MSD was calculated using the Tukey method.
Statistically significant results (p<0.05) are indicated by a plus sign (+). A red plus sign (+)
indicated that the results in the presence of 10% (v/v) FBS induced a statistically significant
reduction in the cell viability in comparison to the cells in the absence of FBS. A green plus
sign (+) indicated that the results in the absence of 10% (v/v) FBS induced a statistically
significant reduction in the cell viability in comparison to the cells in the presence of FBS.
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5.3.2 The internalisation of nanoscale alumina and cobalt
chromium particles into L929 fibroblasts in the absence
or presence of foetal bovine serum
The internalisation and localisation of nanoscale alumina and CoCr particles in the
presence or absence of FBS into L929 fibroblasts was investigated using TEM
analysis. Due to time constraints only the nanoscale particles were tested.
5.3.2.1 Internalisation of nanoscale alumina particles into L929 fibroblasts in
the absence or presence of foetal bovine serum
Based on the cell viability results (section 5.3.1) the time point of 5 days was chosen.
Nanoscale alumina particles were observed within the L929 cells at all particle
concentrations regardless of the presence of 10% (v/v) FBS. For the cells cultured
with nanoscale alumina particles at a particle volume of 50 µm3 per cell in the
presence of serum, agglomerates of particles were observed. These agglomerates
appeared to be in vesicle or vesicle-like structures with in the cytoplasm of the cells
(Figure 5.8A and B). On occasion some of the particles within vesicles surrounded
the nuclear membrane as shown in Figure 5.8B. Few particles were detected within
the cells cultured with alumina particles at a particle volume of 5 µm3 per cell in the
presence of serum. However, some particles were observed within vesicles of the
cytoplasm (Figure 5.8C and D). No particles were observed in the cell only controls
(Figure 5.8E and F).
In the absence of 10% (v/v) FBS, nanoscale alumina particles were also detected
within the cells as shown by the white arrows in Figure 5.9. Again the particles at all
concentrations were observed in vesicles within the cytoplasm. The particles
appeared as agglomerates within the vesicles. However at the particle volumes of 5
µm3 per cell the particles were much less prevalent within the cells (Figure 5.9C and
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D). No particles were observed within the cell only controls (Figure 5.9E and F). The
TEM images were used to measure the diameters of the particle agglomerates
within the cells (Figure 5.9). A large variation in the sizes of the particle
agglomerates at any particle concentration, in the presence or absence of 10% (v/v)
FBS was observed. The largest particle agglomerate of 2 µm was measured for the
particles incubated in the absence of 10% (v/v) FBS at a particle volume of 5 µm3
per cell. No statistical differences were observed between the particle agglomerate
sized within the cells in the presence or absence of 10% (v/v) FBS at any particle
volume tested. In addition, no statistical differences were measured between the
different particle volumes used.
The presence of the alumina nanoscale particles was confirmed by EDX analysis as
shown by the white arrows in Figure 5.11. Only particle like structures within
vesicles were confirmed as containing alumina. The aluminium peak can clearly be
observed within the EDX spectra (Figure 5.11A, spectra 1 and 2). Particle like
structures which were not bound within vesicles were found to be remnants of the
staining process during sample preparation (Figure 5.11B, spectrum 3). No
aluminium peak was observed in the EDX spectrum; instead, the main elements
detected included copper (grid material) and silica.
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Figure 5.8 – Transmission electron microscopy analysis of alumina nanoscale
particles within L929 fibroblasts cultured in the presence of foetal bovine serum. Cells
were cultured in the presence of 10% (v/v) FBS and nanoscale alumina particles at particles
volumes of 50, 5 and 0.5 µm3 per cell for 5 days. Arrows indicate particles within cells. A & B
– 50 µm3 per cell. C & D – 5 µm3 per cell. E & F – Cell only control.
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Figure 5.9 – Transmission electron microscopy analysis of nanoscale alumina
particles within L929 fibroblasts cultured in the absence of foetal bovine serum.
Fibroblast cells were cultured in the absence of 10% (v/v) FBS with nanoscale alumina
particles at particles volumes of 50, 5 µm3 per cell for 5 days. Arrows indicate particles within
cells. A & B – 50 µm3 per cell. C & D – 5 µm3 per cell. E & F – Cell only control.
Figure 5.10 – Sizing of nanoscale alumina particle agglomerates within L929
fibroblasts. Alumina particle agglomerates within the L929 fibroblasts were sized using the
corresponding TEM images and the computer software Image Pro Plus (version 6.1). Error
bars represent 95% CI levels.
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Figure 5.11 – Energy-dispersive X-ray spectroscopy of nanoscale alumina particles.
L929 fibroblasts were cultured with 10% (v/v) FBS and nanoscale alumina particles at a
particle volume of 50 µm3 per cell (A) or 50 µm3 per cell (B) for 5 days. Confirmation of
particles was performed using the INCA EDX analysis system and the Tecnai F20 TEM.
Example EDX plots (1 & 2) of particles within vesicles and corresponding image are
displayed. Major peaks of aluminium and oxygen are indicated by black arrows. Example
EDX plots (3) of staining precipitates and corresponding image is also displayed.
5.3.2.2 Internalisation of nanoscale cobalt chromium particles into L929
fibroblasts in the absence or presence of foetal bovine serum
The internalisation and localisation of nanoscale CoCr particles into L929 fibroblasts
in the presence or absence of FBS was also investigated. From the cell viability
results (section 5.3.1) the time point of 2 days was chosen as the largest difference
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between cell viability, in the presence or absence of serum, was observed at this
incubation period. In the presence of 10% (v/v) FBS, CoCr nanoscale particles were
observed within vesicles in the cytoplasm of the L929 fibroblasts at all the particle
volumes tested. Nanoscale CoCr particles volumes of 50 and 5 µm3 per cell formed
large agglomerates as shown by the white arrows in Figure 5.12. Furthermore for
both the particle volumes of 50 and 5 µm3 per cell, multiple vesicles containing CoCr
particles were detected within the cells. Occasional vesicles containing CoCr
particles were observed at the particle volume of 0.5 µm3 per cell as shown in
Figure 5.12E and F. No particles were observed in the cell only control (Figure
5.12G and H).
In the absence of 10% (v/v) FBS, the images were very similar to the cells cultured
with the CoCr particles in the presence of serum. Again multiple vesicles within
single cells containing CoCr nanoscale particles were observed at particle volumes
of 50 and 5 µm3 per cell as shown in Figure 5.13A – D. These vesicle-bound
particles were most prevalent at the highest particle volume of 50 µm3 per cell.
However at the lower particle concentration of 0.5 µm3 per cell, very few particles
were detected within the cells (Figure 13E and F). Again, no particles were detected
in the cell only control (Figure 13G and H).
The TEM images were used to measure the diameters of the particle agglomerates
within the cells (Figure 5.14). The largest particle agglomerate of 2.6 µm was
measured for the particles incubated in the presence of 10% (v/v) FBS at a particle
volume of 50 µm3 per cell. No statistical differences were observed between the
size of the particle agglomerates, at any particle concentration tested in the
presence 10% (v/v) FBS and the corresponding particle concentration in the
absence of 10% (v/v) FBS. However, in the presence of 10% (v/v) FBS, the
agglomerates at the particle volume of 50 µm3 per cell were statistically different to
the aggregates at the particle volume of 0.5 and 5 µm3 per cell.
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Figure 5.12 – Transmission electron microscopy analysis of nanoscale cobalt
chromium particles within L929 fibroblasts cultured in the presence of foetal bovine
serum. Fibroblast cells were cultured in the presence of 10% (v/v) FBS and nanoscale CoCr
particles at particles volumes of 50, 5 and 0.5 µm3 per cell. After 48 hours, the cells were
harvested, fixed and stained before being imaged using TEM. White arrows indicate
particles within cells. A & B – 50 µm3 per cell. C & D – 5 µm3 per cell. E & F – 0.5 µm3 per
cell. G & H – Cell only control.
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Figure 5.13 – Transmission electron microscopy analysis of nanoscale cobalt
chromium particles within L929 fibroblasts cultured in the absence of foetal bovine
serum. Fibroblast cells were cultured in the absence FBS and nanoscale CoCr particles at
particles volumes of 50, 5 and 0.5 µm3 per cell. After 48 hours, the cells were harvested,
fixed and stained before being imaged using TEM. White arrows indicate particles within
cells. A & B – 50 µm3 per cell. C & D – 5 µm3 per cell. E & F – 0.5 µm3 per cell. G & H – Cell
only control.
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Figure 5.14 – Sizing of nanoscale cobalt chromium particle agglomerates within L929
fibroblasts. The CoCr particle agglomerates within the L929 fibroblasts were sized using
the corresponding TEM images and the computer software Image Pro Plus (version 6.1).
Error bars represent 95% CI levels.
The aggregates of particles within the vesicles were confirmed to be CoCr using
EDX analysis, by the presence of cobalt and chromium peaks within the spectra
(Figure 5.15A, spectra 1 and 2). Other peaks within the spectra, including lead are
from the sample preparation process or from the copper TEM grid. Similar to the
nanoscale alumina particle samples, particle like structures not within vesicles were
found to not be particles but remnants of the staining process (Figure 5.15B, spectra
3). Only peaks for elements used in the sample preparation process were detected
in the EDX spectrum.
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Figure 5.15 – Energy-dispersive X-ray spectroscopy of nanoscale cobalt chromium
particles. L929 fibroblasts were cultured with 10% (v/v) FBS and nanoscale CoCr particles
at a particle volume of 50 (A) or 0.5 (B) µm3 per cell for 2 days. Confirmation of particles was
performed using the INCA EDX analysis system and the Tecnai F20 TEM. Example EDX
plots (1 & 2) of particles within vesicles and corresponding image are displayed. The black
arrows indicate the element peaks of the particles. Example EDX plots (3) of staining
precipitates and corresponding image is displayed.
5.3.3 The effect of particles on the vesicle leakage of a model
lipid plasma membrane in the presence of foetal bovine
serum
The effect of nanoscale and micron sized alumina and cobalt chromium particles on
membrane integrity, in the presence of 10% (v/v) FBS, was assessed.
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5.3.3.1 The effect of nanoscale and micron sized alumina particles on the
vesicle leakage of a model lipid plasma membrane in the presence of
foetal bovine serum
The effect of nanoscale alumina particles on membrane integrity was measured in
the presence of 10% (v/v) FBS. The addition of 10% (v/v) serum alone, without any
particles, induced vesicle leakage of up to 7.6% (Figure 5.16A). A dose dependent
increase in the vesicle leakage was measured in the presence of serum. At the
highest particle concentration of 100 µg.ml-1, an average 33.5% leakage was
measured, which was statistically significant in comparison to the 10% (v/v) FBS
control and the lower particle concentrations of 1 and 10 µg.ml-1. No statistically
significant increase in vesicle leakage for nanoscale alumina particles at particle
concentration of 1 and 10 µg.ml-1 were measured.
The micron sized alumina particles induced less vesicle leakage in comparison to
the nanoscale alumina particles (Figure 5.16B). Whilst a dose dependent increase
in vesicle leakage was observed, the highest particle concentration of 100 µg.ml-1
only induced 20% leakage, which was much less than the 33.5% leakage caused by
the nanoscale alumina particles. However, this leakage was partly caused by the
presence of the 10% (v/v) FBS. Due to sample variability, no statistically significant
differences were measured in comparison to the 10% (v/v) FBS only control.
5.3.3.1.1 Quenching effects of nanoscale and micron sized alumina particles
on the vesicle leakage assay
The effect of the nanoscale and micron sized alumina particles on the quenching of
the fluorescent dye used in the vesicle leakage assay was assessed. The vesicles,
which encapsulated an autoquenching fluorescent dye, were formed as stated in
section 2.2.6.2. As described in section 2.2.6.3.3 the vesicles diluted in DMEM,
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without phenol red and in the presence of 10% (v/v) FBS were first lysed using 0.1%
(v/v) Triton-X 100. Incremental concentrations of the particles (1, 10 and 100 µg.ml-1)
were subsequently added to the vesicles and the fluorescent intensity was observed
over time. The vesicle leakage from each treatment was expressed as a percentage
of the Triton-X 100 (100%) reading and the baseline prior to the addition of particles
represented 0% vesicle leakage.
In the presence of the nanoscale alumina particles, no significant quenching effects
were measured in the presence of 10% (v/v) FBS at all the particle concentrations
tested as shown in Figure 5.17A. Although there was a slight decrease in the
fluorescence at the highest particle concentration of 100 µg.ml-1. No significant
quenching effect was observed for the micron sized alumina particles at all the
particle concentrations tested (Figure 5.17B). However, the highest particle
concentration of 100 µg.ml-1 induced a slight increase in fluorescence.
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Figure 5.16 – The effect of nanoscale (A) and micron sized (B) alumina particles on
vesicle leakage in the presence of foetal bovine serum. Data (n=3) was expressed as
percentage vesicle leakage of the detergent Triton-X 100, which represented 100% leakage.
Vesicle leakage of fluorescent dye encapsulated with vesicles was measured in real time in
the presence of 10% (v/v) FBS and subsequent increasing particle concentrations (1, 10 and
100 µg.ml-1). Raw data were analysed using paired t-test in comparison to FBS only control
and statistically significant results (p< 0.05) are indicated by an asterisk (*). Error bars
represented 95% confidence levels.
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Figure 5.17 – The effect of nanoscale (A) and micron sized (B) alumina particles on
the quenching of the fluorescent dye. Vesicles loaded with an autoquenching fluorescent
dye were formed from lipid membranes. In the presence of 10% (v/v) FBS, the vesicles were
then lysed with Triton-X 100 followed by the addition of increasing particle concentrations (1
– 100 µg.ml-1). The release of fluorescent dye was measured, in real-time, using a
fluorometer. Data (n=3) was expressed as percentage vesicle leakage of the detergent
Triton-X 100, which represented 100% leakage. Raw data were analysed using paired t-test
and statistically significant results (p< 0.05) are indicated by an asterisk (*). Error bars
represented 95% confidence levels.
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5.3.3.2 The effect of particles on the vesicle leakage of a model lipid
membrane in the presence of foetal bovine serum
The effect of nanoscale CoCr particles on membrane integrity was measured in the
presence of 10% (v/v) FBS. The addition of serum alone (no particles) induced
vesicle leakage of up to 4% (Figure 5.18A). At the highest particle concentration of
100 µg.ml-1, an average 11% leakage was measured, which was statistically
significant in comparison to the 10% (v/v) FBS control and all the other particle
concentrations tested. However, vesicle leakage at the highest particle
concentration was approximately three fold lower than the leakage measured for
nanoscale alumina particles (section 5.3.3.1)
The micron sized CoCr particles induced less vesicle leakage in comparison to the
nanoscale CoCr particles (Figure 5.18B). The highest particle concentration of 100
µg.ml-1 only induced an average 7% leakage. Due to sample variability, no
statistically significant differences were measured in comparison to the 10% (v/v)
FBS only control.
5.3.3.2.1 Quenching effects of nanoscale and micron sized cobalt chromium
particles on the vesicle leakage assay
The effect of the nanoscale and micron sized CoCr particles on the quenching of the
fluorescent dye used in the vesicle leakage was assessed. The vesicles, which
encapsulated an autoquenching fluorescent dye, were formed as stated in section
2.2.6.3. As described in section 2.2.6.3.3 the vesicles were then diluted at least
1000 times in DMEM, without phenol red. In the presence of 10% (v/v) FBS, the
vesicles were first lysed using 0.1% (v/v) Triton-X 100 and incremental
concentrations of the particles (1, 10 and 100 µg.ml-1) were subsequently added to
the vesicles and the fluorescent intensity was observed over time. The vesicle
Chapter 5
234
leakage from each treatment was expressed as a percentage of the Triton-X 100
(100%) and the baseline prior to the addition of particles represented 0% leakage.
A small quenching effect was measured in the presence of 10% (v/v) FBS for the
nanoscale CoCr particles at the highest particle concentration of 100 µg.ml-1.
However, this was not statistically significant in comparison to of the other particle
concentrations tested (Figure 5.19A). No quenching effects were observed for the
lysed vesicles incubated with the micron sized CoCr particles at any of the particle
concentrations tested (Figure 5.19B).
Chapter 5
235
10% FBS 1 µg/ml 10 µg/ml 100 µg/ml
0
5
10
15
20
25
%
 V
es
ic
le
 L
ea
ka
ge
Treatment
A
** *
10% FBS 1 µg/ml 10 µg/ml 100 µg/ml
-5
0
5
10
15
20
25
%
 V
es
ic
le
 L
ea
ka
ge
Treatment
B
Figure 5.18 – The effect of cobalt chromium nanoscale (A) and micron sized (B)
particles on vesicle leakage in the presence of foetal bovine serum. Data (n=3) is
expressed as percentage vesicle leakage of the detergent Triton-X 100, which represented
100% leakage. Vesicle leakage of fluorescent dye encapsulated with vesicles was measured
in real time in the presence of 10% (v/v) FBS and subsequent increasing particle
concentrations (1, 10 and 100 µg.ml-1). Raw data were analysed using paired t-test in
comparison to FBS only control and statistically significant results (p< 0.05) are indicated by
an asterisk (*). Error bars represented 95% confidence levels.
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Figure 5.19 – The effect of nanoscale (A) and micron sized (B) cobalt chromium
particles on the quenching of the fluorescent dye. Vesicles loaded with an
autoquenching fluorescent dye were formed from lipid membranes. In the presence of 10%
(v/v) FBS, the vesicles were then lysed with Triton-X 100 followed by the addition of
increasing particle concentrations (1 – 100 µg.ml-1). The release of fluorescent dye was
measured, in real-time, using a fluorometer. Data (n=3) was expressed as percentage
vesicle leakage of the detergent Triton-X 100, which represented 100% leakage. Raw data
were analysed using paired t-test and statistically significant results (p< 0.05) are indicated
by an asterisk (*). Error bars represented 95% confidence levels.
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5.3.4 Investigation of the binding of particles to a solid
supported bilayer lipid membrane using quartz crystal
microbalance with dissipation in the presence of foetal
bovine serum
The effect of the protein corona on alumina and CoCr particle interactions with the
sBLM was investigated using QCM-D techniques in the presence of 10% (v/v) FBS.
5.3.4.1 Optimising the concentration of foetal bovine serum for quartz crystal
microbalance with dissipation
The initial aim of this part of the study was to supplement the starting solution,
DMEM, with 10% (v/v) FBS, which reflects the serum concentration used for the cell
viability experiments. However, upon the addition of DMEM, supplemented with 10%
(v/v) FBS to the sBLM, a large reduction in the frequency from -27 Hz to -68 Hz was
observed (Figure 5.20). This was also accompanied by a sharp increase in the
dissipation as shown in Figure 5.20. Furthermore, the subsequent addition of
DMEM (without 10% (v/v) FBS) only induced a slight reverse in the frequency and
dissipation trend. Therefore FBS had a high binding affinity to the sBLM, whereby
irreversible binding occurred. Preliminary results had demonstrated no binding of
CoCr nanoscale particles had occurred in the presence of 10% (v/v) FBS and it was
hypothesised that the high concentration of FBS would masked any small binding
events of the particles to the sBLM (Appendix C). Therefore the concentration of
FBS was lowered to 0.1% (v/v) for all experiments. In order for a protein corona to
form, the particles were incubated for 16 hours at 37°C with DMEM supplemented
with 0.1% (v/v) FBS prior to being added to the sBLM.
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Figure 5.20 – Binding of 10% (v/v) foetal bovine serum to the solid supported bilayer
lipid membrane for protein corona studies. The binding of DMEM supplemented 10%
(v/v) FBS onto a sBLM was measured using QCM-D. This was followed by a DMEM only
wash to establish if the binding of the serum was reversible. Changes in the frequency (blue)
and dissipation (red) were measured (Ninth overtone is displayed).
5.3.4.2 The interaction of nanoscale and micron sized alumina particles with
a solid supported bilayer lipid membrane using quartz crystal
microbalance with dissipation in the presence of foetal bovine serum
A sBLM consisting of the model lipid membrane was formed and the starting
solution of DMEM (without supplements) was added to the sBLM. For both the
nanoscale and micron sized alumina particles, no changes in the frequency were
observed for any of the particle concentrations tested (Figure 5.21A and 5.21B,
respectively). No effect was observed for the dissipation results either, thus
suggesting that no particles bonded to the sBLM at particle concentrations of 100
µg.ml-1 or below.
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Figure 5.21 - QCM-D plot of a solid supported bilayer lipid membrane in the presence
alumina nanoscale (A) and micron sized (B) particles and foetal bovine serum. A
sBLM was formed in DMEM onto a crystal (not shown) followed by the addition of DMEM
plus 0.1% (v/v) FBS. Incremental concentrations (1 – 100 µg.ml-1) of alumina nanoscale or
micron sized particles diluted in DMEM plus FBS (0.1% v/v) were added at times indicated
by the arrows. Changes in the frequency (blue) and dissipation (red) were measured (Ninth
overtone is displayed).
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5.3.4.3 The interaction of nanoscale and micron sized cobalt chromium
particles with a solid supported bilayer lipid membrane using quartz
crystal microbalance with dissipation in the presence of foetal bovine
serum
A stable sBLM consisting of a model lipid membrane was formed for both the CoCr
nanoscale and micron sized particle QCM-D experiments (Figure 5.22A and 5.22B,
respectively). Cobalt chromium nanoscale or micron sized particles diluted in DMEM
plus 0.1% (v/v) FBS were added to the sBLM at incremental concentration of 1, 10
and 100 µg.ml-1. The changes in frequency and dissipation were measured overtime.
As also observed for the alumina particles no change in the frequency was
observed for all the particle concentrations of the CoCr nanoscale and micron sized
particles added to the sBLM. Similarly, no change in dissipation was measured thus
suggesting that no binding of the particles to the sBLM occurred at particle
concentrations tested.
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Figure 5.22 - QCM-D plot of a solid supported bilayer lipid membrane in the presence
cobalt chromium nanoscale (A) and micron sized (B) particles and foetal bovine
serum. A sBLM in DMEM was formed onto a quartz crystal (not shown) followed by the
addition of DMEM plus 0.1% (v/v) FBS. Incremental concentrations (1 – 100 µg.ml-1) of CoCr
nanoscale or micron sized particles diluted in DMEM plus FBS (0.1% v/v) added at times
indicated by the arrows. Changes in the frequency (blue) and dissipation (red) were
measured (Ninth overtone is displayed).
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5.3.5 The incorporation of isolated membrane proteins into the
model lipid membrane in the presence of foetal bovine
serum
To further increase the complexity of the model membrane systems used to assess
alumina and CoCr particle toxicity, isolated membrane proteins were incorporated
into the model lipid membrane and used for the vesicle leakage and QCM-D studies.
In addition to this, the effect of the protein corona was explored by adding the
particles in the presence of 10% (v/v) FBS. The isolated membrane proteins used
for the vesicle leakage assays originated from U937 histiocytes and primary HFBs.
In chapter four, the protein content within the membrane was optimised at 20%
which was shown to enable stable bilayer formation for the QCM-D experiments.
5.3.5.1 The effect of particles on the vesicle leakage of a model lipid
membrane with incorporated membrane proteins in the presence of
foetal bovine serum
The effect of incorporating membrane proteins isolated from primary HFBs and
U937 histiocytes on the membrane integrity in the presence of nanoscale and
micron sized alumina and CoCr particles, in the presence of 10% (v/v) FBS was
investigated.
5.3.5.1.1 The effect of nanoscale and micron sized alumina particles on the
vesicle leakage of a model lipid membrane with incorporated
membrane proteins in the presence of foetal bovine serum
In the presence of membrane proteins isolated from primary HFBs, the nanoscale
alumina particles only induced vesicle leakage of 5% at the highest particle
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concentration of 100 µg.ml-1 (Figure 5.23A). This result was statistically significant in
comparison to the 10% (v/v) FBS control. However, the 10% FBS (v/v) control did
not induce any overall vesicle leakage. This same trend was also observed for the
nanoscale alumina particles incubated with vesicles containing U937 histiocyte
membrane proteins (Figure 5.23B). The highest nanoscale alumina particle
concentration of 100 µg.ml-1 induced 14% vesicle leakage, which was statistically
significant in comparison to the 10% FBS (v/v) control. The particle concentration of
10 µg.ml-1 also induced a 1.2% significant vesicle leakage in comparison to the
control.
A larger amount of vesicle leakage was observed for the micron sized particles in
the presence of vesicles containing either human fibroblast or U937 histiocyte
membrane proteins and in the presence of 10% (v/v) FBS (Figure 5.23C and D,
respectively). For the micron sized alumina particles, incubated with vesicles
containing human fibroblast membrane proteins, the particle concentrations of 10
and 100 µg.ml-1 induced a statistically significantly vesicle leakage of 1.3% and 25%,
respectively. Similarly, in the presence of isolated U937 histiocytes, the micron
sized alumina particles induced a statistically significant increase in vesicle leakage
of 19% in comparison to the 10% FBS (v/v) control.
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Figure 5.23 – The effect of nanoscale and micron sized alumina particles on vesicle
leakage of a lipid membrane with isolated membrane proteins from primary HFBs and
U937 histiocytes in the presence of foetal bovine serum. Nanoscale alumina particles
were incubated with lipid vesicles consisting of 20% isolated proteins from human fibroblast
membranes (A) or isolated U937 histiocytes (B). Micron sized alumina particles were
incubated with lipid vesicles consisting of 20% isolated human fibroblast membrane proteins
(C) or isolated U937 histiocytes (D). Data (n=3) is expressed as a percentage vesicle
leakage of the detergent Triton-X 100. Vesicle leakage of on fluorescent dye encapsulated
around vesicles was measured and subsequent increasing particle concentrations (1, 10
and 100 µg.ml-1) in the presence of 10% (v/v) FBS. A paired t-test was performed in
comparison to FBS only control and statistically significant results (p< 0.05) is indicated by
an asterisk (*). Error bars represented 95% confidence levels.
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5.3.5.1.2 The effect of nanoscale and micron sized cobalt chromium particles
on the vesicle leakage of a model lipid membrane with incorporated
membrane proteins in the presence of foetal bovine serum
The nanoscale CoCr particles induced 23% vesicle leakage at the highest particle
concentration of 100 µg.ml-1, in the presence of membrane proteins isolated from
primary HFBs and 10% (v/v) FBS (Figure 5.24A). This result was statistically
significant in comparison to the 10% (v/v) FBS control. In contrast, no increase in
vesicle leakage was observed for all the nanoscale CoCr particle concentrations
tested in the in the presence of membrane proteins isolated from U937 histiocytes
(Figure 5.24B). The result for the micron sized CoCr particles at the particle
concentration of 100 µg.ml-1 is unexpected, suggesting that it may have been an
outlier.
A small increase in the vesicle leakage was observed for the micron sized CoCr
particles in the presence of vesicles containing either primary HFBs or U937
histiocyte membrane proteins (Figure 5.24C and D, respectively). For the micron
sized CoCr particles, incubated with vesicles containing human fibroblast
membrane proteins, the highest particle concentration of 100 µg.ml-1 induced an
average 6% in vesicle leakage in the presence of 10% (v/v) FBS. This result was
statistically significant in comparison to the 10% (v/v) FBS control. Similarly, in the
presence of isolated U937 histiocytes, the micron sized CoCr particles induced
statistically significant vesicle leakage of 10% in comparison to the 10% (v/v) FBS
control.
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Figure 5.24 – The effect of nanoscale and micron sized cobalt chromium particles on
vesicle leakage of a lipid membrane with isolated membrane proteins from primary
HFBs and U937 histiocytes in the presence of foetal bovine serum. Nanoscale CoCr
particles were incubated with lipid vesicles consisting of 20% isolated proteins from primary
HFB membranes (A) or isolated U937 histiocytes (B). Micron sized CoCr particles were
incubated with lipid vesicles consisting of 20% isolated human fibroblast membrane proteins
(C) or isolated U937 histiocytes (D). Data (n=3) is expressed as a percentage vesicle
leakage of the detergent Triton-X 100. Vesicle leakage of on fluorescent dye encapsulated
around vesicles was measured and subsequent increasing particle concentrations (1, 10
and 100 µg.ml-1) in the presence of 10% (v/v) FBS. A paired t-test was performed in
comparison to FBS only control and statistically significant results (p< 0.05) is indicated by
an asterisk (*). Error bars represent 95% confidence levels (n = 3).
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5.3.6 The binding of particles to a solid supported bilayer lipid
membrane with incorporated membrane proteins using
quartz crystal microbalance with dissipation in the
presence of foetal bovine serum
The effects of 10% (v/v) FBS on the binding of nanoscale and micron sized alumina
and CoCr particles to a sBLM were investigated in the presence of isolated
membrane proteins. The membrane proteins from primary HFBs were isolated and
incorporated into the sBLM. Time constraints and poor yield meant that
incorporation of U937 membrane proteins into sBLMs was not possible.
5.3.6.1 Nanoscale and micron sized alumina particles
A sBLM was formed on the quartz crystal surface which consisted of 20% (w/w)
membrane proteins isolated from primary HFBs. The particles were incubated with
DMEM supplemented with 0.1% (v/v) FBS at 37°C for 16 hours prior to being added
to the sBLM. The changes in frequency and dissipation are shown in Figure 5.25A
for the alumina nanoscale particles and Figure 5.25B for the micron sized alumina
particles. A stable sBLM, with 20% (w/w) isolated fibroblast membrane proteins,
was formed for both the nanoscale and micron sized alumina particle experiments
and the changes in frequency and dissipation are shown in Figure 5.25A for and
Figure 5.25B, respectively. However, variability in the frequency of the established
bilayer was observed. The addition of DMEM supplemented with 0.1% (v/v) FBS
lowered the frequency slightly, but no overall effect on the dissipation was
measured for both experiments. Upon the addition of 1 µg.ml-1 of nanoscale alumina
particles, a minor decrease in the frequency was measured from -45 Hz to -50 Hz
(Figure 5.25A). A further reduction in the frequency was observed when the alumina
nanoscale particle concentrations of 10 and 100 µg.ml-1 were added to the sBLM.
Chapter 5
248
Indeed the greatest rate in frequency decrease was measured for the highest
particle concentration of 100 µg.ml-1 from -52 Hz to -62 Hz. Furthermore, this
particle concentration also induced a large increase in the dissipation to 16 x 10-6.
Similar results were also observed for the micron sized alumina particles (Figure
25B). A large decrease in the frequency, coupled with a larger increase in
dissipation (24 x 10-6) was measured after the addition of 100 µg.ml-1 micron sized
alumina particles to the sBLM. This change in the frequency and dissipation
stabilised upon the addition of the DMEM supplemented with 0.1% (v/v) FBS. The
binding of alumina micron sized particles to sBLM with 20% (w/w) isolated fibroblast
membrane proteins, in the presence of 10% (v/v) FBS, was repeated. However, it
must be noted that whilst a positive result (a reduction in frequency) was observed,
the overall decrease in the frequency varied between repeats. For example the
decrease in frequency for one repeat was -16 Hz, whilst a frequency of -3Hz was
measured for another repeat.
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Figure 5.25 - QCM-D plot of a solid supported bilayer lipid membrane with
incorporated membrane proteins in the presence nanoscale (A) and micron sized (B)
alumina particles and foetal bovine serum. A sBLM with 20% isolated membrane
proteins from primary HFBs was formed in DMEM onto an oscillating quartz crystal (not
shown) followed by the addition of DMEM plus 0.1% (v/v) FBS. Incremental concentrations
(1 – 100 µg.ml-1) of alumina nanoscale or micron sized particles diluted in DMEM plus FBS
(0.1% v/v) were added at times indicated by the arrows. Changes in the frequency (blue)
and dissipation (red) were measured (Ninth overtone is displayed).
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5.3.6.2 Nanoscale and micron sized cobalt chromium particles
A bilayer was formed consisting of 20% (w/w) isolated fibroblast membrane proteins
from primary HFBs and DMEM supplemented with 0.1% (v/v) FBS was added to the
sBLM, as described previously. In contrast to the alumina results, for the nanoscale
(Figure 5.26A) and micron sized (Figure 5.25B) CoCr particles data, no large
reduction in the frequency was observed. A minor decrease in the frequency was
measured when 1 µg.ml-1 of CoCr nanoscale particles was added to the sBLM.
Similarly a drop in the frequency was observed at the particle concentration of 100
µg.ml-1 for the micron sized CoCr particles (Figure 5.26B). However, overall no
significant changes in the frequency were observed at any particle concentration.
A small increase in the dissipation was observed for the nanoscale CoCr particles,
with increasing particle concentration. A much larger increase in the dissipation was
measured for the micron sized CoCr particles at 100 µg.ml-1 with a 6 x 10-6 increase.
This increase plateaued when the DMEM supplemented with 0.1% (v/v) FBS wash
was added.
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Figure 5.26 - QCM-D plot of a solid supported bilayer lipid membrane with
incorporated membrane proteins in the presence nanoscale (A) and micron sized (B)
cobalt chromium particles and foetal bovine serum. A sBLM with 20% isolated
membrane proteins from primary HFBs was formed in DMEM onto an oscillating quartz
crystal (not shown) followed by the addition of DMEM plus 0.1% (v/v) FBS. Incremental
concentrations (1 – 100 µg.ml-1) of CoCr nanoscale or micron sized particles diluted in
DMEM plus FBS (0.1% v/v) were added at times indicated by the arrows. Changes in the
frequency (blue) and dissipation (red) were measured (Ninth overtone is displayed).
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5.4 Discussion
This part of the study aimed to investigate the effect of alumina and CoCr particles
in the presence of 10% (v/v) FBS, to determine the effect on fibroblast cell viability,
membrane integrity and binding to the cell membrane. Proteins within FBS are
known to bind to surface of particles causing the formation of a protein corona
(Mahmoudi et al. 2011). The bound proteins on the particle surface can change the
surface characteristics and in turn can alter the cellular response to the particles,
such as the effect on cell viability (Rauch et al. 2013).
Studies on the effect of the protein corona on particle toxicity in vitro have reported
conflicting results, with some studies suggesting the presence of serum increases
particle uptake and induce inflammation and cell death (Borgognoni et al. 2015;
Cheng et al. 2015). However, other studies have reported the formation of protein
coronae on particle surfaces generates a protective barrier, thus reducing particle
binding to the cell membrane and inducing lower levels of cell death (Duan et al.
2015; Landgraf et al. 2015; Shang and Nienhaus 2015). The inconsistencies
reported from these studies maybe due to the lack of standardisation between
different methods (Horie et al. 2009). This part of the study aimed to use QCM-D
and vesicle leakage assay techniques to generate a highly controlled environment
in which to explore the role of serum proteins on particle interactions with the
plasma membrane and how this relates to the effects on cell viability of fibroblasts.
5.4.1 The effect of the presence of foetal bovine serum on
particle cell viability
The effect of nanoscale and micron sized alumina and CoCr particles on the cell
viability of L929 fibroblasts in the presence or absence of 10% (v/v) FBS was
investigated. This followed on from an undergraduate final year project exploring the
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role of serum on the cell viability of L929 fibroblasts in the presence of CoCr and
alumina particles (Moisley 2014). However, Moisley (2014) reported large variation
between repeats and therefore, these series of experiments were repeated. The
results from this current study revealed that nanoscale and micron sized alumina
particles induced a greater reduction in the cell viability in the absence of FBS in
comparison to cells cultured with 10% (v/v) FBS. These results suggest that the
formation of a protein corona around the alumina nanoscale and micron sized
particles reduced the cytotoxic effects.
In contrast to the alumina particle results, the absence of FBS seemed to have a
positive effect on cell viability for the L929 cells cultured with CoCr particles
However, it must be noted that after day 2, there was no statistically significant
difference between the cell viability of the fibroblasts cultured with nanoscale CoCr
particles in the absence or presence of FBS. This highlights that the effect of FBS
on particle toxicity is short term and the cells may partly recover over time. Another
consideration is that over the incubation period, the nanoscale CoCr particles, in the
absence of FBS, could have been coated with biological materials from cell
secretions or cell damage and these moieties may have modified particle uptake
and effect cell viability (Lesniak et al. 2013).
No overall difference in the effect of serum on the cytotoxicity of micron sized CoCr
particles was observed over the 5 days of culture, which was in contrast to the
nanoscale CoCr results previously discussed. This suggested that for CoCr, particle
size was the major factor influencing on cell viability rather than the presence or
absence of FBS. Cheng et al. (2015) also reported that particle size had a
significant effect on cell viability and particle uptake of 5, 20 and 50 nm gold
nanoparticles into Raw 264.7 cells cultured in the presence or absence of serum for
24 hours. The formation of protein coronae on the larger particles caused them to
be less readily internalised in comparison to the smaller particles. These authors
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hypothesised that in the presence of serum, particles of different sizes bind to
different domains on the cell plasma membrane. This in turn causes the particles to
be internalised into the cells via different endocytic pathways. For example, using
endocytic inhibitors, Cheng et al. (2015) concluded that 50 nm gold nanoparticles in
the absence of serum proteins would be taken into Raw 264.7 cells via caveolin-
mediated endocytosis. In the presence of serum, the same particles were observed
to be internalised via scavenger receptors.
Alongside particle size, these results suggest that particle cytotoxicity in the
presence of serum is dependent on particle composition. The formation of a protein
corona induced more cytotoxic effects, as in the case of CoCr nanoscale particles,
or alternatively reduced the effects, as seen with the alumina nanoscale and micron
sized particles. Whilst no direct comparisons with the literature on CoCr and
alumina particles can be made, these varying results are consistent with the
reported literature on other particle types investigated in nanotoxicology studies.
Overall, whilst a number of other factors are involved, such as particle size, particle
composition seems to play a major role on particle cytotoxicity in the presence or
absence of serum as described previously (Rauch et al. 2013).
The presence of serum may have influenced the release of Co and Cr ions from the
nanoscale CoCr particles, which in turn could have had an effect on the cell viability.
Cobalt and Cr ions have been demonstrated to significantly reduce the cell viability
of macrophages and osteoblasts over time in vitro, suggesting that the ions as well
as the particles have cytotoxic effects (Catelas et al. 2005; Fleury et al. 2006; Kwon
et al. 2009). Hedberg et al. (2014) demonstrated that Co and Cr ion release from
CoCr particles was greater in the presence of BSA than in the absence of BSA.
Vidal and Muñoz (2011) also revealed that the pH conditions had an effect on CoCr
corrosion in the presence of BSA. At pH 3, BSA had a protective effect on particle
corrosion, however at neutral and alkaline conditions, BSA promoted ion release.
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Furthermore, molybdenum ion release has been reported to be increased in the
presence of BSA (Simoes et al. 2015). Therefore the rate of ions released from the
nanoscale CoCr particles may be higher in the presence of serum and subsequently
have a greater effect on the cell viability. In contrast when in serum free (or reduced
serum) conditions, the ion release is lower and therefore the potential effect on cell
viability is reduced (Hedberg and Wallinder 2014). Further it could be speculated
that this phenomenon may have occurred with the micron sized CoCr particles
cultured with the fibroblasts with or without FBS. It has previously been
demonstrated in vitro that micron sized particles corrode less than nanoscale
particles when internalised within cells (Papageorgiou et al. 2007; Brown et al.
2013). Therefore the effect of ion release on cell viability may be reduced in the
presence of CoCr micron particles compared to nanoscale CoCr particles, which
may explain why no difference in cell viability was observed in the absence or
presence of FBS with micron sized CoCr particles.
One drawback of the cell viability experiments performed in this study is that the
protein coronae formed on the surface of alumina and CoCr particles was not
characterised. Preliminary studies of nanoscale alumina particles using dynamic
light scattering (DLS) demonstrated that particle agglomeration occurred in the
presence of DMEM and DMEM supplemented with 10% (v/v) FBS. However,
agglomerations greater than 1 µm were formed, which is too large for accurate
sizing using DLS. Further experiments could investigate particle agglomeration
under different conditions this using TEM and EDX techniques, as described by
Simoes et al. (2015). This would provide useful information on formation of protein
coronae by analysing the EDX spectra for element peaks representing the particles
(cobalt, chromium or molybdenum) and proteins (nitrogen). Alongside this the rate
of Co and Cr ion release from the surface of clinically relevant CoCr particles could
also be determined in the presence or absence of serum using inductively coupled
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plasma mass spectrometry (ICP-MS). These results would highlight the potential
role of ion and protein complexes and their effect on cell viability.
5.4.2 The internalisation of nanoscale alumina and cobalt
chromium particles into L929 fibroblasts in the absence
or presence of foetal bovine serum
Following on from the cell viability assays, the internalisation of nanoscale and
micron sized alumina and CoCr particles into fibroblast cells were investigated using
TEM analysis. The cell viability experiments revealed that particle composition was
a major influencing factor on cell viability in the presence or absence of FBS.
Therefore, the effect of the presence or absence of 10% (v/v) FBS on particle
uptake was explored to provide an greater insight into the potential mechanisms
involved in particle cytotoxicity and potential effects of proteins on the interactions of
particles with the cell plasma membrane. For these series of experiments, due to
time pressures, only the nanoscale alumina and CoCr particles were investigated as
these represent particles that have been reported to be released in vivo.
The nanoscale alumina particles at particle volumes of 50 and 5 µm3 per cell were
observed within the fibroblasts after 5 days using TEM analysis. Due to the
hardness of alumina, it was technically very difficult to successfully section particle
volumes over 50 µm3 per cell, even with a diamond blade as the presence of a high
particle concentration would cause major tears in the slides. Therefore, it was not
possible to analyse the highest particle volume of 500 µm3 per cell using TEM. The
time point of 5 days was chosen as the largest differences in cell viability results
was observed at this time point, in the presence or absence of FBS. However,
overall no differences in particle uptake were observed between the samples
cultured in the presence or absence of FBS. For all samples, the alumina particles
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were revealed to be within membrane bound vesicles within the cytoplasm of the
cells. Further, the particles were found to form large agglomerates, regardless of
whether the particles were incubated with serum or not. No statistically significant
differences were measured between the particle agglomerates in the presence or
absence of 10% (v/v) FBS, at any particle volume.
Similar results to the alumina particles were also observed for the L929 fibroblasts
cultured with nanoscale CoCr particles. Particle volumes of 50, 5 and 0.5 µm3 per
cell were cultured with L929 fibroblasts in the presence or absence of 10% (v/v)
FBS over 2 days. Again this time point was chosen as the greatest effects on cell
viability results were observed at this time point, in the presence or absence of FBS.
Nanoscale CoCr particles were observed in all samples in the presence and
absence of serum and appeared to have formed large agglomerates. The particles
were also observed within membrane bound vesicles within the cytoplasm of the
cells. However, the aggregates were much larger than those observed for the
alumina particles, and many cells had multiple vesicles of CoCr particles. No
statistically significant differences were measured between the particle
agglomerates, at each particle volume, in the presence or absence of 10% (v/v)
FBS. However, in the presence of serum, at the particle volume of 50 µm3 per cell,
the particle agglomerates were statistically larger than the lower particle volumes of
5 and 0.5 µm3 per cell. Furthermore, in the presence of serum, at the particle
volume of 50 µm3 per cell, the particle agglomerates were statistically larger than
the particle volume of 0.5 µm3 per cell.
These results demonstrated that at higher particle volumes, the particles formed
larger sized agglomerates regardless of the presence of serum. However, due to
time constraints of the project, it was difficult to obtain a large number of images of
particles within cells to size. This was particularly difficult for the lower particle
volumes of 5 and 0.5 µm3 per cell, where as little as 10 cells were observed to have
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particles within the cells. Therefore the conclusions from these results are limited
and would require further quantification.
Occasional particle-like structures were observed in the cytoplasm and nucleus of
the cells which were not bound within vesicles for both the alumina and CoCr
samples. EDX analysis revealed that these structures, for both the alumina and
CoCr samples, were precipitates from reagents used in the sample preparation
process. For example a lead peak in the EDX spectra corresponded to the lead
citrate used in sample preparation. This suggests that in order for the particles to be
internalised within vesicles, the particles are taken up via an active process.
Corroded, cobalt chromium wear particles, which were nearly devoid of cobalt, have
previously been visualised within vesicles of the cytoplasm of macrophages isolated
from the periprosthetic tissues of a patient with a CoCr alloy metal-on-metal hip
resurfacing implant (Goode et al. 2012). Furthermore, CoCr particles have been
reported to be readily taken up and found within vesicles of the cytoplasm by a
variety of cells, including HFBs and macrophages in vitro (Lewis et al. 2007;
Papageorgiou et al. 2007).
At present this study is the only study to have confirmed the internalisation of
alumina nanoscale particles within fibroblasts using TEM. Hashimoto et al (2015)
investigated the internalisation of model alumina particles into macrophages.
Analysis using TEM revealed that the particles were found within the nucleus of the
cells and many particle were not within vesicles. However the authors failed to
confirm the presence of the particles using EDX or equivalent analysis and therefore
particle uptake was not validated.
This series of experiments which investigated the internalisation of alumina and
CoCr particles by fibroblasts revealed no difference in particle uptake regardless of
whether the fibroblasts were cultured in the presence or absence of serum.
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Interestingly, these results do not reflect the results from the cell viability
experiments. Cheng et al. (2015) also reported inconsistencies between cell viability
and cell uptake results for Raw 264.7 macrophages cultured with gold nanoparticles
in the presence or absence of serum. The cell viability results revealed no difference
in the cell viability in the presence of gold nanoparticles with or without serum after
24 hours. However, particles were more readily internalised into the macrophages
when incubated with serum proteins. This indicated that whilst the particles could be
readily taken up by the fibroblast cells, this in itself does not necessarily correlate
with cell viability results. This may suggest that more downstream effects are
occurring, such as ion release into the cytoplasm, or that the particles may be
interacting with the cell plasma membrane differently, depending on the formation of
a protein corona.
5.4.3 The effect of particles on membrane integrity and particle
binding to model membranes in the presence of foetal
bovine serum
As previously described, the cell viability results revealed that alumina and CoCr
particle size and composition induced an effect on fibroblast viability, in the absence
or presence of FBS. Nanoscale alumina and CoCr particles cultured with L929 cells
in the presence and absence of serum were confirmed to be internalised within
vesicles of the cytoplasm using TEM techniques. The interaction of nanoscale and
micron sized alumina and CoCr particles on the interactions with the cell plasma
membrane, in the presence of serum proteins, were investigated. Specifically, the
effect of alumina and CoCr particles on membrane integrity and particle binding in
the presence of serum was explored.
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The effect of nanoscale and micron sized alumina and CoCr particles on membrane
integrity, in the presence of 10% (v/v) FBS, was explored using the vesicle leakage
assay. Lipid vesicles, loaded with an autoquenching dye, were incubated with
particles at concentrations of 1, 10 and 100 µg.ml-1. The release of fluorescent dye
from any damaged vesicles over time was measured and expressed as a
percentage of the positive control, Triton-X 100, which is a detergent that disrupts
vesicles. A dose dependent increase in vesicle leakage was measured for the
nanoscale and micron sized alumina and CoCr particles. However, only the highest
dose of 100 µg.ml-1 of nanoscale alumina and CoCr particles induced significant
damage to the vesicles, in comparison to the FBS only control. Nevertheless, even
at this highest concentration of the nanoscale alumina particles, only 33.5% vesicle
leakage was measured. This particle concentration is approximately five times
higher than the highest particle volume used in the cell viability assays in this study
and hence, is unlikely to be the main mode of particle toxicity.
Currently there is minimal published data on the role of wear particles and the
integrity of the plasma membrane, especially in the presence of serum.
Papageorgiou et al. (2007) reported observing vesicle damage in the presence of
CoCr nanoscale particles in fibroblasts. Nevertheless no vesicle damage was
observed during TEM analysis of the samples used in this current study. Silica and
zinc oxide nanoparticles have been reported to induce pores within the membrane
of A549 lung epithelial cells (Mu et al. 2012; Churchman et al. 2013; Mu et al. 2014).
However, the formation of these pores did not necessarily induce cell death and
therefore it was hypothesised that the formation of pores within the membrane must
be extensive in order to reduce cell viability. Based upon the results from this model
membrane, without the incorporation of isolated membrane proteins, it is unlikely
that the nanoscale and micron sized alumina and CoCr particles, regardless of type
or size elicited membrane damage or that this was a major mode of toxicity.
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The interaction of nanoscale and micron sized alumina and CoCr particles with a
sBLM in the presence of serum were also explored. As previously discussed in
section 5.3.4.1, it was revealed that the FBS rapidly and irreversibly bound to the
sBLM, making analysis of any subtle particle binding events difficult to detect.
Therefore, it was decided to reduce the FBS concentration to 0.1% (v/v) and to
incubate the particles with the FBS, diluted in DMEM, for 16 hours at 37°C. As
previously described, the formation of a protein corona is a continuous process and
overtime consists of a hard and soft corona. This incubation period allowed the
formation of a stable protein corona. As previously described, there is a conflicting
data on the role of serum on particle interactions with the membrane and
subsequent uptake. One of the major reasons for this is the inconsistency between
studies, making direct comparisons difficult. A select number of reports have
recommended the standardisation of in vitro studies on the effect of particles on the
membrane. For example Horrie et al. (2009) recommended the pre-adsorption of
particles with serum before testing, and hence this study follows this
recommendation.
The nanoscale and micron sized alumina and CoCr particles demonstrated no
overall binding to the sBLM in the presence of serum. As stated in chapter four, in
the absence of serum, the particles had an effect on the dissipation at a particle
concentration of 100 µg.ml-1. However, no effect on the frequency or dissipation was
observed at any of the particle concentrations tested here (1 – 100 µg.ml-1). The
presence of serum has also been reported to reduce nanoparticle binding to a
sBLM. Lesniak et al. (2012) reported reduced binding of carboxylated polystyrene
nanoparticles to a POPC sBLM in the presence of serum, using QCM-D.
Furthermore these authors reported that the serum bound irreversibly to the sBLM,
with a large decrease in the frequency. The presence of the serum may have
reduced the number of non-specific interactions of the native particle surface with
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the sBLM, and hence a decrease in particle binding to the membrane. Duan et al.
(2015) reported a reduction in the interaction of graphene oxide nanoparticles with
the cell membrane of A549 lung epithelial cells, again stating that the formation of a
protein corona reduced the exposed surface area of the particles and reduced
particle: membrane interactions. Nevertheless it must be noted that the presence of
protein has been reported to promote particle uptake. For example gold
nanoparticles coated in fibrinogen have been demonstrated to bind with a greater
affinity to the integrin receptor Mac-1 on macrophages than when fibrinogen was not
present (Deng et al. 2011). Therefore particles with a low binding affinity for the lipid
membrane may be more likely to interact with the membrane in the presence of
serum. However, the conclusions from these studies are limited and should be
viewed with caution, as simplified membranes are used, often only consisting of one
type of lipid. In the current study the sBLM used was more representative of the cell
plasma membrane of human fibroblasts, with representative concentrations of types
of lipids and the inclusion of cholesterol. Therefore it can be concluded that in the
presence of serum, no overall binding to the sBLM occurred for the nanoscale and
micron sized alumina and CoCr particles, and that other factors, such as the
presence of specific binding sites, determine particle binding and subsequent
uptake into fibroblasts.
5.4.4 The effect of particles binding to a solid supported bilayer
lipid membrane with incorporated membrane proteins in
the presence of foetal bovine serum
To further increase the complexity and physiological relevance of the model
membrane, membrane proteins isolated from primary HFB and U937 histiocytes
were incorporated into the model lipid membrane. The recovery of isolated
Chapter 5
263
membrane proteins from U937 histiocytes was very low and therefore due to
sample shortage and time constraints, these proteins were only used for the vesicle
leakage assays. The effect of FBS in the presence of the isolated membrane
proteins was explored for nanoscale and micron sized alumina and CoCr particles
using vesicle leakage and QCM-D studies.
The effect of alumina and CoCr nanoscale and micron sized particles on membrane
integrity, for membranes containing isolated membrane proteins from either
histiocytes or fibroblasts was investigated, in the presence of 10% (v/v) FBS. The
vesicle leakage assays revealed a dose dependent increase in membrane damage
for vesicles containing isolated primary HFB proteins, for all particle types, in the
presence of serum. With the exception of the nanoscale CoCr particles, this was
observed for vesicles containing U937 isolated membrane proteins. The increase in
vesicle leakage measured was much lower than the vesicle leakage measured in
the absence of membrane proteins (section 5.3.3). For example 100 µg.ml-1 of
nanoscale alumina particles, incubated with vesicles consisting of 20% (w/w) U937
histiocyte isolated membrane proteins, induced 14% leakage. However in the
absence of isolated membrane proteins, 33% vesicle leakage was measured. This
suggests that the proteins provide a protective effect against particle induced
membrane damage. Again, these results highlight that nanoscale and micron sized
alumina and CoCr particles do not damage the membrane integrity.
The QCM-D studies were performed using a sBLM formed from 20% (w/w) isolated
membrane proteins from primary HFBs. Due to the low yield of isolated membrane
protein from U937 histiocytes, only primary HFB membrane proteins were
investigated. Again, as described in section 5.4.3.1 the particles were incubated
with 0.1% (v/v) FBS for 16 hours at 37°C to allow the proteins within the serum to
coat the particles and form a protein corona. For the alumina nanoscale and micron
sized particles, a reduction in the frequency, accompanied with an increase in the
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dissipation was observed at the highest particle concentration of 100 µg.ml-1. These
observations suggested that particle binding to the sBLM occurred. These results
suggest that particle size for the alumina particle had no effect on particle binding.
Moreover, in order for particle binding to occur, FBS and isolated membrane
proteins from primary HFBs must be present. However it must be noted that with the
alumina micron sized particles interaction with the sBLM was observed, the
changes in frequency and dissipation were different each time the experiment was
repeated. For example a frequency change of -12 Hz was measured for one repeat,
but another only measured -3 Hz. Nevertheless, this study is the first to report that
the presence of serum and proteins within the plasma membrane are key factors in
nanoscale and micron sized alumina particle binding to a human fibroblast model
membrane. These results suggest that alumina particle binding to the plasma
membrane is mediated through the interactions with the proteins within the serum,
which subsequently formed a protein corona. The proteins then act as a mediator to
promote particle binding to the functional groups found on the membrane proteins of
the sBLM.
Nanoparticle uptake via membrane proteins in the presence of serum, have
previously been reported for multiple cell types and particle compositions including
gold, silver and zinc oxide particles (Cheng et al. 2015; Franchi et al. 2015; Shang
and Nienhaus 2015). Fleisher and Payne (2014b) demonstrated that particle
composition can play a key role in particle interactions with the plasma membrane.
In the presence of MEM, supplemented with 10% (v/v) FBS, uptake of cationic
polystyrene nanoparticles was increased in comparison to particles incubated in the
absence of serum in kidney epithelial cells in vitro. In contrast, under the same
conditions, uptake of anionic polystyrene nanoparticles was reduced. This
phenomenon was observed with polystyrene particles of varying diameter and cell
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type, including epithelial and macrophages (Fleischer and Payne 2014a; Fleischer
and Payne 2014b).
No overall binding to the sBLM containing isolated membrane proteins was
observed for the nanoscale and micron CoCr size particles, in the presence of FBS.
These results are in contrast to the QCM-D results for the nanoscale and micron
alumina particles. Interestingly TEM analysis observed the internalisation of
nanoscale CoCr particles into fibroblasts in the absence and presence of serum,
thus suggesting that the particles must interact with the membrane in order to be
taken up by the cells. This could be due to the particles binding to more specific
receptors which not readily available on the sBLM. Potnis et al. (2013) recently
reported that CoCr particles were found to bind to the TLR4 receptors of
macrophages in vitro. Therefore, more specific binding sites could be required for
particle: membrane interactions to occur. Furthermore, the QCM-D experiments
only observed the interactions for a short period of time of 30 minutes and this does
not reflect the timescale used for the cell viability and TEM experiments. It maybe
that over time the CoCr particles can bind to the membrane, however, it can be
concluded that the particles do not readily bind to the membrane. The TEM results
revealed that the nanoscale CoCr particles were located within vesicles of the
cytoplasm of fibroblasts. Another consideration is that once the particles are
internalised within the cells, the particles may induce toxic effects on the cell.
Further the particles within the vesicles could bind to lysosomes. The acidic
conditions of the lysosomes may promote ion release from the particles, which may
induce adverse effects within the cells such as DNA damage (Parry et al. 2010;
Sood et al. 2011). Initial studies demonstrated that CoCr particles at concentrations
greater than 10 µg.ml-1 induced membrane damage at pH 5 using the vesicle
leakage assays. However the extreme pH also caused the vesicle to lyse
Chapter 5
266
irrespective of the presence of CoCr. Therefore future investigations into the
internalisation of CoCr particles require significant optimisation.
It would be expected that in the presence of serum, the alumina particle interactions
with the model membrane would be reduced as the particles were less cytotoxic
than in the absence of serum. This suggests that whilst nanoscale and micron sized
alumina particles bind to the membrane in the presence of FBS and isolated
membrane proteins, the serum proteins do not promote cytotoxic effects. In
contrast, the nanoscale CoCr particles were observed to be more cytotoxic in the
presence of serum, however no binding to the membrane was observed in the
presence of serum. These results further highlight that interactions with the cell
membrane and subsequent uptake in the presence or absence of serum does not
necessarily correlate with the cytotoxic effects observed for fibroblasts.
Furthermore, the discrepancies between cell viability, TEM and membrane
experiments may be due to the sensitivity of the membrane studies. For the vesicle
leakage assay and especially for the QCM-D experiments, the testing conditions
can be carefully controlled, forming a truly protein free environment. Whereas the
TEM and cell viability conditions are unlikely to be completely protein free due to cell
secretions. Therefore the cell viability and TEM results are likely to demonstrate the
effects of reduced protein conditions. Another consideration, which may cause
discrepancies in the results, is the difference in timescales between the various
experiments. For example the particle incubation period with the sBLM is
approximately 30 minutes for the QCM-D experiments, whereas the cell viability
experiments occur over 5 days. In addition to this, the TEM and cell viability assays
used a fibroblast cell line whereas the QCM-D and vesicle leakage experiments
used membrane proteins isolated from primary HFBs. Franchi et al. (2015)
demonstrated differences in particle uptake for silver and titanium dioxide particles
incubated with a fibroblast cell lines and primary cells. The authors hypothesised
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that different membrane proteins on the surface of the cells induced differing binding
affinities. Therefore this must be taken into consideration with the current study.
Future work could extend this study to explore nanoscale and micron sized alumina
and CoCr particle interactions with the cell plasma membrane of more clinically
relevant primary cell types. In addition the differences between phagocytic and
primarily non-phagocytic cells could be investigated.
5.4.5 Conclusion
The role of FBS on nanoscale and micron sized alumina and CoCr particles were
explored. In the absence of FBS, nanoscale and micron sized alumina particles
were reported to significantly reduce the cell viability of fibroblasts in comparison to
cell cultured in the presence of FBS. Interestingly, the opposite was observed for
the CoCr nanoscale particles. However, these results did not correlate with TEM
analysis as no differences in particle uptake were observed in the presence or
absence of FBS for both the nanoscale alumina and CoCr particles.
The presence of serum did not induce particle binding to a sBLM for all particle
types, suggesting that the formation of a protein corona reduced the potential
interactions of the particles with the sBLM. Furthermore, no extensive vesicle
leakage was observed in the presence of serum, even with vesicle containing
isolated membrane proteins. This suggests that the mode of toxicity for both
alumina and CoCr particles is not caused via pore formation in the plasma
membrane.
Interestingly, in the presence of serum, nanoscale and micron sized alumina
particles bound to a sBLM consisting of 20% (w/v) isolated fibroblast membrane
proteins. This suggests that the interaction of the protein corona on the surface of
the particles and the functional groups of the membrane proteins is important for
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particle uptake. In contrast no overall binding was observed for the nanoscale and
micron sized CoCr particles in the presence of serum and isolated membrane
proteins. At present it is unclear what key factors are required to promote CoCr
interaction with the membrane and subsequent uptake. Like the alumina particles
results, this does not correlate with the TEM and cell viability results. This suggests
that the timescales used may have an influence or that CoCr particle require more
specific interactions which are beyond the complexity of the model used. Overall it
can be concluded that particle size does not appear to have an effect on membrane
interactions but rather particle composition is a major influencing factor. However,
particle binding to the membrane does not necessarily induce cytotoxic effects
within fibroblasts.
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Chapter 6
Discussion
Introduction6.1
Hard-on-hard THRs, such as metal-on-metal and alumina ceramic-on-ceramic,
were perceived as attractive alternatives to conventional UHMWPE prostheses for
younger, more active individuals due to the reported low wear rates (Bessette et al.
2003; Dowson et al. 2004). The use of large diameter metal-on-metal THRs and
resurfacing implants were also demonstrated to theoretically improve the range of
motion of the joint (Underwood et al. 2011). However, metal-on-metal THRs,
particularly large diameter bearing prosthesis, such as the ASR implant, have been
associated with adverse reactions in patients such as necrosis of periprosthetic
tissue, delayed-type IV hypersensitivity reactions, and pseudotumours (Pandit et al.
2008; Campbell et al. 2010; Hart et al. 2012). These tissue reactions have been
reported to be associated with the CoCr wear particles and associated ions
released from the implants, however the severity of the adverse reactions did not
necessarily correspond to the wear rate of the implant (Hart et al. 2012; Matthies et
al. 2012). In contrast alumina ceramic-on-ceramic THRs have been reported to be
very low wearing, even under adverse conditions such as rotational or translational
malpositioning (Al-Hajjar et al. 2013a; Al-Hajjar et al. 2013b). Subsequently few
adverse biological effects of ceramic-on-ceramic THRs have been reported in
patients (Esposito et al. 2012).
In vitro studies on CoCr wear particles have revealed cytotoxic and genotoxic
effects, the ability to induce inflammatory responses and oxidative stress in a
variety of cell types (Tkaczyk et al. 2010; Behl et al. 2013; Brown et al. 2013b).In
addition, at very high particle doses, not usually achieved in vivo, alumina wear
particles have been demonstrated to be cytotoxic and genotoxic (Germain et al.
2003; Tsaousi et al. 2010). Nevertheless the number of studies on the effect of
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alumina wear particles in vitro is very limited. This is further compounded by a
number of studies not using clinically relevant wear particles in terms of size,
morphology and composition (Hallab et al. 2000; Dalal et al. 2012). Therefore the
mechanisms of CoCr and alumina wear particle toxicity are not fully understood.
An area of wear particle toxicity that has not been extensively investigated is the
interaction and effect of wear particles on the cell plasma membrane. The cell
plasma membrane plays a particularly important role in the cellular response to
particles and effects whether the particles are internalised or cause membrane
damage (Gill et al. 2012). This area of research is increasingly popular within the
field of nanotoxicology, such as improving drug delivery, and a number of
techniques can be employed to study the effect of wear particles on the cell plasma
membrane. These include the use of biomimetic techniques of QCM-D and SPR,
which provide a sensitive analysis of particle interactions with a model membrane
(Dixon 2008; Mahmoudi et al. 2011). Furthermore, parameters such as the
formation of protein coronas and the incorporation of proteins within the membrane
can be investigated due to the highly controlled environment that these techniques
provide (Mahmoudi et al. 2011).
This project aimed to investigate if nanoscale and micron sized alumina and CoCr
particles were able to damage or passively pass the cell membrane with adverse
consequences.
Generation and characterisation of nanoscale and6.2
micron sized alumina and cobalt chromium particles
The first objective of the study was to generate and isolate nanoscale and micron
sized alumina and CoCr particles for subsequent cell and model membrane
experiments in terms of particle size, morphology, and composition. These particle
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properties have widely been demonstrated to affect cellular responses, such as
cytokine production, genotoxic responses and cell viability (Hallab et al. 2010;
Tsaousi et al. 2010; Sood et al. 2011; Behl et al. 2013; Brown et al. 2013b). The
main findings from this current study are summarised in the following:
 Nanoscale CoCr particles were generated using a simple pin-on-plate wear
simulator, which mimicked the loading and kinematics conditions of the
standard gait cycle (Jin et al. 2000). The isolated nanoscale CoCr particles from
this current study were analysed and a mode particle size of 40 – 49 was
measured. Simulator studies and ex vivo particle studies have reported
nanoscale wear particles of a similar size under standard conditions (Doorn et
al. 1998; Firkins et al. 2001b; Brown et al. 2007; Papageorgiou et al. 2007).
 In order to investigate the effect of particle size on cell viability and membrane
integrity, commercially available micron sized CoCr particles were used. The
mode particle size was measured at 2 – 3 µm, with a mean particle size of 3.26
µm (± SD 1.30 µm). Comparable results to the findings from this study, in terms
of particle size range, morphology and composition, have been reported in the
published literature (Papageorgiou et al. 2007).
 Using sequential filtration techniques, the micron sized alumina particles were
isolated from an alumina powder and a mode particle size of 400 – 449 nm, with
a particle size range of 17 – 1464 nm was measured. As the particle size range
fell within the micron size range, this particle stock was referred to as micron
sized alumina particles to differentiate from the smaller nanoscale alumina
particles. As previously described a bimodal particle size distribution has been
reported for ceramic-on-ceramic THRs (Hatton et al. 2002).
 A commercially available alumina powder was purchased and used for the
nanoscale alumina particles. The particles had a mode particle size of 30 – 39
nm, which was greater than the particle sizes in the published literature of less
than 20 nm (Hatton et al. 2002; Tipper et al. 2002; Germain et al. 2003).
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However comparisons against the micron sized alumina particles were still
investigated.
 Prior to using the nanoscale and micron sized alumina and CoCr particles for
the membrane experiments, the effect of the particles on cell viability was also
measured. Due to the highly reactive nature of the nanoparticles, a false
negative or false positive readout can be generated during cell viability
experiments (Monteiro-Riviere et al. 2009). Therefore, more than one cell type
and using a least two cell assays was used in this current study. Furthermore a
particle only control was also used in all cell viability experiments to measure
the potential interference of the particles with the assay. The presence of
nanoscale and micron sized alumina particles were revealed to increase the
MTT readouts at the highest particle volume. The particle only control corrected
for this. The use of particle only controls, when assessing the effect of particles,
are often not considered within the published literature (Dalal et al. 2012).
 Primary HFBs and a U937 histiocyte cell line were cultured with the particles as
these cell types have been reported to interact and engulf the particles in vivo.
A U937 histiocyte cell line was chosen as only a limited number of cells can be
isolated from human blood and the large numbers of cells were required,
particularly for the QCM-D studies and therefore it was not feasible to use
PBMNCs. The ATPlite and MTT assays were used to measure the effect of the
particles on cell viability.
 The nanoscale and micron sized alumina particles were observed to have
limited effects on the cell viability of both U937 histiocytes and primary HFBs,
using the ATPlite and MTT assays at particle volumes of 0.0005 – 500 µm3 per
cell over five days. The only significant effects on the cell viability were for the
nanoscale and micron sized alumina particles were observed at the higher
particle volumes. Nevertheless, as previously reported, the wear rates of
ceramic-on-ceramic THRs are very low, with wear rates of 0.1 mm3/ 106 cycles
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reported under adverse conditions (Al-Hajjar et al. 2010). Therefore the
likelihood of cells encountering particle volumes as high as those used in these
experiments is very rare. Studies using commercially available alumina particles
have also reported the effect of alumina particles on the viability of a number of
cell types, with most studies also only reporting cytotoxic effects at high particle
concentrations (Catelas et al. 1999; Germain et al. 2003; Hatton et al. 2003;
Granchi et al. 2004; Gutwein and Webster 2004; Dalal et al. 2012).
 The nanoscale CoCr particles were observed to have significant adverse effects
on primary HFB and U937 viability. Overall the results suggested that the
nanoscale CoCr particles had a dose and time-dependent effect on primary
HFB and U937 viability. Studies using the same pin-on-plate simulator method
to generate CoCr particles reported very similar results to this current study
(Germain et al. 2003; Brown et al. 2006; Papageorgiou et al. 2007; Bhabra et al.
2009; Papageorgiou et al. 2014).
 The micron sized CoCr particles only induced a significant reduction in the
U937 and primary HFB viability at the highest particle volume dose of 50 µm3
per cell, when assessed using the MTT assay. Micron sized CoCr particles
have also been reported to have a less of an effect on cell viability of primary
HFBs in comparison to nanoscale CoCr particles (Papageorgiou et al. 2007).
The effect of particles on the cell plasma membrane6.3
In order to investigate the effect of nanoscale and micron size alumina and CoCr
particles on the cell plasma membrane, recently developed methods within the field
of nanotoxicology have been implemented. These include the use of simple vesicle
leakage assays, QCM-D and SPR techniques, which have been used in this current
study (Green et al. 2000; Cho et al. 2010; Mu et al. 2014). In an attempt to make
the model membranes more clinically relevant, the composition of the model lipid
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membrane employed in this study consisted of a phospholipid: cholesterol mixture
similar to the composition of primary HFBs (Schroeder et al. 1984; Mahadik et al.
1994). At present this is the first instance where a model fibroblast membrane has
been used to investigate particle: membrane interactions.
The effect of particles on the binding and integrity of a6.3.1
model lipid cell plasma membrane
Initially, the effects of nanoscale and micron size alumina and CoCr particles on
membrane integrity were investigated using a simple vesicle leakage assay
previously described in the literature (Mu et al. 2012). The results revealed that both
the nanoscale and micron size alumina and CoCr particles induced a minor
increase in the vesicle leakage of the model lipid membrane. The nanoscale and
micron sized alumina particles induced a larger vesicle leakage than the nanoscale
and micron size CoCr particles, whereby the highest nanoscale alumina particle
concentration of 100 µg.ml-1 caused a 16% increase in vesicle leakage. In addition
to this the particle concentrations used in the vesicle leakage assays (up to and
including 100 µg.ml-1) are much higher than the volume concentrations used in the
cell viability assays (approximately 25 fold higher) described in Chapter three and
five and would not be observed within a clinical scenario. Therefore it is unlikely that
the main modes of toxicity for nanoscale and micron size alumina and CoCr
particles are direct damage to the plasma membrane and is unlikely to occur in
vivo.
The binding of nanoscale and micron sized alumina and CoCr particles to model
lipid membranes were also investigated using QCM-D. This technique has recently
been implemented within the field of nanotoxicology and is highly sensitive and can
measure changes in mass as low as 100 pg.cm-2 over the crystal area. (Cho et al.
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2010). The results for the QCM-D experiments revealed that none of the nanoscale
and micron sized alumina and CoCr particles caused a significant reduction in the
frequency at any particle concentrations tested. A reduction in the frequency would
indicate particle binding. An example of binding to a membrane can be observed in
Appendix C and section 1.6.3.2. For all particle types, a rise in the dissipation was
observed with increasing particle concentration. This has been previously described
by Karlsson et al. (2013) for copper nanoparticles in the presence of a sBLM
however, no reasoning or further investigation into the increase in dissipation was
provided by these authors.
To quantify the binding of the nanoscale and micron sized alumina and CoCr
particles to the sBLM, the frequency and dissipation data at all overtones was
modelled using the Voight model. The Voight model is commonly used for QCM-D
studies of sBLMs (Voinova et al. 1999). The modelling outputs for the nanoscale
and micron sized alumina and CoCr particles revealed that stable sBLMs had been
formed. However, the second layer of the model was not characteristic of either
alumina or CoCr particles. Therefore it was hypothesised that the increase in
dissipation may have been caused by an intermediate layer being formed between
the sBLM and the particles, known as a slippage layer (Daikhin et al. 2000). The
presence of the slippage layer would have caused no overall change in the
frequency but may have increased the dissipation outputs. However, it was not
possible to model this using the Voight model as this is limited to modelling only two
layers. Therefore, a complementary technique to QCM-D of SPR was used to
confirm particle binding. Using the nanoscale CoCr particles as an example no
particle binding was observed at the highest particle concentration tested of 100
µg.ml-1 using this technique. These results suggest that the change in dissipation
may have been caused by very weak interactions between particles and sBLM or,
alternatively, a minor disrupting effect on the sBLM without permanent adherence of
the particles.
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The incorporation of fibroblast membrane proteins into6.3.2
the model lipid membrane on the binding of particles
Membrane proteins, isolated from the cell membranes of U937 histiocytes and
primary HFBs were incorporated into the model lipid membrane to further increase
the complexity and clinical relevance of the model. Preliminary experiments
revealed that the optimal protein concentration to form a solid supported planar
membrane was 20%, which was in good agreement with the literature (Dodd et al.
2008). This complex model membrane has not been used in literature and was
considered a novel, clinically relevant model of a human fibroblast cell membrane.
The effect of nanoscale and micron sized alumina and CoCr particles on membrane
integrity in the presence of membrane proteins was investigated using the vesicle
leakage assay. The membrane proteins isolated from U937 histiocytes and primary
HFBs were used in these experiments. For both types of isolated proteins, no
extensive vesicle leakage was observed for the nanoscale and micron sized
alumina and CoCr particles. This suggests that pore formation within the cell
membrane is not the main mode of particle toxicity.
Nanoscale and micron sized alumina and CoCr particle interaction with the sBLM
containing 20% (w/w) isolated membrane proteins was also explored. Due to low
protein recovery rates from U937 histiocytes, only the proteins isolated from primary
HFBs were tested. Again the results for the nanoscale and micron sized alumina
and CoCr particles demonstrated no overall decrease in the frequency. Instead an
increase in the dissipation was observed which was considered to indicate no or
only weak particle binding to the sBLM.
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The effect of serum proteins on the interaction of6.4
particles with a model lipid membrane
This part of the study aimed to investigate the effects of alumina and CoCr
particles, which were cultured with in the presence of 10% (v/v) FBS, to determine
the effect on fibroblast cell viability, membrane integrity and binding to the cell
membrane. Currently there are a limited number of studies that have investigated
the effect of serum on wear particle toxicity as described in section 1.5.4 (Hallab et
al. 2000; Lewis et al. 2007; Vidal and Muñoz 2011; Hedberg and Wallinder 2014;
Hashimoto and Imazato 2015). However, proteins within FBS are known to bind to
the surface of particles causing the formation of a protein corona, which can in turn
alter the cellular responses to the particles, such as the effect on cell viability
(Mahmoudi et al. 2011; Rauch et al. 2013).
The effect of the presence of foetal bovine serum on6.4.1
particle cell viability
The results revealed that particle cytotoxicity in the presence of serum was
dependent on particle composition. Nanoscale and micron sized alumina particles
induced a greater reduction in the cell viability, in the absence of FBS, in
comparison to cells cultured with 10% (v/v) FBS. These results suggest that the
formation of a protein corona around the alumina nanoscale and micron sized
particles reduced the cytotoxic effects. In contrast, the absence of FBS seemed to
have a less of an effect on cell viability for the L929 cells cultured with CoCr
particles at 48 hours. However by day 5, this effect was no longer apparent,
suggesting that the effects were short term and the cells may partly recover over
time. No differences in the effect of serum on the cytotoxicity of micron sized CoCr
particles were observed over the 5 days of culture. This suggested that for CoCr,
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particle size was the another major factor influencing on cell viability rather than the
presence or absence of FBS, whereby the nanoscale CoCr particles were more
cytotoxic than the micron sized particles. The influence of particle size in the
presence of serum has also been described in the literature for gold nanoparticle
uptake into Raw 264.7 macrophage cells. The formation of protein coronae was
reported to decrease particle uptake with increasing particle size (Cheng et al.
2015).
The internalisation of nanoscale alumina and cobalt6.4.2
chromium particles into L929 fibroblasts in the presence or
absence of foetal bovine serum
The internalisation of nanoscale alumina and CoCr particles into fibroblast cells was
investigated using TEM analysis. Based upon the results obtained in Chapter five,
particle volumes and time points which caused a significant reduction in cell viability
were selected. Nanoscale alumina particles at particle volumes of 50 and 5 µm3 per
cell were cultured with L929 fibroblasts with or without 10% (v/v) FBS for 5 days.
Nanoscale CoCr particles at particle volumes of 50 and 5 µm3 per cell were cultured
with L929 fibroblasts with or without 10% (v/v) FBS for 2 days. For both particle
types, at all particle doses tested, no differences in particle uptake were observed
between the samples cultured in the presence or absence of FBS. For all samples,
the particles were revealed to have formed aggregates within membrane bound
vesicles within the cytoplasm of the cells.
Interestingly, these results do not reflect the results from the cell viability
experiments. Cheng et al. (2015) also reported inconsistencies between cell
viability and cell uptake results for Raw 264.7 macrophages cultured with gold
nanoparticles, in the presence or absence of serum. The cell viability results
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revealed no difference in the cell viability in the presence of gold nanoparticles with
or without serum after 24 hours. However, particles were more readily internalised
into the macrophages when incubated with serum proteins. This indicated that
whilst the particles could be readily taken up by the fibroblast cells, this in itself
does not necessarily correlate with cell death.
The effect of particles on membrane integrity and particle6.4.3
binding to model membranes in the presence of foetal
bovine serum
The effect of nanoscale and micron sized alumina and CoCr particles on membrane
integrity, in the presence of 10% (v/v) FBS, was explored using the vesicle leakage
assay. Only the highest doses of 100 µg.ml-1 of nanoscale alumina and CoCr
particles induced significant damage to the vesicles, in comparison to the FBS only
control, again highlighting that it is unlikely to be the main mode of particle toxicity.
The formation of these pores did not necessarily induce cell death and therefore it
was hypothesised that the formation of pores within the membrane was not
extensive enough to reduce cell viability.
Particle binding to a sBLM in the presence of serum was also investigated.
However, FBS rapidly and irreversibly bound to the sBLM, making analysis of any
subtle particle binding events difficult to detect. This also demonstrated that the
QCM-D and model membrane used were able to measure membrane binding.
Therefore, it was decided to reduce the FBS concentration to 0.1% (v/v) and to
incubate the particles with the FBS, in DMEM, for 16 hours at 37°C prior to the
membrane experiments. The nanoscale and micron sized alumina and CoCr
particles demonstrated no overall binding to the sBLM in the presence of serum.
This has also been reported within the literature. For example, Lesniak et al. (2012)
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reported reduced binding of carboxylated polystyrene nanoparticles to a POPC
sBLM in the presence of serum, using QCM-D. It is hypothesised that the serum
binding to the membrane reduces the available sites of interactions of the
membrane for the particles to bind to.
The effect of particles binding to a solid supported bilayer6.4.4
lipid membrane with incorporated membrane proteins in the
presence of foetal bovine serum
Membrane proteins isolated from primary HFB and U937 histiocytes were
incorporated into the model lipid membrane to investigate particle effects on
membrane integrity and binding. Due to the low recovery rates and time constraints,
the isolated membrane proteins from U937 histiocytes were only used for the
vesicle leakage assays. Therefore only proteins from HFBs were used for the QCM-
D experiments.
The vesicle leakage assays revealed minor increases in membrane damage for
vesicles containing isolated primary HFB proteins, for all particle types, in the
presence of 10% (v/v) FBS. However the membrane damage induced by the
particles was low and required particle concentrations much greater than those
observed within the clinical scenario. Again, these results highlighted that
nanoscale and micron sized alumina and CoCr particles did not damage the
membrane integrity.
The QCM-D studies were performed using a sBLM formed from 20% (w/w) isolated
membrane proteins from primary HFBs. The particles were incubated with 0.1%
(v/v) FBS for 16 hours at 37°C, to allow the proteins within the serum to coat the
particles and form a protein corona prior to the start of the QCM-D experiments. For
the alumina nanoscale and micron sized particles, a reduction in the frequency,
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accompanied with an increase in the dissipation was observed at the highest
particle concentration of 100 µg.ml-1. These observations suggested that particle
binding to the sBLM occurred in the presence of FBS and isolated membrane
proteins from primary HFBs. However, it must be noted that with the alumina
micron sized particle interaction with the sBLM was observed, the changes in
frequency and dissipation were different each time the experiment was repeated.
For example a frequency change of -12 Hz was measured in one experiment, but
another only -3 Hz was measured in another. This could be caused by variation in
the structure of the proteins incorporated in the membrane between each repeat.
Nanoparticle binding via membrane proteins in the presence of serum, has
previously been reported for multiple cell types and particle compositions including
gold, silver and zinc oxide particles (Cheng et al. 2015; Franchi et al. 2015; Shang
and Nienhaus 2015). This phenomenon was observed with polystyrene particles of
varying diameter and cell type, including in epithelial and macrophages (Fleischer
and Payne 2014a; Fleischer and Payne 2014b).
No overall binding to the sBLM containing isolated membrane proteins was
observed for the nanoscale and micron CoCr size particles, in the presence of FBS.
Interestingly TEM analysis observed the internalisation of CoCr nanoscale particles
into fibroblasts in the absence and presence of serum, thus suggesting that the
particles must interact with the membrane in order to be taken up by the cells.
Possible reasons for the lack of binding include the particles binding to more
specific receptors, which are not readily available in the sBLM. Potnis et al. (2013)
recently reported that CoCr particles were found to bind to the TLR4 receptors of
macrophages in vitro. Therefore, more specific binding sites could be required for
particle: membrane interactions to occur. Furthermore, the QCM-D experiments
only observed the interactions for a short period of time of 30 minutes and this does
not reflect the timescale used for the cell viability and TEM experiments. It maybe
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that overtime the CoCr particles can bind to the membrane, however, it can be
concluded that the particles do not readily bind to the membrane.
Furthermore, the discrepancies between cell viability, TEM and membrane
experiments may be due to the sensitivity of the membrane studies. For the vesicle
leakage assay and especially for the QCM-D experiments, the testing conditions
can be carefully controlled, forming a truly serum free environment. Whereas the
TEM and cell viability conditions are unlikely to be completely protein free due to
cell secretions. Therefore the cell viability and TEM results are likely to demonstrate
the effects of reduced serum conditions, rather than serum free conditions.
Novelty of current study6.5
The following novel approaches were used in this current study to investigate the
interaction of particles with the model membrane, which are summarised in the
following:
 The effect of nanoscale and micron sized alumina and CoCr particles on
membrane damage using the vesicle leakage assay has not been investigated
previously.
 The interactions of nanoscale and micron sized alumina and CoCr particles with
a model membrane using QCM-D.
 The use of a membrane model, which represents the membrane composition of
fibroblasts has not been studied previously.
 The incorporation of membrane proteins into the model membrane and
subsequent effects on particle induced membrane damage or particle binding
have not been studied in the context of nanoscale and micron sized alumina
and CoCr particles.
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 Similarly, the presence of serum on the model membrane and subsequent
effects on particle induced membrane damage or particle binding have not been
studied in the context of nanoscale and micron sized alumina and CoCr
particles.
Limitations of current study6.6
There are a number of limitations and proposed future experiments, which were
beyond the scope and time frame of this present study. One such limitation is the
use of commercially available nanoscale and micron sized alumina particles within
this present study. Due to the low wear rates of ceramic-on-ceramic bearings,
currently there is no isolation protocol which would isolate sufficient volumes of
particles for the cell membrane experiments. Therefore, it was not feasible to isolate
particles from simulator lubricant. However, for completeness it would have been
ideal to compare the results with particles isolated from serum lubricant.
Furthermore, different alumina composites are currently used in the manufacture of
ceramic-on-ceramic THRs and include ATZ and ZTA (Stewart et al. 2003; Stewart
2010). Future studies could investigate the effect of the different alumina
composites on membrane interactions to determine if there are any differences. No
significant differences have been observed between alumina and zirconia particles
on the macrophage viability, however it would be interesting to determine if this is
also reflected in subsequent membrane studies (Catelas et al. 1999).
A limitation of the cell viability assays is that the effect of Co and Cr ions was not
separately investigated. Ions are known to be released from the bearing surface
and wear particles and have been reported to be cytotoxic, even at physiological
relevant levels (Bhabra et al. 2009; Andrews et al. 2011; Goode et al. 2012; Brown
et al. 2013a; Posada et al. 2014). However, the current study only investigated
CoCr particles and therefore, it cannot be determined if the reduction in cell viability
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was caused by the particles, the release of ions into the surrounding culture
medium, or a combination of both. In addition to this, the effect of ions in the
presence of a protein corona could be investigated. The formation of a protein
corona on CoCr particles has been associated with the accelerated release of ions
into the surrounding medium (Simoes et al. 2015). The release of ions from the
CoCr particles could also be assessed, using TEM and EDX analysis, to determine
if the presence of serum promotes ion release as described by Simoes et al.
(2015).
Another limitation of this present study was that the particles were not confirmed to
be endotoxin free. The nanoscale and micron sized alumina and CoCr particles
were sterilised, using a hot air oven at 190°C for 4 hours, which has been
demonstrated to reliably produce endotoxin free particles (Brown et al. 2006; Sood
et al. 2011; Papageorgiou et al. 2014). However, for completeness it would have
been ideal to have confirmed this.
One of the major limitations of the QCM-D and vesicle leakage studies is that the
timings of the experiments did not reflect the timings used in the cell viability assays
as it is not possible to perform the membrane experiments over a period of days.
Therefore it is difficult to directly compare the results from the membrane studies
with the cell viability or internalisation experiments from Chapter three and five,
respectively. As previously mentioned, the concentration of FBS had to be reduced
from 10% (v/v) to 0.1% (v/v) for the protein corona membrane experiments. This
was due to the FBS binding to the membrane and possibly inhibiting any binding
occurring. Ideally, the membrane experiments would have been performed in the
presence of 10% (v/v) FBS to make comparisons with the cell studies easier.
Furthermore the sensitivity of the QCM-D method meant that it was difficult in some
instances to determine if particle: membrane interactions were occurring or were
due to a possible artefact.
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Future studies6.7
Future studies on certain aspects of this current study could be implemented to
improve the design of the experiments and to further investigate the potential effect
of nanoscale and micron sized alumina and CoCr particles on membrane toxicity.
The findings from this present study revealed that nanoscale alumina and CoCr
particles were internalised into L929 fibroblasts in the presence or absence of 10%
(v/v) FBS. It is not known the proportion of particles were internalised by the cells.
However, these results did not correlate with the cell viability assays of Chapter
five, which suggested that the presence of 10% (v/v) FBS affects the viability of
L929 fibroblasts cultured with the particles. Future studies could investigate this
further and one proposed idea is to explore more closely the localisation of the
particles within the cells. This could highlight the potential mechanisms of particle
toxicity once inside the cells. In the case of the CoCr particles, if they were located
within the lysosomes of the cells, the acidic environment could promote ion release,
which could be a possible mode of toxicity once internalised. One possible method
to explore this hypothesis would be to use specific gold-labelled antibodies for
lysosome or other organelles, which could be observed using TEM (Kuo 2007).
Confirmation of particle localisation as well as antibody binding could be confirmed
using EDX analysis as described in Chapter five.
The results from Chapter five revealed that in the presence of 10% (v/v) FBS,
nanoscale and micron sized alumina particles bound to a tethered membrane
containing membrane proteins, using QCM-D. These results suggested that in
order for alumina particle binding to occur, both 10% (v/v) FBS and membrane
proteins were required. However, this was only observed at very high
concentrations, much greater than those generated under normal conditions by
ceramic-on-ceramic THRs. Future studies could further investigate the potential
particle: protein interactions. The formation of a protein corona could be confirmed
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by analysing particles in the presence or absence of 10% (v/v) FBS using dynamic
light scattering methods as described by Churchman et al. (2013). The main
proteins within the protein corona could also be analysed using a method adapted
from Fleischer and Payne (2014a). In brief, repeated centrifugation steps are
performed on the particles incubated with 10% (v/v) FBS. The supernatant would
be loaded onto a polyacrylamide gel for analysis using electrophoresis and a
Coomassie protein stain performed. The molecular weight of the protein band can
be compared to commonly found proteins within FBS to determine which proteins
bound to the particles. For example the presence of albumin corresponds to a
protein band at 66 kDa. For proteins still bound to the particle surface a SDS wash
could be used to solubilise the proteins for further electrophoresis analysis.
Another future study would be to determine if the nanoscale and micron sized
alumina and CoCr particles are actively taken up into cells. As previously stated,
the nanoscale alumina and CoCr particles were observed within the cytoplasm of
L929 fibroblasts using TEM, However to establish if the particle were taken up via
an active process, the cells could be cultured with the particles at 4°C, as described
by Mu et al. (2012). This drop in temperature would prevent any active cell uptake
to occur. The cells cultured with the particles could then be prepared for TEM
analysis as described in Chapter five and if the particles were no longer located
within the cells or are significant reduced in number, then the particles are more
likely to be actively taken up. Alongside this the use of specific inhibitors of different
types of endocytosis, such as clathrin- and caveolae-mediated endocytosis could
be used as described by Rejman et al. (2004) to determine the uptake mechanism
of the particles.
This present study was unable to determine the specific factors required for
nanoscale and micron sized CoCr particles to interact with the model lipid
membrane. The CoCr particles were demonstrated to be internalised within L929
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fibroblasts. However, the interactions with the membrane were not apparent using
the techniques employed in this study. The interaction of CoCr particles with
membrane proteins isolated from primary HFBs were only assessed using QCM-D.
A limitation of the QCM-D experiments employed in Chapter five is that the
orientation and composition of the proteins within the membrane were not
considered and it is possible that the binding sites for the CoCr particles were not
readily available. However, cell specific responses and particle interactions with
membrane proteins isolated from L929 fibroblasts and U937 histiocytes could also
be investigated. Indeed, TLR-4 receptors have been associated with CoCr particle
induced inflammation, suggesting CoCr particle binding to the membrane is limited
to specific proteins (Potnis et al. 2013). This is a particularly interesting area of
research and could be a potentially important factor in CoCr particle toxicity in
patients. The binding of CoCr particles to the TLR-4 receptor or other specific
membrane receptors could be investigated using the QCM-D and vesicle leakage
methods used in this current study. The TLR-4 could be isolated and incorporated
in the model membrane and the effect on particle: membrane interactions could be
measured via QCM-D. The environment during QCM-D experiments can be tightly
controlled and the addition of certain factors can be investigated. This is particularly
advantageous in comparison to in vitro cell studies whereby the environment in
which the cells are cultured in the presence of the particles can be affected by other
compounding factors. For example, investigating the effect of serum on cell viability
and forming a truly serum-free environment as described previously.
Another proposed method is to investigate CoCr particle interactions with the
plasma cell membrane using QCM-D methods in conjunction with other techniques.
Whilst QCM-D is highly sensitive, this can make analysis of data particularly
challenging. Therefore techniques such as atomic force microscopy and SPR could
be used to provide a greater insight into the interaction of particles with the cell
plasma membrane (Mahmoudi et al. 2011). Dual-Polarization Interferometry (DPI)
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with QCM-D has also been used to investigate protein binding and the combination
of  techniques have allowed the measurement of surface coverage, layer structural
parameters, water content, and viscoelastic properties of the protein layers
(Escorihuela et al. 2015). The combination of DPI and QCM-D could be used to
study particle: membrane interactions as the use of DPI can provide details on
structural changes to the membrane (Escorihuela et al. 2015).
Conclusion6.8
This study aimed to investigate if alumina and CoCr particles were able to damage
or passively pass the cell membrane with adverse consequences. Nanoscale and
micron sized alumina and CoCr particles were characterised using SEM, EDX and
cell viability assays. Using QCM-D techniques the nanoscale and micron sized
alumina and CoCr particles were revealed to not significantly bind to model lipid
bilayers which mimicked the composition of the phospholipid membrane of
fibroblasts. Using vesicle leakage assays, the particles were also observed to not
induce membrane damage, even in the presence of 10% (v/v) FBS and the
inclusion of membrane proteins within the model membrane.
Nevertheless differences in the cell viability of L929 fibroblasts cultured with
alumina and CoCr particles was observed in the absence of serum. Nanoscale
alumina and micron sized alumina particles in the absence of 10% (v/v) FBS, were
revealed to have more of an effect on the cell viability in comparison to cells
cultured in the presence of serum. Interestingly, the opposite was observed for
CoCr particles, whereby the presence of 10% (v/v) FBS caused a more detrimental
effect on cell viability. However, TEM analysis of sectioned cells cultured with
nanoscale alumina and CoCr particles revealed no differences in particle uptake in
the presence or absence of serum.
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Further analysis using QCM-D and a lipid membrane containing fibroblast
membrane proteins revealed that nanoscale and micron sized alumina particles did
bind to the model membrane. This suggests that the formation of a protein corona
and the presence of membrane proteins are integral for alumina particle binding,
regardless of particle size. Furthermore, the effect on cell viability did not correlate
to membrane binding. In contrast no particle binding was observed for the
nanoscale and micron sized CoCr particles, thus suggesting that particle
composition rather than size has a greater impact on the series of experiments
used in this present study. Further investigation is required to determine how the
CoCr particles interact with the cell plasma membrane and elicit cytotoxic effects.
Main conclusions6.8.1
 Nanoscale and micron sized alumina and CoCr particles caused a reduction
in viability of U937 and primary HFBs.
 Nanoscale and micron sized alumina and CoCr particles did not extensively
damage the model membrane by producing pores within the membrane,
even in presence of 10% (v/v) FBS.
 Nanoscale alumina and CoCr particles were internalised within L929
fibroblasts, at particle volumes of 5 μm3 and 0.5 μm3 per cell, respectively.
This suggested that the particles do interact with the membrane in order to
be taken up by the cells.
 No or weak interactions were detected for nanoscale and micron sized CoCr
particles to model membranes of increasing complexity and in presence of
10% (v/v) FBS.
 Nanoscale and micron sized alumina particles were demonstrated to
interact with the model membranes, consisting of 20% (v/v) isolated
membrane proteins and in the presence of 10% (v/v) FBS at particle
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concentrations of 10 and 100 μg.ml-1. This key finding demonstrated that in
order for alumina particles to interact with the cell membrane, a protein
corona must form around the particles.
 Nanoscale and micron sized alumina and CoCr particles did not cause
damage to the membrane and therefore do not contribute directly to particle
toxicity.
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